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CHAPTER I
INTRODUCTION

Fetal alcohol syndrome (FAS) refers to the characteristic anomalies found in the
children born to alcoholic women. It is composed of facial dysmorphology, pre- and
post-natal growth retardation and central nervous system (CNS) abnormalities. FAS is
one of the leading causes of mental retardation in the western world. In the United States
alone, more than 1200 children are born with FAS each year (Abel and Sokol, 1991).
As children grow, facial abnormalities and retarded growth become less marked.
However, CNS abnormalities, especially abnormal behavior, learning and memory
deficits, and mental retardation, become persistent devastating problems.
During the last 20 years, neuroanatomical and neurochemical studies in animal
models of FAS have been performed in order to understand the underlying causes of
abnormal behavior and mental retardation. These studies have shown that many brain
structures and major neurotransmitter systems were abnormally developed. The
serotonergic system, one of the most expansive neurotransmitter systems in the brain, has
been shown to be affected by in utero ethanol exposure at the level of the concentrations
of the neurotransmitter and its metabolites, uptake sites and certain receptors (Rathbun
and Druse, 1985; Druse et al., 1991; Druse and Paul, 1989; Tajuddin and Druse, 1989).
However, the mechanism by which ethanol acts on the developing serotonergic
system is unknown. The purpose of this dissertation is to assess two potential underlying
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mechanisms by which in utero ethanol exposure contributes to the abnormal development
of the serotonergic system. (1) The decreased serotonin (5-hydroxytryptamine, 5-HT)
content in ethanol-exposed fetuses (Druse et al., 1991) could lead to decreased
stimulation of raphe 5-HT1A receptors and astroglial 5-HT1A receptors. Decreased
stimulation of raphe 5-HT1Areceptors may result in altered development of serotonergic
neurons. Decreased stimulation of astroglial 5-HT1A receptors leads to decreased
production of neurotrophic factors for fetal 5-HT neurons (Azmitia et al., 1990;
Whitaker-Azmitia et al., 1990). (2) In addition, a generalized decrease in astroglial
protein synthesis and content (Guerri et al., 1990; Snyder et al., 1992) could lead to
decreased production of important astroglial growth factors, which are essential for
neuronal growth and differentiation. Thus, the hypothesis of this dissertation is that part
of abnormal development of serotonergic system caused by in utero ethanol exposure
may be due to in part a decreased level of essential growth factors such as serotonin
and/or astroglial-derived growth factors.
In order to examine this hypothesis, an in vivo animal model and in vitro cell
culture studies were used. In the in vivo rat model, quantitative autoradiographic studies
were performed. Specifically, I examined the effects of in utero ethanol exposure on the
extent of abnormalities in 5-HT reuptake sites and 5-HT1Areceptor sites in offspring. In
addition, I assessed the possibility that maternal treatment with a 5-HT 1Areceptor agonist,
buspirone, could prevent abnormalities involving 5-HT reuptake and 5-HT 1Areceptors in
ethanol-exposed rats. In in vitro cell culture studies, the effects of ethanol treatment on
the production of astroglial-derived growth factors were studied. Conditioned media from
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control and ethanol-treated astroglia were used to culture fetal serotonergic neurons. The
effects of the conditioned media on the growth of serotonergic neurons was determined.

CHAPTER II
REVIEW OF RELATED LITERATURE

Fetal Alcohol Syndrome (FAS)

Human Studies
A characteristic pattern of anomalies was found in children whose mothers
chronically abused alcohol during pregnancy. These symptoms were described as FAS
(Jones and Smith, 1973). FAS is characterized by facial dysmorphology, growth
deficiency and signs of CNS dysfunction (Jones et al., 1973; Clarren and Smith, 1978;
Clarren et al., 1978; Kyllerman et al., 1985; Aronson et al., 1985; Streissguth et al.,
1988). It has been recognized that all infants exposed to prenatal alcohol may not develop
the full spectrum of symptoms. Affected infants may show symptoms ranging from mild
to severe. The lesser affected infants may be described as having fetal alcohol effects
(FAE). The facial abnormalities in FAS include malformations in the major components
of the face: short palpebral fissures, low nasal bridge, upturned nose, indistinct philtrum,
thin upper lip, and flat midface (Jones and Smith, 1973). Malformations of other organs
also occur in the children with FAS. These include cardiac, genital and renal
malformations (Sandor et al., 1981; Clarren and Smith, 1978). The growth retardation
of FAS children exhibited by decreased weight, height and head circumference, starts
4
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prenatally and persists throughout adolescence (Clarren and Smith, 1978; Golden et al.,
1982; Streissguth et al., 1985). Intrauterine growth retardation is directly proportional
to the degree of maternal alcohol intake (Streissguth et al., 1980).
There are a number of CNS abnormalities associated with FAS. Microcephaly,
reflecting deficient brain growth, has been observed in greater than 80 % of children with
FAS. The microcephaly has a prenatal onset and becomes quite apparent as the child
matures (Clarren and Smith, 1978). Neural tube defects such as anencephaly and
meningomyelocele also occur at a higher rate in FAS children (Freidman, 1982). Other
neurological abnormalities such as altered cerebellar function, hypotonicity and increased
incidence of cerebral palsy and seizure are also found in FAS children (Burd and
Martsolf, 1989; Hanson et al., 1978; Olegard et al., 1979). Behaviorally, newborns born
with FAS usually show irritability, tremulousness, and poor suckling and eye-hand
coordination (Golden et al., 1982; Hanson et al., 1976). Young children with FAS show
hyperactivity, emotional instability, and poor motor skills and eye-hand coordination
(Aronson and Olegard, 1987; Harris et al., 1993; Kyllerman et al., 1985; Steinhausen
et al., 1993). In addition, FAS children have higher rates of speech and language
problems and visual-perceptual problems (Aronson et al., 1985; Greene et al., 1990).
Mental retardation is one of the most common and serious problems associated with in

utero ethanol exposure. IQ studies of FAS children showed an average score of around
65 with a range from 16 to 105 (Streissguth et al., 1988). There is a close association
between the severity of physical abnormalities and the severity of intellectual deficits.
However, brain malformation and intellectual deficits also occur in the absence of
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detectable physical abnormalities in the offspring of moderate drinking mothers (Clarren
et al., 1978; Peiffer et al., 1979; Conry, 1990; Streissguth et al., 1990).

Animal Studies
In human studies it is extremely difficult to separate the effects of alcohol from
other complicating factors because chronic alcoholic women are frequently malnourished,
are heavy smokers, and may abuse other drugs (Abel, 1984). These factors could also
independently affect the fetal development. Animal models make it possible to control
the compounding variables of human research. Among the animal species, mice and rats
have been popularly used to study fetal alcohol effects because of their inexpensiveness
and short gestation periods.
Ethanol is administered in animal models using a number of different methods.
Alcohol has been administered in drinking water (Borges and Lewis, 1982), in a liquid
diet (Barnes and Walker, 1981), by vapor inhalation (Phillips and Cragg, 1982) or by
stomach intubation (Abel et al., 1983; West et al., 1981). Since most animals do not
voluntarily consume sufficient quantities of ethanol to obtain and sustain blood alcohol
levels comparable to those of human alcoholics, administration of alcohol in drinking
water is considered the least preferable procedure. By the intubation method high blood
alcohol levels can be achieved. However, the procedure is stressful and may cause an
irritation of the gastrointestinal tract, which leads to inhibited absorption of essential
nutrients. The intubation procedure has been reported to significantly reduce maternal
body weights compared to rats given the same quantity of alcohol by liquid diet (Vorhees
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and Butcher, 1982). This may have an adverse effect on fetal development that is
unrelated to the direct effect of ethanol. Therefore, the most appropriate method seems
to be a liquid diet procedure which is not stressful to the animal and provides stable
intoxicating blood alcohol levels as well as adequate nutrition. In addition, this method
allows one to control alterations of food intake by using a pair-feeding paradigm.
In the rat model of FAS neonatal alcohol exposure has also been studied because

the first postnatal week of the rat pups is equivalent to the third trimester in humans.
This time period corresponds to the brain growth spurt (Dobbing and Sands, 1979).
Postnatal alcohol exposure in rats has been accomplished using a variety of techniques:
through the milk of lactating alcohol-consuming mother (Abel, 1974), through gastric
intubation (Diaz and Samson, 1980) and artificial rearing (Bonthius and West, 1990;
Grant et al., 1983). The artificial rearing technique seems to be the best because it allows
stable blood alcohol levels and adequate nutrition. This technique involves maintaining
the rat pup in a cup which floats in the 37°C water bath. Alcohol-containing milk formula
is infused into the pup through an implanted intragastric feeding tube.
Many of the symptoms seen in human infants prenatally exposed to alcohol, have
also been found in animal models of FAS (Chernoff, 1977; Randall et al., 1977). These
include microcephaly (Tze and Lee, 1975; Randall et al., 1977; Lancaster et al., 1982;
Miller, 1987), hyperactivity as measured in the open-field (Bond and DiGiusto, 1976,
1977; Branchey and Friedhoff, 1976; Shaywitz et. al., 1979) and impairment in learning
and memory (Abel, 1979; Lochry and Riley, 1980; Shaywitz et. al., 1979). Prenatal
alcohol exposure also impairs maternal behavior in rats. Adult female rats that had been
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exposed to alcohol prenatally, displayed poor nest building and pup-retrieving behaviors
(Hard et al., 1985a).
In addition, ethanol-exposed offspring exhibit abnormalities of neuroendocrine
responses which are associated with hypothalamic neuronal activity. Adrenocortical
responses to stressor or drug challenges were disturbed in rats exposed to ethanol in

utero. These disturbances induced by in utero ethanol exposure were found in two
opposite directions: the stress responses were decreased in both neonatal and prepubertal
ages (Taylor et al., 1986; Weinberg, 1989), but the responses were increased in
adulthood (Weinberg, 1988; Taylor et al., 1982). Male rats exposed to ethanol in utero
had a feminized pattern of sexually dimorphic reproductive (Parker et al., 1984) and
nonreproductive behaviors (McGivem et al., 1984). Fetuses and neonates exposed to
ethanol in utero had a decreased testosterone surge (McGivern et al., 1988, 1993; Redei
and McGivern, 1988). Since testosterone plays a role in the masculinization and
defeminization of sexually dimorphic behavior and brain morphology (Dohler et al.,
1984, 1986), the reduced size of the sexually dimorphic nucleus of the preoptic area
(SDN-POA) in male rats prenatally exposed to ethanol (Barron et al., 1988) may be the
result of a decreased testosterone surge.

In Utero Ethanol Effects on Brain Structures
The evidence that in utero ethanol exposure results in abnormalities of learning
and motor function suggests that ethanol-induced defects may be caused by abnormalities
in the neocortex, hippocampus and cerebellum. Anatomical investigations have confirmed
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this hypothesis.
In prenatal ethanol-exposed rats, the total number of neurons and glia is
decreased in the somatosensory cortex. These changes are accompanied by decreased
neuronal and increased glial cell body size. The noted changes result in a decrease of
overall volume of the somatosensory cortex (Miller and Potempa, 1990). The decreased
number of neurons could be due to either a decrease in neuronal generation, or an
increase in neuronal death, or both. In the cerebral cortex, neurons are generated
between embryonic day (ED; day of insemination= EDO) 12 and ED 21. These neurons
are generated by the proliferation of neuronal precursors particularly within the
ventricular and subventricular zones (Angevine and Sidman, 1961). In ethanol-exposed
rats generation of cortical neurons was decreased between ED12 and ED19, but after
ED19 more neurons were generated (Miller, 1988). Decreased neurogenesis between
ED12 to ED19 corresponds to the decreased cell proliferation in the ventricular zone,
whereas increased neurogenesis after ED19 corresponds to the stimulated cell
proliferation in the subventricular zone (Miller, 1989). Overall neuronal generation in the
cortex of developing ethanol-exposed rats appears to be delayed. In contrast, specific
neurons such as corticospinal neurons are increased in the ethanol-exposed rat offspring.
This suggests that in utero ethanol exposure may also affect the process of axonal
pruning (Miller, 1987).
Disturbed neuronal migration has also been observed. Normally, neuronal
migration occurs in an inside-to-outside pattern, which means that early-generated
neurons reside in deep layers and late-generated neurons migrate along the earlier
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neurons, and ultimately reside in the outer layer of cortex (Angevine and Sidman, 1961;
Rakic, 1972). However, in ethanol-exposed rat offspring, late-generated neurons are
found in the deep cortical layer (Miller, 1988). In addition, dendritic arborization of
cortical pyramidal cells was stunted and less matured by in utero ethanol exposure
(Hammer and Scheibe!, 1981; Schapiro et al., 1984; Stoltenburg-Didinger and Spohr,
1983).
A number of abnormalities have been found regarding hippocampal and dentate
gyms neurons. Anatomical and electrophysiological vulnerability of the hippocampal
formation to the neurotoxic effects of alcohol may contribute to the learning and
cognitive deficits seen in FAS (Hoff, 1988). Although no change was observed in the
number of hippocampal CA3 and dentate gyms (DG) granule cells, the neuronal
connections between CA3 and DG were affected. Mossy fibers are the axons of granule
cells of the dentate gyms innervating pyramidal cells of CA3. The mossy fibers were
hypertrophied in rat offspring exposed to ethanol in utero (West et al., 1981). Prenatal
alcohol exposure also delayed the appearance of complex synapses and multiple synaptic
contacts on single neurons in dentate gyms (Hoff, 1988). In addition to these
morphological disturbances, electrophysiological responses of the hippocampal neurons,
such as long-term potentiation and potassium-induced excitability, were impaired
(Swartzwelder, et. al., 1988). In contrast to the CA3 and DG regions, the number of
pyramidal neurons in the hippocampal CAI region is decreased, and the dendritic
morphology of these neurons is altered in rats exposed to ethanol prenatally (Barnes and
Walker, 1981; Abel et al., 1983). Excitability of the neurons in the CAI region was
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increased in rats exposed to ethanol in utero (Hablitz, 1986; Tan et. al., 1990).
Behaviorally, these rats exhibit impaired passive avoidance learning (Tan et. al., 1990).
In the cerebellum, Purkinje cells are generated prenatally and granule cells are
generated postnatally. Ethanol exposure during the gestation period decreased the number
of Purkinje cells, and delayed both the maturation of those cells and synaptogenesis in
the molecular layer (Volk et al., 1981; Volk, 1984). Purkinje cell loss has been also
shown in rats exposed to ethanol during the neonatal period, a time when these neurons
are in the process of maturation. The influence of neonatal ethanol exposure on the
degree of Purkinje cell loss in different regions correlates with the maturational state of
the cells. The lobules I, IX, and X, in which Purkinje cells tend to mature early, were
the most severely affected. In contrast, lobules VI and VII, in which Purkinje cells tend
to mature late, were the least affected (Bonthius and West, 1990). In contrast to the
hippocampus where no granule cell loss occurred, there is a loss of cerebellar granule
cells in rats exposed to ethanol neonatally (Borges and Lewis, 1983; Bonthius and West,
1990).
Ethanol has been shown to affect neurogenesis, neuronal migration and/or
neuronal cell death (Borges and Lewis, 1983; Bonthius and West, 1990). However, the
effects of ethanol on the development of neurons appear to depend on the brain regions
where the cells are located and the timing of ethanol exposure relative to the birth or
development of the neurons.

In Utero Ethanol Effects on the Development of Serotonergic System
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Neurotransmitters and their receptors play an important role in neuronal activity.
The effects of ethanol on the adult alcoholic brain have been studied in terms of the
metabolism, turnover,

storage and uptake of neurotransmitters,

and receptor

concentration (Rawat, 1974; Walsh et al., 1970; Kuriyama, et al., 1971). Similarly, the
effects of in utero ethanol exposure on the levels of neurotransmitters, their metabolites
and receptors have been studied in developing brains of animal models of FAS in order
to elucidate the underlying causes of the CNS disorders associated with FAS. These
studies have reported that development of many neurotransmitter systems are disturbed
by in utero ethanol exposure (see Druse, 1992 for review). The serotonergic system, the
most expansively distributed system throughout the brain (Tork, 1990), is one of the
affected neurotransmitter systems.
A number of studies suggested that the behavioral changes in FAS may be
associated with altered serotonin activity. In utero ethanol-exposed mice and rats have
shown hyperactivity, aggression, decreased sensory-motor responses and altered maternal
behavior, all of which are signs of decreased 5-HT activity. In fact, the same animals
have decreased brain serotonin content (Krsiak et al., 1977; Hard et al., 1985a, 1985b).
Rat offspring exposed to ethanol prenatally have also been shown to have a significant
decrease in the content of serotonin and its metabolites in its cell body region (the brain
stem) and in its terminal regions, motor and somatosensory cortex at PN19 and PN35
(Rathbun and Druse, 1985; Druse et al., 1991). One of the serotonergic terminal regions,
motor cortex, also has decreased 5-HT uptake sites in prenatally ethanol-exposed rats
(Druse and Paul, 1989). In addition, 5-HT1 receptors are decreased in the motor and
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somatosensory cortex (Tajuddin and Druse, 1989). Cortical 5-HT 2 receptors, however,
are not affected by in utero ethanol exposure (Tajuddin and Druse, 1989a).
Interestingly, the deficit of serotonin in the brain stem, cell body region, has been
found as early as ED15. Since fetal serotonin plays an important role for the development
and maturation of the serotonergic neuron and its target areas (Whitaker-Azmitia and
Azmitia, 1986; Whitaker-Azmitia et al., 1987; Lauder and Krebs, 1978, 1984; Chubakov
et al., 1986), the early deficiency of 5-HT may disturb the outgrowth of 5-HT fibers, and
lead to abnormal CNS development seen in FAS.

Effects of Ethanol on Astrocytes
Astrocytes exert important roles in neuroembryogenesis by promoting neuritic
growth over the astroglial surfaces and by providing trophic factors for the survival and
functional maintenance of neurons (reviewed by Manthorpe et al., 1986). Abnormalities
in the development of radial glial cells and astroglial cell dysfunction caused by ethanol
treatment may contribute to the abnormal CNS development as in FAS. This may happen
by disrupting neurite outgrowth and/or neuronal survival. Radial glial cells transform into
astroglial cells after they serve as guides for migrating neurons (Schmechel and Rakic,
1979). In utero ethanol exposure has been shown to induce premature degradation of
radial glia, and accelerate the transformation of radial glia into astrocytes (Miller and
Robertson, 1993). This may cause abnormal migration of cortical neurons seen in
ethanol-exposed rats (Miller, 1988). Ethanol-exposed astrocytes exhibit abnormal
morphology. They have a smoothened cell surface, less developed processes, decreased
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content of glial fibrillary acidic protein (GFAP) and ultrastructural alterations (Babu et
al., 1994; Davies and Cox, 1991; Mayordomo et al., 1992; Renau-Piqueras et al., 1989).
In addition to the morphological changes, the activity of astroglial glutamine synthetase
has been decreased by ethanol treatment (Babu et al., 1994; Davies and Vemadakis,
1984). 5-HT uptake by astroglial cells was also decreased by ethanol exposure. The
decrement of 5-HT uptake was due in part to decreased protein content in astroglial cells
because 5-HT uptake was reduced to the same extent as astrocytic proteins (Lokhorst and
Druse, 1993b). Astrocytes, cultured in the presence of ethanol, or astrocytes from
ethanol-treated rats, cultured in the absence of ethanol have decreased protein content and
decreased synthesis of DNA, RNA and protein (Babu et al., 1994; Davies and
Vemadakis, 1984; Guerri et al., 1990; Snyder et al., 1992). Since astrocytes are known
to synthesize and secrete neurotrophic factors which are essential for neuronal survival
and growth, any alteration in the synthetic machinery may result in abnormal production
of neurotrophic factors, which, in tum, can cause abnormal development of neurons.

Possible Mechanisms
Many clinical reports have demonstrated that ethanol can induce a wide range of
detrimental effects on the developing fetus. Recently, many possible mechanisms by
which in utero ethanol exposure adversely affects the development of CNS have been
proposed.
These effects of ethanol on the developing fetus could arise indirectly through
the actions on the mother. For example, ethanol could affect maternal hormonal or
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nutritional status, or altered placental function. The placental abnormalities can affect the
developing fetus because it is totally dependent on the maternal oxygen and nutrient
supply through placenta. Decreased placental transport of 14C-valine and placentalfacilitated diffusion of glucose have been observed. The latter has been correlated with
intrauterine growth retardation (Henderson et al., 1981; Snyder et al., 1986). Since
ethanol has been shown to decrease fetoplacental blood flow and cause umbilical artery
spasm (Jones et al., 1981; Altura et al., 1983; Savoy-Moore et al., 1989), fetal hypoxia
has been suggested as a mechanism by which in utero ethanol exposure causes the
abnormal development of the brain (Michaelis, 1990). The regions of cell loss induced
by in utero ethanol exposure include the CAl region of the hippocampus and cerebellar
Purkinje cells (Barnes and Walker, 1981; Volk, 1984). Interestingly, cell loss in these
regions is similar to those induced by hypoxia or ischemia (Jorgensen and Diemer, 1982;
Auer et al., 1989).
Ethanol is a lipophilic molecule which freely crosses the placental barrier
(Waltman and Iniquez, 1972; Idanpaan-Heikkila, et al., 1972; Cook et al., 1975). In the
human, the transfer of ethanol occurs within a minute and the alcohol concentration in
the fetus can be as high as that in the mother (Idanpaan-Heikkila, et al., 1971; Waltman
and Iniquez, 1972). In comparison with adults, fetuses have a relatively low activity of
alcohol dehydrogenase, an ethanol-metabolizing enzyme (Pikkarainen, 1971). Thus,
elimination of fetal alcohol depends on passive diffusion along the concentration gradient
generated by effective maternal elimination of alcohol. Furthermore, it has been also
reported that alcohol elimination from the amniotic fluid takes a much longer time than
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from the maternal circulation (Brien et al., 1983). Thus, ethanol can be present for a
longer period of time in the fetus than in the mother. Indeed, the direct effect of ethanol
on fetal development has been shown in the chick embryo (Heaton et al., 1992). In
addition, an investigation which cultured rat embryos in an ethanol-containing medium
showed impaired development of the fetus in an ethanol concentration-dependent manner
(Brown et al., 1979).
Another possible mechanism by which ethanol can directly affect the fetal CNS
may be through the alteration of either second messenger systems or the level of
neurotransmitters. Neurotransmitters, such as serotonin, dopamine and norepinephrine,
and second messengers, such as cyclic AMP, diacylglycerol, inositol phosphates and ca+ 2
are important mediators of cell proliferation and differentiation (reviewed by Lauder,
1993). In fact, ethanol-exposed fetuses and neonates had a decreased level of cyclic AMP
and decreased cyclic AMP binding to the regulatory subunit of protein kinase A
(Pennington, 1988). 3H-Forskolin binding sites (associated with cAMP) and [3H]-phorbol
ester binding sites (associated with protein kinase C) were increased in the hippocampus
and cortex of rat offspring exposed to ethanol in utero (Nio et al., 1991).
Direct inhibition of protein synthesis in the fetal tissue by ethanol may also
contribute to the damage associated with FAS. In utero ethanol administration has been
shown to inhibit the synthesis of protein, RNA and DNA in fetal and neonatal brain
tissue (Rawat, 1975; Sharma and Rawat, 1989). The neuronal cell loss in ethanolexposed rats may be due in part to decreased DNA synthesis (Michaelis, 1990). In
addition, diminished neuronal growth and differentiation may be related to decreased
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synthesis of proteins such as the astroglial growth factors (Dow and Riopelle, 1985;
Heaton et al., 1992; Walker et al., 1990).

In utero ethanol exposure may alter gene expression. Fetuses of the ethanoltreated mice showed hypomethylation of DNA, and decreased nuclear methylase activity
(Garro et al., 1991). Generally, hypermethylated regions of DNA are not transcribed,
but hypomethylated regions are transcribed (Cedar, 1988). Thus, alterations of DNA
methylation during embryogenesis can affect normal fetal gene expression, and thus fetal
development. In vitro ethanol treatment has been shown to increase gene expression in
neuronal cell lines. In NlE-115 neuroblastoma cells, ethanol increased tyrosine
hydroxylase mRNA expression in a dose-dependent manner (Gayer et al., 1991). Ethanol
also induced the gene transcription of the stress protein, Hsc70, and two related
molecules, GRP94 and GRP78, in the NG 108-15 neuroblastoma x glioma cell line (Miles
et al., 1991; Wilke et al., 1994). In the pheochromocytoma cell line (PC12) chronic
ethanol exposure increased expression and function of dihydropyridine-sensitive calcium
channels and enhanced neurite outgrowth induced by nerve growth factor (Roivainen et
al., 1994). These effects of ethanol appear to be mediated through the activation of
protein kinase C (Roivainen et al., 1994). Altered gene expression by prenatal ethanol
exposure was also demonstrated in in vivo. Myelin basic protein mRNA levels (Kojima
et al., 1994) and the mRNA for insulin-like growth factors I and II (Singh et al., 1994)
were decreased in ethanol-exposed rat offspring.

The Serotonergic Neurotransmitter System
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Serotonin Receptors
Fourteen serotonin receptor subtypes have been identified so far. It has been
recently suggested that serotonin receptors could be classified according to the amino acid
sequence homology, pharmacological properties, and transductional components
(Humphrey et al., 1993). Thirteen serotonin receptor subtypes belong to the G proteinlinked superfamily and one belongs to the ligand-gated ion channel superfamily. Those
which belong to the G protein superfamily can be divided into two subfamilies, the 5-HT1
and 5-HT2 receptor families, based on the second messenger system with which they are
coupled. The 5-HT1 receptor family is linked to the inhibition of adenylyl cyclase and
includes 5-HT 1A, 5-HTrn, 5-HT10 , 5-HTrn, and 5-HTiF· The 5-HT2 receptor family is
linked to the stimulation of phospholipase C and includes 5-HT2A, 5-HT28 , and 5-HT2c.
The serotonin receptors linked to a ligand-gated ion channel are the 5-HT3 receptors. The
other subtypes which are linked to G proteins are 5-HT4, 5-HT5A, 5-HT58 , 5-HT6 , and 5HT7. Among these, three (5-HT4, 5-HT6 and 5-HT7) subtypes are linked to the stimulation
of adenylyl cyclase.
Binding affinity for spiperone was initially used to discriminate high affinity 5HT1A receptors from the low affinity 5-HTrn sites (Pedigo et al., 1981). Now, a more
selective agonist, 8-hydroxy-2-(N,N-dipropylamino)tetralin (8-0H-DPAT), can be used
to label the 5-HT 1Areceptor sites. The regional distribution of 5-HT1Areceptors is similar
in many species including rat, mouse, guinea pig, calf, cat, pig, monkey, and humans
(Pazos and Palacios, 1985; Waeber et al., 1989; Kohler et al., 1986; Pazos et al., 1987).
The highest density of 5-HT1A receptors are localized in limbic structures such as
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hippocampus, septum, amygdala and entorhinal cortex. Astroglia cells in the septum and
hippocampus of adult rats have been shown to express dense 5-HT1A receptors (WhitakerAzmitia et al., 1993). 5-HT 1A receptors are present on the serotonergic cell bodies in
dorsal and median raphe nuclei (Hall et al., 1985; Verge et al., 1985) where they serve
as somatodendritic autoreceptors regulating 5-HT neuronal cell firing activity and thus
serotonin release (Sprouse and Aghajanian, 1987). In the terminal region, for example,
hippocampus and cortex, 5-HT1A receptors are located postsynaptically (Hall et al., 1985;
Verge et al., 1986). These postsynaptic receptors are involved in the modulation of the
release of other neurotransmitters. Stimulation of 5-HT1A receptors enhances acetylcholine
release in the rat cortex (Sinniscalchi et al., 1990). In addition, postsynaptic 5-HT1A
receptors are involved in the hypothalamo-hypophyseal axis. Stimulation of postsynaptic
5-HT1A receptors results in the release of adrenocorticotrophin (ACTH), corticosterone,
corticotrophin-releasing factor, prolactin and

~-endorphin

(reviewed by Van de Kar,

1991).
5-HTrn sites have previously been identified by their low affinity for spiperone.
Few drugs can bind to the 5-HTrn receptors with a nanomolar affinity. 5-HTrn sites are
found only in some species such as rat and mouse brain in which they are densely
localized in the substantia nigra and glob us pallidus (Pazos and Pallacios, 1985; Hoyer
et al., 1985). 5-HTrn sites have been demonstrated to be presynaptic terminal
autoreceptors in the frontal cortex, where they regulate the release of 5-HT (Middlemiss
et al., 1988; Engel et al., 1986). These receptors are also located postsynaptically in the
terminals of cholinergic fibers in the hippocampus, where they modulate the release of
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acetylcholine (Maura and Raiteri, 1986).
5-HT2A receptors are the classical 5-HT2 receptors. Initially PH]-spiperone was
used to label the 5-HT2 sites. A high density of 5-HT2 receptor sites is found in the
cortex. Low levels are present in the hippocampus, caudate, putamen and nucleus
accumbens (Pazos et al., 1985; Biegon et al., 1986). 5-HT2 receptors are involved in the
release of other neurotransmitters in a region-specific way. In the cortex and
hippocampus activation of 5-HT2 receptors inhibits the K+ -evoked acetylcholine release
(Muramatsu et al., 1988), whereas in the striatum 5-HT2 receptor agonists increase the
basal release of acetylcholine and inhibit dopamine release (Bianchi et al., 1989;
Muramatsu et al., 1988a).
The receptors previously named as 5-HT1c have characteristics similar to the 5HT2 receptor family in terms of the nucleotide sequence homology, pharmacological
profiles and second messenger system (Hoyer, 1988; Hartig et al., 1990). The 5-HT1c
receptor has been renamed the 5-HT2c receptor. These receptors are highly localized in
the choroid plexus and control the exchange between CNS and cerebrospinal fluid (Hartig
et al., 1990). Low levels of 5-HT2c receptors are also present in the substantia nigra,
globus pallidus, cortex and olfactory tubercles (Pazos et al., 1985a).
5-HT3 receptors are ligand-gated ion channels, composed of four hydrophobic
transmembrane regions (Maricq et al., 1991). 5-HT3 receptors are localized highly in the
area postrema and some other areas such as cortex, amygdala, hippocampus, nucleus
accumbens, thalamus and hypothalamus (Kilpatrick et al., 1987; Waeber et al, 1989a).
Activation of 5-HT3 receptors facilitates the nonselective movement of monovalent
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cations, resulting in the depolarization of cells (Yakel and Jackson, 1988; Neijt et al.,
1988). Activation of 5-HT3 receptors seems to stimulate the release of dopamine in the
nucleus accumbens and amygdala (Hagan et al., 1990; Imperato and Angelucci, 1989).

Roles of Serotonin in Various Regions

5-HT and the Basal Ganglia
The striatum and substantia nigra (SN) receive serotonergic projections mainly
from the dorsal raphe (Dray et al., 1976; Fibiger and Miller, 1977; Palkovits, et al.,
1974; Steinbusch, 1981a). A majority of 5-HT terminals in the SN appear to be
collaterals of the dorsal raphe-striatal projection (Van der Kooy and Hattori, 1980; Imai
et al., 1986). In the striatum, dorsal raphe stimulation or local application of 5-HT
suppresses spontaneous firing activity of most striatal neurons (Olpe and Koella, 1977).
Selective destruction of 5-HT fibers entering the striatum decreased dopamine turnover
and tyrosine hydroxylase activity within the striatum, suggesting that 5-HT terminals in
the striatum facilitate dopamine transmission (Giambalvo and Snodgrass, 1978). These
observations were extended by behavioral studies. Generally, animals tum towards the
side where nigrostriatal neurons are less stimulated (Pycock, 1980). Striatal infusion of
the serotonergic neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT), facilitated turning
behavior towards the ipsilateral side which implies that destruction of 5-HT terminals
with 5, 7-DHT results in less stimulation of nigrostriatal dopamine neurons (Jacobs et al.,
1977).
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In the SN, dorsal raphe stimulation inhibits the activity of most compacta cells
and some reticulata cells (Fibiger and Miller, 1977). Serotonergic terminals in the SN
synapse onto dopaminergic dendrites (Nedergaard et al., 1988). Microiontophoretic
application of 5-HT increased dendritic calcium conductance of dopaminergic neurons
in SN, which could result in dendritic dopamine release (Nedergaard et al., 1988; Trent
and Tepper, 1991; Williams and Davies, 1983). Dopamine, released from dendrites
following stimulation by 5-HT, may interact with somatodendritic D2 autoreceptors, and
then cause decreased somatodendritic excitability of dopaminergic neurons (Groves et
al., 1975; Bunney and Aghajanian, 1978). Behavioral effects caused by alterations of 5HT transmission in the SN have been studied. Local infusion of 5,7-DHT into the SN
facilitated spontaneous locomotor activity (Carter and Pycock, 1979). Unilateral infusion
of 5,7-DHT or p-chlorophenylalanine (pCPA) elicited turning behavior towards the
contralateral side (Giambalvo and Snodgrass, 1978). Raphe nuclei lesions or pCPA
treatment also facilitated amphetamine-induced locomotor hyperactivity (Costall et al.,
1979). It has been demonstrated that microinjection of the 5-HT uptake blocker,
fluoxetine, into SN exerts an anticonvulsant action in the forebrain (Pasini et al., 1992).
Behavioral studies, thus, suggest that 5-HT terminals in the SN play an important
inhibitory role in controlling motor behavior.
In the basal ganglia the actions of 5-HT appear to be modified by other
neurotransmitters and 5-HT itself. Several neurotransmitters such as glutamate, GABA,
substance P, acetylcholine, and dopamine have been shown to modify 5-HT release in
the SN (Reisine et al., 1982; Soubrie et al., 1981; Hery et al., 1980). For example, SN
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contains high levels of GABA, which is localized in nerve terminals of the striato- and
pallido-nigral neurons (Di Chiara et al., 1980; Ribak et al., 1980). GABA tonically
inhibits 5-HT transmission in the SN (Soubrie et al., 1981) through GABA receptors
located on nigral 5-HT terminals (Gale, 1979). 5-HT itself released from dendrites in the
raphe nuclei controls the terminal 5-HT release in the SN through the activation of the
somatodendritic autoreceptors (Adell et al., 1993; Ferre and Artigas, 1993).

5-HT and the Hippocampus
Although the hippocampus receives fibers from both the median raphe and dorsal
raphe, the median raphe is its major source of serotonergic innervation (Azmitia and
Segal, 1978). 5-HT fibers from the median raphe project to the Comu Ammons (CA)
areas and polymorphic layers of dentate gyrus (DG) where they innervate calbindin- and
calretinin-containing GABAergic neurons (Freund et al., 1990; Acsady et al., 1993).
Dorsal raphe neurons project to the molecular layer of DG where 5-HT fibers innervate
dendrites of the granule cells (Azmitia and Segal, 1978).
Either stimulation or application of 5-HT to the median raphe elicits long lasting
inhibition of spontaneous activity of hippocampal pyramidal cells through an increase in
potassium conductance (Segal, 1975, 1976; Beck and Choi, 1991). Lesioning of
hippocampal serotonergic innervation results in hyperexcitability of granule cells in DG
(Richter-Levin et al., 1994).
The hippocampus appears to play an important role in the learning and memory
process. The long-term potentiation (LTP) of synaptically evoked responses, believed to
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be the cellular mechanism of learning and memory, has been described in a number of
excitatory pathways in the hippocampus (Bliss, 1979; Milner, 1972). LTP can be
recorded in the granule cells of DG and in the pyramidal cells of the CA3 by the
electrical stimulation of the perforant path and mossy fibers, respectively. Studies with
serotonergic fiber lesioning and raphe tissue grafts confirmed that serotonergic
modulation of hippocampal activity is important in cognitive function. LTP in the DG
was decreased in the rats treated with 5,7-DHT (Bliss et al., 1983). The activation of 5HT3 receptors seems to inhibit the induction of LTP in the CA3 (Maeda, et al., 1994).
Lesioning of hippocampal serotonergic innervation results in impairment of spatial
learning (Richter-Levin et al., 1994). There is a recovery of learning when rap he tissue
is grafted into the hippocampus of animals which had combined serotonergic and
cholinergic lesions (Richter-Levin et al., 1993). However, these results were not
consistent. There is a report that serotonergic deafferentation of the hippocampus
enhances spatial discrimination learning in rats (Altman et al., 1990).

5-HT and the Amygdala
The amygdala receives serotonergic inputs from both rostral and caudal raphe
groups. Especially, the basolateral nucleus of the amygdala uniformly receives dense 5HT input from the dorsal raphe (Imai et al., 1986). Electrical stimulation or iontophoretic
application of 5-HT on dorsal raphe inhibited the spontaneous firing of amygdaloid cells
(Wang and Aghajanian, 1977). This inhibition was prevented in 5,7-DHT or pCPA
treated

rats. A marked decrease of 5-HT and 5-HIAA in pCPA-treated rats was
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associated with increased sexual activity and aggressive behavior (Ferguson et al., 1970).
Also, lesions of the amygdala showed alterations in sexual and aggressive behavior
(Goddard, 1964). The inhibitory influence of dorsal raphe nucleus on amygdaloid cells,
thus, has been

connected with its important influence over sexual and aggressive

behavior.

5-HT and the Lateral Hypothalamus
The lateral hypothalamic area contains medial forebrain bundle and the lateral
hypothalamic nucleus (Sipe and Moore, 1977). The lateral hypothalamic nucleus (LHN)
receives input from the brainstem reticular formation, medial hypothalamus, other lateral
hypothalamus and basal forebrain (Millhouse, 1969; Nauta and Haymaker, 1969;
Raisman, 1970). The neurons of LHN project into the adjacent medial hypothalamic
zone. The LH is involved in the regulation of behaviors such as feeding (Baillie and
Morrison, 1963; Teitelbaum and Epstein, 1962), locomotor activity (Balagura et al.,
1969; Gladfelter and Brobeck, 1962), sensorimotor integration (Marshall et al., 1971;
Turner, 1973) and reward (Ols, 1973: Rolls, 1975). LH also contains serotonergic
terminals (Moore, et al., 1978; Steinbusch, 198la; Heym and Gladfelter, 1982; Kai et
al., 1988). 5-HT in LH plays an inhibitory role in food intake (Blundell, 1979; Coscina
et al., 1972).

5-HT and the Septum
The septum is a part of the limbic system (Kohler et. al., 1982; Swanson and
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Cowan, 1979) and is involved in the process of learning and memory, and
neuroendocrine and autonomic regulation (De France, 1976). The septum can be divided
into two parts, the lateral septa! and the medial septa! nuclei (Raisman, 1966; Chafetz
et al., 1981). The lateral septum contains dense 5-HT terminals whereas the medial
septum receives 5-HT fibers en route to other parts of the septum (Dinopoulos, et al.,
1993; Kohler et al., 1982). The lateral septum sends efferents to dorsal and medial raphe
nuclei (Staiger and Nurnberger, 1991). Functionally, 5-HT in the lateral septum seems
to play a role in memory consolidation. Direct infusion of the 5-HT uptake blocker,
fluoxetine, into the lateral septum enhanced memory in rats (Lee et al., 1992). In the
medial septum 5-HT appears to be involved in the regulation of neuronal discharge of
both the medial septum and hippocampus. Some neurons in the medial septum discharge
in an irregular manner which is synchronous with hippocampal theta spikes (Apostol and
Creutzfeldt, 1974). Repetitive stimulation of the median raphe nucleus disrupts the
bursting discharge of septa! neurons and hippocampal theta spikes (Assaf and Miller,
1978).

5-HT and the Frontal Cortex
Serotonergic fibers innervate whole cortex, but the motor regions in the frontal
lobe receive a lower extent than other cortical areas (Azmitia and Gannon, 1986).
Laminar distribution of 5-HT fibers in monkeys shows that the highest densities are in
layer I and IV (Azmitia and Gannon, 1986; Morrison et al., 1982). In adult rat brain,
serotonergic fibers are localized in layer V whereas layer IV is densely innervated in the
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developing brain (Blue and Molliver, 1985). 5-HT fibers projecting to cortex have been
distinguished by the morphology and origin (Kosofsky and Molliver, 1987; Tork, 1990).
One type is the thick fibers with large, spherical varicosities. These fibers arise from the
median raphe nuclei and innervate equally to parietal, occipital and frontal cortex
(O'Hearn and Molliver, 1984). Another type of 5-HT fibers is the thin fibers with small
varicosities. These axons arise from the dorsal raphe nucleus and project heavily to
frontal cortex (O'Hearn and Molliver, 1984). The exact functional role of dual
serotonergic projections to the frontal cortex is unknown. However, serotonergic
projections from the dorsal raphe nucleus to the frontal cortex could be involved with
basal ganglia-motor system since frontal cortex is associated with motor function and DR
nucleus also project to the caudate putamen (Steinbusch et al., 1980, 1981b). Additional
studies suggest that the serotonergic system in the frontal cortex is associated with
affective disorders and cognitive function (Stanley and Mann, 1983; Stanley et al., 1982;
Bennett et al., 1979; Morris et al., 1993).

Development of The Brain Serotonergic System

Ontogeny
5-HT containing neurons in the rat brain first appear at the ventricular zone along
the border between the metencephalon and the rostral myelencephalon, and develop as
bilateral superior and inferior cell groups (Lidov and Molliver, 1982; Wallace and
Lauder, 1983; Aitken and Tork, 1988). Autoradiographic studies showed that
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neurogenesis of 5-HT neurons in the superior cell groups occurs between EDll and
ED 15 in the rat. 5-HT immunopositive cells in the superior cell group can be identified
as early as ED12 (Lauder and Bloom, 1974; Levitt and Moore, 1978; Lidov and
Molliver, 1982; Lauder et al., 1982; Aitken and Tork, 1988). The results of
immunohistochemistry and [3H]-thymidine autoradiography studies indicate that
serotonergic neurons synthesize their transmitter soon after they have completed their
terminal mitosis (Lauder et al., 1982). 5-HT neurons in the superior cell group then
differentially migrate during ED14 - ED19 to form subgroups of cells. These subgroups
correspond to rostral raphe nuclei; dorsal raphe, median raphe, caudal linear raphe
nuclei, and the B9 group in the adult rat brain. Midline fusion of bilateral superior cell
groups starts at ED18.
In contrast to the superior cell group, 5-HT immunoreactive cells in the inferior
group are first detected at sites away from the ventricular zone around ED 14 in rat
embryo (Lidov and Molliver, 1982). Thus, inferior 5-HT cells seem to complete much
of their initial migration prior to the onset of phenotypic expression. These inferior cells
give rise to the raphe magnus, raphe obscurus, and raphe pallidus and B3 group, found
in the medulla of adult rat brain. Around the end of the embryonic period changes in the
surrounding brainstem structures re-shape both the superior and inferior 5-HT cell groups
to resemble that of adult 5-HT nuclei (Aiken and Tork, 1988; Lidov and Molliver,
1982). In addition, most of these 5-HT neurons acquire more complex dendritic trees and
undergo decreased cellular packing density.
Nearly all ascending projections of the raphe nuclei are derived from the rostral
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group of 5-HT neurons, whereas neurons in the caudal group give rise to the majority
of descending fibers. Ascending projections seem to begin at ED13 and enter the basal
forebrain as axons in the medial forebrain bundle (MFB) (Lidov and Molliver, l 982a;
Lauder, 1990). According to the whole mount study of Aiken and Tork (1988), the 5-HT
fibers contained within the MFB appear to be segregated into medial and lateral
components which project to different regions of the forebrain. The medial part of the
MFB contains fibers destined for the frontal pole of the telencephalon, whereas the lateral
part contains fibers which project medially into the hypothalamus and cross in the
supraoptic commissure. 5-HT axons reach the vicinity of all structures in the brain that
are to receive a serotonergic innervation by ED19 and arrive at the cerebral cortex by
the end of gestation. However, parieto-occipital areas of the cerebral cortex remain
devoid of 5-HT fibers until the first postnatal week. The branching or arborization of
axon terminals develop during the postnatal period. Initial development of ascending 5HT axons seems to follow a very circumscribed and directional growth. In all primary
sensory areas of the cortex, dense patches of serotonergic innervation are seen in the rat
brain from the neonatal period to postnatal day 21. This innervation pattern becomes
more uniform in the adult rat neocortex (D' Amato, et al., 1987). By adulthood, 5-HT
axons ramify extensively and innervate most of the brain (Steinbusch, 1981).
Descending projections from the caudal raphe nuclei to the spinal cord course in
the marginal zone along the ventricular and lateral funiculi and adult pattern of cord
innervation seems to be achieved by postnatal day 21 (Rajaofetra et al., 1989).
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5-HT Synthesis
Although 5-HT-containing neuroblasts first appear as early as the twelfth day of
gestation in the rat central nervous system, as shown using histofluorescence and
immunohistochemistry (Olson and Seiger, 1972; Lauder et al., 1982; Lidov and
Molliver, 1982), measurable amounts of 5-HT are first detected at ED15 (Liu et al.,
1987). This low concentration of 5-HT remains almost constant until the end of gestation.
At birth, the concentration of whole brain 5-HT increases dramatically (Liu, et al., 1987;
Herregodts, et al., 1990). However, its levels are still 25-50% of those in adult rats
(Zeisel et al., 1981; Baker and Quay, 1969; Lauder and Bloom, 1974; Tissari, 1973).
5-HT levels in the cell body and terminal regions show differences in the developmental
profile. In the brain stem, the cell body region, 5-HT levels at birth are 32-75 % of those
found in the same region of adult rats (Bourgoin et al., 1977; Nomura et al., 1976). The
levels increase progressively till the end of the third postnatal week to a value slightly
higher than those of adult rats. After that they level off to the adult level. In the
forebrain, one of the terminal regions of 5-HT neurons, 5-HT levels at birth are about
22 % of those in adult rat brain. 5-HT levels increase much more slowly in the forebrain
region than in the brain stem, and are only 75 % of the adult levels at the end of the fifth
postnatal week (Bourgoin et al., 1977).
The developmental changes in 5-HT content seem to parallel the changes in the
activity of tryptophan hydroxylase (TPH), the rate-limiting enzyme in the synthesis of
5-HT (Schmidt and Sansers-Bush, 1971). Low levels of whole brain TPH activity have
been detected at ED16 with in vitro assay (Renson, 1973) and ED15 with in vivo assay
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(Liu et al., 1987). At birth, brain stem TPH activity is about 30-50% of that in adult rats
(Deguchi and Barchas, 1972; Hamon and Bourgoin, 1982). The activity rapidly increases
and reaches peak activity at the end of third postnatal week. It then decreases to adult
levels (Park et al.,1986; Hamon and Bourgoin, 1982; Deguchi and Barchas, 1972). In
the terminal regions, TPH activity is much lower than that in the cell body region, and
reaches adult levels at around postnatal day 30 (Park et al., 1986; Hamon and Bourgoin,
1982; Deguchi and Barchas, 1972). The apparent Km of the TPH in the newborn is about
twice as high as in adult rats. The concentration of tryptophan, the substrate for TPH,
is very high in the brain of newborn rat. For the first 2 days following birth, the brain
tryptophan concentration is four to eight times higher than in adult rats (Zeisel et al.,
1981; Bourgoin et al., 1974). In the adult brain, the tryptophan concentration is between
30 and 40 µM which is close to the Km value (50 µM) of TPH (Kaufman, 1974). The
ratio of the tissue concentration of tryptophan to the apparent

~

of TPH is considered

as an index of the saturation state of the enzyme (Bourgoin et al., 1974). Although the
affinity of TPH is low in neonate brain, the enzyme is in a highly saturated state
compared to that of the adult because the concentration of the substrate is very high in
the neonate brain.
Such a high concentration of tryptophan is characteristic of the developing brain.
The high tryptophan is due in part to the high activity of the tryptophan carrier in brains
of newborn rats. In addition, the binding of circulating tryptophan to serum albumin is
extremely low during the early postnatal period (Bourgoin et al., 1974). Therefore, free
serum tryptophan is almost totally available for the tryptophan carrier. The increased
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activity of the tryptophan carrier seems to be associated with an increased V

max

since the

apparent affinity of the tryptophan uptake carrier is similar to that of adults (Hamon and
Bourgoin, 1979).

5-HT Metabolism
5-HT is taken up by the serotonin transporter after it is released from the neuron.
It is then degraded to 5-hydroxyindolacetic acid (5-HIAA) by monoamine oxidase

(MAO). In vitro synaptosomal uptake of 5-HT increases rapidly in various brain regions
for the first 2 weeks following birth (Kirksey and Slotkin, 1979). The Km values for 5HT reuptake are indistinguishable from adult values (Nomura et al., 1976). The
increment in the 5-HT reuptake in the developing brain has been associated with an
increase in the number of nerve endings or reuptake sites per ending (Kirksey and
Slotkin, 1979) during the critical period of a developmental stage of the rat brain
(Davison and Dobbing, 1968).
The level of 5-HIAA is higher than that of 5-HT in the developing brain of rats.
5-HIAA levels can be detected at ED17 and increase significantly around birth (Ribary
et al., 1986). At birth, 5-HIAA levels are already as high as that of adults in the brain
stem and about 50% of the adult value in the forebrain (Bourgoin et al., 1977). 5-HIAA
levels increase progressively during the first three postnatal weeks in both the brain stem
and the forebrain. Especially in the brain stem, the levels are significantly higher (85 %)
than adult values at the end of the third postnatal week (Bourgoin et al., 1977; Zeisel et
al., 1981). Thereafter, the levels decrease to adult values by the sixth postnatal week.
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The ratio of 5-HIAA/5-HT is very high during the fetal period and the first three
postnatal weeks. During this period the ratio of 5-HIAA/5-HT remains two to four times
higher than in adult rats (Herregodts et al., 1990; Bourgoin et al., 1977). In adult rats,
the ratio of 5-HIAA/5-HT is dependent on the electrical activity of serotonergic neurons
(Aghajanian et al., 1967). Similarly, the high value of the 5-HIAA/5-HT ratio in young
brain may be the consequence of an enhanced rate of neuronal firing. However, the
neurons of the dorsal raphe in neonate brain showed a regular discharge pattern, and the
firing rate is not significantly different from that of the adult neurons (Lanfumey and
Jacobs, 1982; Gallager, 1982). Alternatively the high turnover of 5-HT in the young
brain may be due to either poor storage capacity of vesicles or enhanced enzymatic
degradation. However, poor storage capacity may not play a role in the high turnover
of 5-HT in newborn rat brain, since the conversion of PH]5-HT into [3H]5-HIAA is
faster in the newborn than in adult rats even after reserpine treatment, which depletes 5HT storage capacity in tissues (Bourgoin et al., 1977). Rather, the high rate of enzymatic
degradation of 5-HT seems to be the main cause of the high 5-HT turnover in developing
rat brain. In fact, monoamine oxidase (MAO) activity peaks around birth. At ED15, total
activity of MAO is composed of an equal proportion of MAO type A and type B (Liu
et al., 1987). The activity of MAO A increases faster than that of type B. The high MAO
A activity found in young rats seems to be associated with a high Vmax (Nelson et al.,
1979). The apparent affinity of MAO A for 5-HT does not change significantly
throughout the development (Bourgoin et al., 1977).
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Receptors
In the human brain, 5-HT 1A binding shows a prenatal peak (Bar-Peled et al., 1991)
and decreases with age in the cortex, hippocampus and raphe nuclei (Dillon et al., 1991).
However, in the rat brain, the levels of 5-HT1A receptors in the cortex, hippocampus and
septum, are increased during the first three weeks after birth (Daval et al., 1987; Gozlan
et al., 1990). In the cerebellum, high levels of 5-HT1A receptors are present at birth but
disappear with age, suggesting that 5-HT1A receptors are involved in the regulation of the
brain development (Daval et al., 1987; Hamon et al., 1990). Transcripts of 5-HT1A
receptors are detected as early as ED 12 in the rat. The level of transcripts reaches its
maximum concentration at ED 15 and decreases progressively to very low concentrations
at ED20 (Hillion et al., 1993). Even though the level of 5-HT 1A receptor mRNA at
postnatal day (PN) 18 is higher than at ED18, its level is still markedly lower than at
ED15.
In the developing rat brain, 5-HT 18 receptors appear in a vibrissa-related pattern
in the primary somatosensory cortex. This pattern is no longer present in the adult brain
(Leslie et al., 1992). The developmental profile of the 5-HT18 receptor is closely matched
to that of 5-HT fiber immunoreactivity, which implies 5-HT 18 receptors are expressed in
the terminals of the developing 5-HT fibers (Leslie et al., 1992). The expression of 5HT18 receptor mRNA is detected at ED17 in whole brain (Voigt et al., 1991). The
mRNA level is unchanged during development, whereas high levels of 5-HT 18 receptor
mRNA are expressed in the striatum, thalamus, and cerebellum at birth up to PN 12 and
then remarkably decreases at adulthood (Voigt et al., 1991).

35
The 5-HT2 receptors are present prenatally in the rat cortex, hippocampus,
caudate, pontine tegmentum (Morilak and Ciaranello, 1993). The expression of 5-HT2
receptors in the developing brain parallels mRNA levels. 5-HT 2 transcripts are detected
as early as ED14 (Hellendall et al., 1993), and the expression of 5-HT2 receptor mRNA
in whole brain increases 13-fold between ED 17 and PN 5 (Roth et al., 1991). The
increase of the number of 5-HT2 receptors is about 8-fold between ED 17 and PN13 and
then the number is reduced by 50% at PN 27 (Roth et al., 1991). These 5-HT2 receptors
in immature brain are functionally active. 5-HT2 receptor-induced phosphatidyl inositide
breakdown was greater in immature rat cortex than in adult (Claustre et al., 1988). 5HT1c receptor mRNA is also detected at ED14 (Hellendall et al., 1993). 5-HT 1c receptor
levels increased 2-fold between ED17 and PN13 and its mRNA levels increased 5-fold
between PN2 and PN13 (Roth et al., 1991).

Serotonin as a Developmental Signal
In the developing brain, monoamine neurotransmitters appear early, especially one
to several days before the generation of their target cells (Lauder and Bloom, 1974).
These monoamines are believed to act as developmental signals in fetal brain before they
act as neurotransmitters. Neurotransmitters seem to be released from the growing axon
terminals into the surrounding environment (Hume et al, 1983; Young and Poo, 1983).
They regulate neurite outgrowth of neighboring axons and the morphology of target cells
during development (Handa et al., 1986; Lankford, 1987).
The specific actions of serotonin as an extrinsic factor for the growth cone have

36
been demonstrated in cultures of identified neurons from the CNS of the snail helisoma.
Application of serotonin to the culture medium inhibited growth cone motility, neurite
elongation and electrical synaptic connections of identified snail buccal neurons (Haydon
et al., 1987; McCobb et al., 1988). Altered 5-HT fiber growth was also observed in the
snail nervous system by treating snail embryo with 5,7-DHT, which transiently lowers
5-HT levels (Goldberg and Kater, 1989).
Serotonin also regulates the growth of its own neurons (Whitaker-Azmitia and
Azmitia, 1986). In co-cultures of fetal serotonergic neurons and target cells, low
concentrations of 5-methoxytryptamine (5-MT) inhibited the growth of 5-HT neurons,
whereas high concentration of 5-MT stimulated the growth of 5-HT neurons. These dual
effects of serotonin on the growth of its own neurons were also demonstrated in whole
animal studies, in which 5-HT terminal density was decreased with a low concentration
of 5-MT treatment and increased with a high concentration of 5-MT (Shemer et al.,
1991). Serotonin has been shown to initiate and autoamplify its own synthesis in
embryonic hypothalamic neurons (De Vitry et al., 1986). The autoregulatory function of
5-HT is further demonstrated by the observation that Drosophila mutants, incapable of
5-HT synthesis, exhibit altered branching of serotonergic axons (Budnik et al., 1989).
The involvement of 5-HT in the target cell morpho-functional development was
demonstrated in organotypic cultures. When 5-HT was added to cultured neurons from
5-HT target tissues (e.g. cerebral cortex or hippocampus), it stimulated growth and
differentiation of neurons, and enhanced synaptogenesis (Chumasov et al., 1980;
Chubakov et al., 1986). The role of 5-HT in the target cell differentiation in vivo has
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also been studied by manipulating the content of 5-HT in the embryonic brain. Maternal
administration of pCPA, a 5-HT synthesis inhibitor, delayed neurogenesis of 5-HT target
cells (Lauder and Krebs, 1978).
These actions of 5-HT as a developmental signal seem to be mediated through 5HT receptors in the developing brain. 5-HT receptors are expressed in the fetal brain
(Hillion et al., 1993; Hellendall et al., 1993; Morilak and Ciaranello, 1993; Roth et al.,
1991), and the number of 5-HT1 receptors was altered in the offspring treated with
maternal pCPA or 5-MT (Whitaker-Azmitia et al., 1987). Also, stimulation of 5-HT1A
receptors has been shown to modify neuritic branching of developing rat cortical neurons

in vitro (Sikich et al. , 1990).
The effect of serotonin on neuronal development can also be mediated through
astroglia. Cultured astroglia possess a high affinity 5-HT uptake system (Katz and
Kimelberg, 1985), serotonin binding proteins (Hertz and Tamir, 1981), the serotonin
degrading enzyme, MAO (Fitzgerald et al., 1990), and 5-HT receptors (Fillion et al,
1980, 1983; Whitaker-Azmitia and Azmitia, 1986a). Serotonin decreases the levels of
GFAP and its mRNA in cultured astroglia derived from rat brainstem (Le Prince et al.,
1990). Application of a 5-HT 1A receptor agonist shifted astroglial morphology to a more
mature state (Whitaker-Azmitia et al., 1990).

Stimulation of 5-HT1A receptors on

cultured astroglial cells caused increased synthesis and release of a serotonergic growth
factor, SlOOP (Whitaker-Azmitiaetal., 1990; Azmitiaetal., 1990). Theeffectof5-HT
on the production of glial-derived trophic factors for dopaminergic neurons has also been
demonstrated. The growth of dopaminergic neurons in the presence of mesencephalic glia
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cells was stimulated by addition of 5-HT to the culture medium (Liu and Lauder, 1992),
but no such effect was found in neurons cultured on the polylysine substrate (Liu and
Lauder, 1991).

The Effects of Buspirone on the CNS
Buspirone is a non-benzodiazepine anxiolytic drug which has been used clinically
for the treatment of anxiety (Feighner et al., 1982). Buspirone has little or no affinity
for any of the major CNS receptors except dopamine D2 and 5-HT 1A receptors. Binding
of 3H-buspirone occurs in the regions rich in 5-HT 1A receptors (Matheson and Tunnicliff,
1991). Electrophysiological studies have shown that either systemic administration or
iontophoretic application of buspirone produces a dose-dependent inhibition of the
activities of serotonergic raphe neurons (VanderMaelen et al.,

1986). Acute

intraperitoneal administration of buspirone in rats reduces the synthesis of 5-HT in the
brain (Hjorth and Carlsson, 1982). These effects of buspirone are due to the activation
of 5-HT 1A autoreceptors in the dorsal raphe. In addition, buspirone treatment results in
increased plasma levels of corticosterone and reduced hippocampal rhythmical slow
activity, both of which are mediated through the activation of the postsynaptic 5-HT1A
receptors (Coop and McNaughton, 1991; Cowan et al., 1990).
Buspirone also binds to dopamine D2 autoreceptors as an antagonist, and thus
enhances dopaminergic neurotransmission (reviewed by Riblet et al., 1984). In the
striatum where dopamine autoreceptors have been identified, buspirone increases tyrosine
hydroxy lase activity and levels of dopamine metabolites (McMillen et al., 1983).

39
Although buspirone does not alter the activities of striatal choline acetyltransferase or
acetylcholinesterase, buspirone reduces acetylcholine levels in the striatum (Kolasa et al.,
1982). Since dopamine inhibits the firing of acetylcholine neurons, the decreased level
of acetylcholine induced by buspirone can be attributed to its antagonistic action on D2
receptors. Buspirone has been shown to increase plasma prolactin levels (Metzer et al.,
1982; Urban et al., 1986), but this increase was only significant from postnatal day 12
onward (Hocld et al., 1993).

CHAPTER III
METHODS

In Vivo Studies

Animals and Diet
Virgin female Sprague-Dawley rats (Harlan) weighing 180 to 200 grams, were
housed in individual cages and maintained at 23°C - 25°C and on a light/dark cycle
(12/12 hour). The rats were allowed to adjust to the environment for 2 days before
initiating liquid diets.
On the first day of diet administration, all rats were given the control liquid diet.
The caloric composition of the diet was 21 % protein, 29% fat, and 50% carbohydrate.
The caloric concentration was 1 kcal/ml (Noronha and Druse, 1982). Water was given
ad libitum. After 3 days of adjustment to the liquid diet, rats were divided into two
weight-matched groups: i) ethanol-consuming dams; ii) pair-fed dams. The ethanol-fed
rats were given liquid diet containing 6.6% (v/v) ethanol, while pair-fed rats received a
volume of control liquid diet equal to the volume consumed by the ethanol-fed rats
during the previous day. Ethanol accounts for approximately 35 % of the total calories
in the ethanol diet, and replaces isocaloric amounts of carbohydrates (e.g. maltosedextrin) in the control diet. Diets were replenished daily. An ad libitum control group

40

41
which was fed with control diet ad libitum was included in experiments of specific aim
1. The ethanol and control diets were pair-fed to rats for 5-6 weeks prior to breeding and
during gestation.
Female rats were mated. Breeding was confirmed by the detection of sperm in
vaginal smears; that day was defined as embryonic day 0 (EDO). At parturition, rat
mothers were given free access to chow plus either the control liquid diet (pair-fed
controls) or half-strength (3.3% v/v) ethanol-liquid diet. On the third day after
parturition, all rats were fed standard lab chow exclusively and litters were adjusted to
9 pups.

Drug Treatment
Buspirone (RBI, Natick, MA) was administered from ED13 to ED20, when 5-HT
neuronal differentiation and growth take place. Buspirone was dissolved in 0.9% sterile
saline solution at a concentration of 3 mg/ml. After weighing, control- and ethanol-fed
rats in drug treatment groups were given either a subcutaneous injection of saline or
buspirone, at a dose of 4.5 mg/kg body weight. Injections were made once a day
between 2 pm and 3 pm. Rats were monitored for a minimum of 30 minutes for any
visible side effects.

Blood Ethanol Level
Blood ethanol levels were determined by using an enzymatic kit (Sigma St. Louis,
MO). This kit measures ethanol by assessing the formation of reduced nicotinamide
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adenine dinucleotide (NADH) in the oxidation-reduction reaction, in which ethanol plus
nicotinamide adenine dinucleotide (NAD) are converted, respectively, to acetaldehyde
and NADH. Alcohol dehydrogenase (ADH) catalyzes this reaction. The increase in
absorbance at 340 nm occurs when NAD is converted to NADH, is directly proportional
to the ethanol concentration in the sample.
Blood samples were obtained from the tail vein two hours after the introduction
of a fresh ration of diet to rats that had been fasted for 12 hours. Blood samples were
collected in heparinized tubes (Becton Dickinson Inc., Lincoln Park, NJ) and
deproteinized by the addition of trichloroacetic acid (6.25% w/v). Each tube was tightly
capped and allowed to stand at room temperature for 5 minutes. The tube was then
centrifuged at 2000 rpm for 5 minutes (Sorvall RT6000). One hundred microliters of
supernatant were added to 2.9 ml of the NAD-ADH solution. The latter solution is
prepared by adding 16 ml of glycine buffer to a multi-assay vial containing NAD-ADH.
Mixed solutions were incubated for 10 minutes at room temperature. The solutions were
transferred to cuvets, and the absorbance was measured at 340 nm (Gilford Response
spectrophotometer).

Dissection and Tissue Sectioning
Rat offspring were sacrificed by decapitation on either postnatal day 5 (PN5),
PN19 or PN35. The brains were quickly removed and frozen on dry ice. To obtain
brains from ED19 rats, mothers were decapitated, and the uterine horn was removed and
placed on an ice-cold glass plate. The brains from the fetuses were quickly removed and
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frozen. Frozen brains were stored at -80 °C. Rats were sacrificed between 7 am and 9
am.
Twenty micron thick coronal sections of brains were cut at -18 °C using a cryostat
(Leitz, Germany). Sections were thaw-mounted onto gelatin-coated microscope slides
(Fisher, Pittsburg, PA). Four consecutive sections were put on one slide and every fifth
section was set aside for staining with cresyl violet . These sections were put in an airtight slide box and stored at -8D°C until use.

Staining of Tissue Sections
Every fifth section was stained with a 0.5 % (w/v) cresyl violet (Sigma, St. Louis,
MO) solution. These sections were compared with those in an atlas (Paxinos and Watson,
1986) for identification of anatomical structures. In radioligand binding assays, brain
sections from the same anatomical levels were selected.
Tissue sections were warmed to room temperature and dehydrated by sequentially
immersing the sections for 5 minute intervals in each of the following: xylene, xylene,
100% (v/v) ethanol, 95% (v/v) ethanol, and 70% (v/v) ethanol. Slides were then dipped
in distilled water and stained in the 0.5% (w/v) cresyl violet in acetate solution (0.06 M
sodium acetate and 0.34 M glacial acetic acid, pH 3.9) for 25 minutes. Following
staining, excess cresyl violet was removed by dipping the sections twice in distilled water
for 3 minutes. Slides were then dehydrated by immersing them in 70% (v/v), 95% (v/v),
and 100% (v/v) ethanol respectively. After dehydration, slides were put in xylene. A
coverslip coated with Depex mounting medium (BDH Laboratory Suppliers, England)
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was affixed to each slide.

Labeling of 5-HT Recognition Sites

5-HT Reuptake Sites
Serotonin reuptake sites were measured according to the method of D 'Amato et
al. (1987a). Slide-mounted tissue sections were brought to room temperature and
preincubated for 15 minutes in 50 mM Tris buffer (pH 7.4) containing 120 mM NaCl,
5 mM KCl and 0.001 % bovine serum albumin (BSA), in order to remove endogenous
ligands. Tissue sections were then incubated for 60 minutes at room temperature in the
incubation buffer containing 0.8 nM or 2.4 nM [3H] citalopram (NEN, Boston, MA).
The K0 for [3H]citalopram is approximately 0.8 nM (D'Amato et al., 1987a). A
concentration approximately three times the K0 concentration was used to estimate the
binding at the Bmax. Non-specific binding was determined in the presence of 1 µM
paroxetine (gift from Smith Kline Beecham Pharmaceuticals). Sections were then dipped
(1-2 seconds) and washed twice for 10 minutes in ice-cold preincubation buffer, dipped
in ice-cold distilled water for a few seconds, and dried in a cold air stream. Radiolabeled
sections and a tritium-radiolabeled reference microscale were exposed to tritium sensitive
Hyperfilm (Amersham, Arlington Heights, IL) at 4 °C for 4 weeks (for PN19 and PN35
brain sections) or 60 days (for ED19 and PN5 brain sections).

5-HT1A Receptor Sites
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5-HT1A receptor sites were labeled with PH]8-hydroxy-2-(N,N-di-n-propylamino)
tetralin ([3H]8-0H-DPAT; NEN) according to a modified protocol of Marlier et al.
(1991). Slides were warmed to room temperature and preincubated in 170 mM Tris
buffer (pH 7.6) containing 4 mM CaCl2 , 0.01 % ascorbic acid, and 0.001 % BSA. Tissue
sections were then incubated for 60 minutes at room temperature in the incubation buffer
containing 1 µM paroxetine, 10 µM pargyline, and 1.1 nM or 2. 75 nM [3H]8-0HDPAT. Non-specific binding was determined in the presence of 1 µM 5-HT. Paroxetine
was included to prevent [3H]8-0H-DPAT binding to 5-HT reuptake sites. Pargyline was
used to prevent degradation of 5-HT. Following incubation, sections were washed twice
for 5 minutes in ice-cold preincubation buffer, dipped in ice-cold distilled water for 5
seconds and dried in a cold air stream. Radiolabeled sections and [3H]-reference
microscales were exposed at room temperature to tritium sensitive Hyperfilm for 4 weeks
(for PN19 and PN35 brain sections) or 60 days (for ED19 and PN5 brain sections).

Development of PH]-Exposed Film
Autoradiograms were generated by developing the [3H] exposed film in the
developing solution for X-ray film (Doehren Co., IL) for 40 seconds, washed in water
for 20 seconds and fixed for 5 minutes at room temperature. Films were then rinsed in
running water for 15 minutes and air-dried.

Analyses of Autoradiograms
The illuminated image of each autoradiogram was collected by a solid state
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camera (Sony CCD Video Camera, Japan) and quantitated using a Macintosh-based
image analysis system, NIH Image. The optical density of the reference microscale was
interpolated to the radioactivity (DPM/mg protein) using tritium labeled brain mash
standards. The optical density of tissue sections was converted to radioactivity based
upon the calibration curve of the reference microscale. The radioactivity of tissue
sections was then converted to pmol/mg protein depending on the specific activity of the
radioligand. Brain structures on autoradiograms were identified in reference to the rat
brain atlas (Paxinos and Watson, 1986). 5-HT reuptake sites were analyzed in the regions
of raphe nuclei, lateral hypothalamus, substantia nigra, medial septal area, CA3 and
frontal cortex. 5-HT 1A receptor sites were examined in the raphe nuclei, amygdala,
dentate gyros, CAl, lateral septal area and frontal cortex.

In Vitro Cell Culture Studies

Astroglial Cell Cultures
Astroglial-conditioned media was obtained by the modified protocol of Rudge et
al. (1985). Primary cultures of astroglial cells were prepared from the cerebral cortex of
embryos from timed-pregnant Sprague-Dawley rats (Harlan) at 20 days of gestation
(ED20; day of insemination = EDO).
The uterine horn was aseptically removed from the body of a decapitated rat and
placed into a sterile petri dish containing cold calcium- and magnesium-free Hank's
balanced salt solution (CMF-HBSS; 5.4 mM KCl, 0.4 mM KH2P04 , 4.2 mM NaHC03 ,

47
140 mM NaCl, 0.34 mM Na2HP04 , 5.6 mM glucose). The embryos were removed from
the uterus and transferred twice to the other petri dishes containing fresh cold CMFHBSS. The brain was separated from the fetus; meninges were carefully removed under
the dissecting microscope (Zeiss, Germany). Cerebral hemispheres were dissected and
cleaned by removing the olfactory bulbs, striatum and hippocampal formation. Cortical
tissues were cut into small pieces and collected in sterile CMF-HBSS. Minced cortical
tissues were transferred to the CMF-HBSS containing 0.25% (w/v) trypsin/0.02% (w/v)
EDTA (Sigma, St. Louis, MO) and 0.1 % (w/v) DNAse (Boehringer Mannheim,
Indianapolis, IN), and incubated for 30 minutes at 37 °C. An equal volume of medium
containing 10% fetal bovine serum (PBS; Gibco, Grand Island, NY) was added to
inactivate trypsin. After centrifugation at 1000 g for 2 minutes, cells were resuspended
and tritulated in a D-valine substituted Eagle's minimum essential medium (MEM),
containing 10% FBS (heat-inactivated at 56°C for 1 hour) (MEM-FBS). D-Valine
substituted MEM was used to inhibit the growth of fibroblasts. The media was modified
to contain 26.4 mM NaHC03 (Sigma), 33.3 mM glucose (Sigma), 25 mM HEPES
(Gibco), 25 µg/ml gentamicin (Gibco) and 0.25 µg/ml amphotericin (Gibco). Tritulated
cells were filtered through a sterile 70 µ.m nylon mesh (Falcon, Lincoln Park, NJ). The
number of viable cells was determined by trypan blue exclusion using a hemacytometer.
Trypan blue excluding cells were placed in 162 cm2 flasks (Costar, Cambridge, MA) at
the density of 7 x 1Q4 cells/cm2 (11.34 x 106 cells/flask). The cultures were maintained
in a humidified atmosphere containing 5% C02 . The culture medium was changed with
fresh MEM-FBS on the day following seeding, and on every third day thereafter. After
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2 weeks, astrocytes were subcultured.
The day before subculture, 6-well plates (Costar, Cambridge, MA) were coated
with poly-omithine (0.1 mg/ml in 1.15 M borate buffer) at room temperature. Two hours
later, poly-omithine (PORN; Sigma) solution was aspirated and plates were washed three
times with sterile water. Plates were then covered with 0.001 % fibronectin (FN; Sigma,
St. Louis, MO.) and placed in a 37°C overnight. The plates were carefully washed three
times with MEM and then covered with MEM until use (Plates should not be air-dried).
On the day of subculture, astrocyte cultures were washed two times with warm
CMF-HBSS and treated with 0.05% trypsin/ 0.02%EDTA/ 0.1 % DNAse solution for 15
minutes. Trypsin action was stopped with MEM-FBS and the lifted cells were gently
tritulated, pooled and centrifuged at 1000 g for 5 minutes. Cells were resuspended in 1
ml of ovalbumin (1 % v/v)-containing MEM. After the number of viable cells were
determined, the cell suspension was diluted with serum- and ovalbumin-free MEM to a
density of 3 x 1()5 cells/ml. The density of 4.5 x 1()5 cells (1.5 ml) was added to each
well, coated with PORN-FN. After 2 hours of incubation, media was changed to remove
any residual ovalbumin and FBS.
On the next day, the culture medium was changed and a portion of the cells were
treated with ethanol (100 mM). Conditioned media from either control astroglia (CCM),
or ethanol treated astroglia (ECM) were collected at the second and fourth day of ethanol
treatment. CMs were centrifuged at 3500 rpm for 10 minutes and the supematants were
preserved at -80 °C until use.
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Neuronal Cell Cultures
Primary neuronal cell cultures were generated from rhombencephalon of ED 14
fetuses from timed pregnant Sprague-Dawley rats (Harlan). The same dissecting protocol
used for the astroglial cultures was used for the rhombencephalic neuronal cultures.
Rhombencephalon from between the rhombencephalic isthmus and the cervical flexure
was dissected into small pieces in CMF-HBSS. The tissues were incubated with a 0.05%
trypsin/EDTA/DNAse solution at 37 °C. After 30 minutes, an equal volume of 0.05%
(w/v) soybean trypsin inhibitor was added to stop the trypsin action. The cells were
centrifuged at 1000 g for 5 minutes. Precipitated cells were resuspended and tritulated
in serum-free medium. Serum-free medium was made of Dulbecco's modified Eagle's
medium and Ham's nutrient F-12 (DMEM/Fl2) containing 1% penicillin-streptomycin
(Sigma) and Bottenstein's N 2 supplements (N2), 5 µglml insulin (Sigma), 100 µg/ml
transferrin (Sigma), 20 nM progesterone (Sigma), 100 µM putrescine (Sigma) and 30 nM
sodium selenite (Sigma). After the number of viable cells was determined, cells were
seeded in the poly-D-lysine (33 µg/ml, Sigma) coated wells at a density of 8 x 1()4
cells/cm2 (7.6 x 105 cells/well). Five hours later, 6 µM fluorodeoxyuridine (ICN,
Cleveland, OH) and 12 µM uridine (Sigma) solution were added to inhibit proliferation
of mitotic cells.
On the day following seeding and on every other day thereafter, neuronal media
was changed to either absolute N2 media or N2 media containing 30% CCM (30-CCM),
60% CCM (60-CCM), 30% ECM (30-ECM), 60% ECM (60-ECM). On the fifth and
sixth day of culture, neuronal cells were assayed.
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Immunohistochemistry
Pure astroglial cultures were identified by staining glial fibrillary acidic protein
(GFAP), an astrocyte marker protein, using a peroxidase immunohistochemistry kit
(Sigma). Astrocyte cultures were washed three times with warm phosphate-buffered
saline (PBS: 2. 7 mM KCl, 1.5 mM KH 2P04, 137 mM NaCl, 8 mM Na2HP04, 0.5 mM
MgCl 2, 0.9 mM CaCl2) and fixed with cold 4% paraformaldehyde for 1 hour. To block
non-specific binding, cultures were incubated for 10 minutes with blocking reagent
containing 1 % normal goat serum in PBS. After the blocking reagent was removed,
cultures were incubated with primary anti-GFAP for 1 hour. Cultures were then washed
three times with PBS and incubated with a biotinylated secondary antibody for 20
minutes. After washing with PBS, cultures were incubated with peroxidase reagent for
20 minutes, washed, and exposed to peroxidase substrate solution, containing chromogen,
3-amino-9-ethylcarbazole (ABC) in N,N-dimethylformamide.
Serotonin containing neurons were stained with anti-serotonin (lncstar, Stillwater,
MN) using the peroxidase vectastain ABC kit (Vector Laboratory Inc., Burlingame, CA).
Neuronal cultures were incubated with 100 µM L-tryptophan (Sigma) and 10 µM
pargyline (Sigma) for 24 hours before staining. The staining procedures were the same
as that for GFAP. For the 5-HT staining peroxidase substrate was composed of 0.03%
H20 2 and 0.01 % diaminobenzidine (Sigma) in O. lM Tris buffer. 5-HT immunostained
neuronal cultures were photographed using a Nikon inverted microscope at a
magnification of 200x. The percentage of 5-HT immunopositive neurons was determined
by counting the number of positively stained and unstained neurons.
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Measurement of Neurite Length
The neurite length was measured on the film negatives using the Macintosh based
image analysis system, NIH Image. The longest neurite of each neuron was measured
starting from the cell body to the end of neurite.

5-HT Uptake
5-HT uptake was determined by measuring the accumulation of [3H]5-HT by the
neuronal cultures. Neuronal cultures were washed three times with warmed Hank's
balanced salt solution (HBSS; 5.4 mM KCl, 0.4 mM KH2P04 , 4.2 mM NaHC03 , 140
mM NaCl, 0.34 mM Na2HP04 , 0.5 mM MgCl2 , 1.26 mM CaCl2 , 0.41 mM MgS04 , 5.6
mM glucose) and then incubated with 60 nM [3H]5-HT (Amersham) in HBSS containing
0.1 mM L-cysteine (Sigma) for 20 minutes at 37 °C. Nonspecific uptake was determined
using 10 µM fluoxetine (Lily, Indianapolis, IN). After incubation, the [3H]5-HT
containing solution was removed and the cultures were washed three times with ice-cold
HBSS. Cultures were then air-dried, and extracted with 1 ml of 95 % (v/v) ethanol for
1 hour. At the end of extraction procedure, cells were scraped from the bottom and the
wells were rinsed with 0.5 ml of 95 % ethanol. Two extracts were combined prior to
tritium counting. An aliquot was saved for protein determination.

Neuronal Number
The number of surviving neurons was determined by counting with a
hemacytometer. Neuronal cultures were rinsed with CMF-HBSS and incubated with 500
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µl of 0.05% trypsin/EDTA/DNAse for 30 minutes at 37 °C. An equal volume of FBSMEM was added to stop the action of trypsin. Lifted cells were tritulated with 10 ml
pipet and 9 inch Pasteur pipet. Dissociated cells were counted with hemacytometer.

DNA Content
DNA content was measured using a colorimetric assay developed by Burton
(1956). Cultures were rinsed three times with HBSS. To each well of neuronal cultures
was added 800 µl of 1 N NaOH. The bottom of each well was scraped after 30 minutes.
Duplicate aliquots of 250 µl were transferred to test tubes. The remaining 300 µl was
saved for protein determination. Standard DNA (Sigma), dissolved in 1 N NaOH was
used at 10 different concentrations. Samples and standards were hydrolyzed for 30
minutes at room temperature using 250 µ1of20% perchloric acid. During incubation,
the acetaldehyde stock solution (16 mg/ml in distilled water) was diluted 1: 10. After the
30 minute incubation, 500 µl of diphenylamine (40 mg/ml in glacial acetic acid) and 25
µl of acetaldehyde (1.6 mg/ml) were added and the tubes were mixed. Test tubes were
capped and shaken overnight in a 30 °C waterbath. The tubes were then centrifuged at
800 g (Sorvall RT6000) for 10 minutes. The optical density of the samples and standards
was read at 595 nm on a spectrophotometer (Gilford).

Protein Determination
Protein content was measured by a micromodification of the Lowry method
(1951). Samples for protein measurement were previously collected from the same
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cultures used for DNA measurements. Standards containing 0 and 25 µg protein were
generated. Samples and standards were hydrolyzed in 100 µl of 1 N NaOH for 30
minutes. During the incubation 1 % (w/v) cupric sulfate, 2 % (w/v) potassium-sodium
tartrate and 2 % (w/v) sodium carbonate were mixed at a ratio of 0.1:0.1:10 (v/v/v)
(solution A). To each sample and standard, 1 ml of solution A was added. The tubes
were then vortexed. After 10 minutes 100 µl of Polin-phenol reagent was added and
allowed to react for 30 minutes. The optical density of the standards and samples was
read at 700 nm on a Gilford spectrophotometer.

Statistical Analysis
In the study of in utero ethanol effects on the development of 5-HT reuptake sites
and 5-HT1A sites the results were analyzed using a two way analysis of variance
(ANOVA) and a post-hoc Tukey's protected t test. The ANOVA with randomized block
design was used. Each experiment was a block. In each experiment, samples from a
given brain region from age-matched dietary groups were included. The results of cell
culture studies were analyzed using a one way ANOVA followed by Tukey's protected
t test. P values less than 0.05 were considered statistically significant.

CHAPTER V
RESULTS

In Vivo Studies

Maternal Weight Gain and Blood Alcohol Levels
After 6 weeks of diet consumption, the average blood alcohol level (BAL) of
ethanol-consuming rats was -

100 mg/dl; the BALs ranged from 75 to 120 mg/dl.

Although the female rats consumed an increasing quantity of diet as pregnancy
progressed, the amount of ethanol consumed (g/kg body weight) was constant because
the maternal weight gains paralleled the increased diet consumption (Figure 1). During
pregnancy (EDO to ED21) the maternal weight gain by pair-fed and ad lib controls (CPF, C-AD) and ethanol-fed rats (E-PF) was comparable (Table 1). The weights of
offspring from these rats were also comparable.

Effects of In Utero Ethanol Exposure on the Development of
5-HT Reuptake Sites
Since 5-HT reuptake sites are localized in nerve terminals, their concentration has
been used as an index of serotonergic nerve fiber innervation of discrete brain areas. 5HT reuptake sites were radiolabeled with [3H]citalopram, a specific blocker of 5-HT
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TABLE 1
EFFECTS OF IN UTERO ETHANOL EXPOSURE ON MATERNAL WEIGHT
GAIN DURING PREGNANCY (EDl - ED21) AND ON OFFSPRING WEIGHTS
Weight (g)

Maternal

C-PF

(n)

E-PF

(n)

C-AD

(n)

115.7±18.1

(7)

108.6±20.5

(7)

153.0±47.3

(4)

9.6±2.1

(6)

11.0±0.8

(8)

8.9±1.4

(4)

51.0±6.1

(8)

PN19
48.2±5.1

(8)

50.6±6.0

(3)

~

Offspring

All the data are presented as the mean ± SD.
Abbreviations are as follows: C-PF, pair-fed control; E-PF, pair-fed ethanol; C-AD, ad
libitum control; PN, postnatal day.
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reuptake sites. Binding was done at 2 ligand concentrations. Binding at 0. 8 nM
[3H]citalopram approximated the K0 , and that at 2.4 nM was used as an estimate of
binding at the Bmax. Figure 2 depicts autoradiograms of brain regions from control rats,
which were radiolabled with [3H]citalopram. Table 2 summarizes the specific binding of
0.8 nM and 2.4 nM [3H]citalopram to brain regions from control rats, aged PN5 to
PN35. In this table, the mean and standard deviation of all control values are provided.
Data from the three groups of offspring are presented in Figures 3-10. These figures
depict the binding in ethanol-exposed and ad lib offspring in comparison with that of agematched control offspring that were analyzed in the same experiment. Multiple (6 - 8)
individual experiments were performed. Rather than pooling the values obtained from all
experiments, each experiment was analyzed as a block. The results of a 2-way analysis
of variance (ANOV A) using a randomized block design is summarized in the legends to
the figures.
On PN5, 5-HT reuptake sites could be quantitated in both the PCx and DR.
However, binding was below the sensitivity of our method in other serotonergic brain
areas at this age. By PN19, binding had increased in both the PCx and DR, as well as
in the other brain regions listed in Table 2. At this age, the highest binding was found
in the DR and MnR. The rank order of binding was DR - MnR > LH > SN >
AMG

> CA3 > PCx - FCx. With few exceptions the rank order of binding was

similar at PN19 and PN35. Other than one data point (of a total of 18), the values for
the specific binding of 0.8 nM and 2.4 nM [3H]citalopram to serotonergic brain regions
was comparable in ad lib (C-AD) and pair-fed control rats (C-PF).

Fig. 2. Autoradiographic images of serotonin reuptake sites in rat brain labeled with [3H)citalopram.
Images of 20 µm thick coronal sections, labeled with 0.8 nM [ 3H]citalopram, are presented. A - D represent
the level of forebrain (A-B), midbrain (C) and brainstem (D) of PN35 rats. E - F represent the level of forebrain
(E) and brainstem (F) of PN5 rats. G represents a coronal section of brain stem from embryonic day 19 fetuses.
H represents image of PN35 brain section showing nonspecific binding of [3 H]citalopram in the presence of
1 µM paroxetine. The color scale and corresponding radioactivity (DPM/mg protein) is shown on the right side.
The warmer colors (red and yellow) correspond to higher densities and the cooler colors (blue and violet)
correspond to lower densities. Abbreviations are as follows: FCX, frontal cortex; PCX, parietal cortex; MS,
medial septum; STR, striatum; LH, lateral hypothalamus; BAL, basolateral nucleus of amygdala; CA3,
hippocampus Comu Ammon 3; SN, substantia nigra; DR, dorsal raphe; MNR, median raphe.
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TABLE2
SPECIFIC BINDING OF [3H)-CITALOPRAM IN CONTROL PAIR-FED RA TS
Specific binding (pmol/mg protein equivalent)
0.8nM [3H]-citalopram
(n)

2.4nM [3H]-citalopram
(n)

Region

Age

FCx

PN19
PN35

0.286±0.094 (6)
0.301±0.090 (6)

0.507±0.197
0.616±0.172

(6)
(6)

PCx

PN5
PN19
PN35

0.119±0.080
0.343±0.120
0.271±0.073

(6)
(6)
(6)

0.196±0.104
0.530±0.152
0.509±0.159

(6)
(6)
(6)

CA3

PN19
PN35

0.541±0.301
0.714±0.284

(8)
(8)

0.910±0.268
1.103±0.277

(8)
(8)

LH

PN19
PN35

1.249±0.313
0.959±0.234

(7)
(7)

1.671±0.335
1.557±0.344

(7)
(7)

AMG

PN19
PN35

0.903±0.378
1.128±0.291

(8)
(8)

1.288±0.280 (8)
1.698±0.245 (8)

SN

PN19
PN35

0.798±0.312
1.105±0.312

(6)
(6)

1.441±0.184 (7)
1.53 7±0.395 (7)

DR

PN5
PN19
PN35

0.515±0.224 (6)
1.713±0.160 (8)
1.571±0.179 (8)

0.838±0.313 (6)
2.098±0.174 (8)
2.079±0.188 (8)

MnR

PN19
PN35

1.459±0.420 (7)
1.129±0.194 (7)

2.071±0.162
1.803±0.193

(7)
(7)

All the data are presented as the mean± SD.
Abbreviation: FCx, frontal cortex; PCx, parietal cortex; CA3, hippocampus comu ammonis
3; LH, lateral hypothalamus; AMG, amygdala; SN, substantia nigra; DR, dorsal raphe; MnR,
median raphe; PN, postnatal day.
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Fig. 3. Effects of in utero ethanol exposure on the binding of [3H)citalopram in the
dorsal raphe. Results are expressed as percent of the specific binding obtained from the
pair-fed control group at each age. The pair-fed control values are given in Table 2. The
asterisk (*) denotes values which are significantly different from those in the age-matched
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Several significant abnormalities were found in the developing ethanol-exposed
offspring. There was a transient increase in [3H]citalopram binding in the DR at PN5
(Fig. 3), and in the MnR on PN35 (Fig. 4). There was also a decrease in binding in the
LH at PN19 and PN35 (Fig. 5). In the SN (Fig. 6), binding was decreased at both PN19
and PN35. In some cases, the significantly altered binding was detected at one but not
both ligand concentrations. At the other ligand concentrations, a similar, though
nonsignificant trend was noted.

Effects of In Utero Ethanol Exposure on the Development of
5-HT 1A Receptors
5-HT1A receptors were radiolabeled with either 1.1 nM or 2. 75 nM [3H]-8-0HDPAT, a specific 5-HT 1A receptor agonist. Figure 11 depicts autoradiograms of control
brain regions from rats aged PN5 and PN35. Table 3 contains the values for the mean
and standard deviations for the specific binding of [3H]-8-0H-DPAT to brain regions
from control rats. In each binding assay, samples from C-PF, C-AD, and E-PF rats were
included. The radiolabeled sections from a given experiment were exposed to a single
film. The results of the multiple experiments were compared using the randomized block
design, in order to adjust for differences between individual experiments. Figures 12 17 depict the values for C-AD and E-PF rats as a percentage of the values for C-PF rats,
included in the same experiment. Statistical differences were calculated using a 2-way
ANOV A with random block design.
At PN5, binding of [3H]-8-0H-DPAT was detectable only in the DG. However,

Fig. 11. Autoradiographic images of 5-HT 1A receptor sites labeled with [3H]-8-0H-DPAT. Images of
20 µm thick coronal sections, labeled with 1.1 nM [ 3H]-8-0H-DPAT, are presented. A - C represents
sections of forebrain (A and B) and brainstem (C) of PN35 rats. D represents the section of forebrain of
PN5 . Nonspecific binding of [3H]-8-0H-DPAT in the presence of 1 µM 5-HT is shown in E. The color scale
and corresponding radioactivity are shown in F. The warmer colors (red and yellow) correspond to higher
densities and the cooler colors (blue and violet) correspond to lower densities. Abbreviations are as follows :
FCX, frontal cortex; PCX, parietal cortex; LS, lateral septum; DG, dentate gyrus; DR, dorsal raphe ; MNR,
median raphe.
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TABLE3
SPECIFIC BINDING OF [3H]-8-0H-DPAT IN CONTROL PAIR-FED RATS
Specific binding (pmol/mg protein equivalent)
1.lnM [3H]-8-0H-DPAT
(n)

2.75nM [3H]-8-0H-DPAT
(n)

Region

Age

FCx

PN19
PN35

0.099±0.033 (7)
0.166±0.042 (7)

0.164±0.076 (6)
0.242±0.069 (6)

PCx

PN19
PN35

0.154±0.070 (7)
0.212±0.057 (7)

0.226±0.071
0.279±0.084

LS

PN19
PN35

0.580±0.168
0 .5 35±0. 066

(6)
(6)

0.709±0.180 (6)
0.658±0.119 (6)

DG

PN5
PN19
PN35

0.232±0.071 (6)
0.584±0.132 (6)
0. 731±0.073 (6)

0.265±0.089 (6)
0.737±0.185 (6)
0.825±0.191 (6)

DR

PN19
PN35

0.575±0.142 (6)
0.581±0.140 (6)

0.685±0.191 (6)
0.646±0.100 (6)

MnR

PN19
PN35

0.270±0.080 (6)
0.150±0.040 (6)

0.354±0.115
0.245±0.082

(7)
(7)

(6)
(6)

All the data are presented as the mean± SD.
Abbreviation: FCx, frontal cortex; PCx, parietal cortex; LS, lateral septum; DG, dendate
gyrus; DR, dorsal raphe; MnR, median raphe; PN, postnatal day.
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Fig. 12. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in
the dentate gyrus. Results are expressed as percent of the specific binding obtained from
the pair-fed control group at each age. The pair-fed control values are given in Table 3.
The asterisk (*) denotes values which are significantly different from those in the agematched pair-fed control group (F = 3.8, p = 0.058), and the pound (#) denotes values
which are significantly different from those in the age-matched ad lib control group (F
= 6.5, p = 0.01). Abbreviations are the same as those in Fig. 3.
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the parietal cortex. Results are expressed as percent of the specific binding obtained
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Fig. 14. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DP AT in
the frontal cortex. Results are expressed as percent of the specific binding obtained from
the pair-fed control group at each age. The pair-fed control values are given in Table 3.
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Fig. 15. Effects of in utero ethanol exposure on the binding of [3H]-8-0H-DPAT in
the lateral septum. Results are expressed as percent of the specific binding obtained from
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by PN19 5-HT 1A receptors could be quantitated in several brain areas. At both PN19 and
PN35 binding was highest in the DR, DG and LS. Somewhat lower binding was noted
in the MnR, PCx and FCx. With one exception, there were no significant differences in
the binding of PH]-8-0H-DPAT to tissue from pair-fed and ad lib control offspring.
However, in ethanol-exposed offspring there was a transient increase in PH]-8-0H-DPAT
binding in the DG (PN19, Fig. 12) and a transient decrease in binding in the PCx (PN35,
Fig. 13).

Effects of Buspirone Treatment on the
Ethanol-Associated Developmental Abnormalities in
5-HT Reuptake Sites and 5-HT 1A Receptors
Previous investigations from this laboratory (Druse et al., 1991) indicated that 5HT content was decreased by -50% in the brain stem of ED15 rats. Since fetal 5-HT
appears to function as an essential trophic factor for the development of serotonergic as
well as other types of neurons, it was hypothesized that the ethanol-induced fetal deficit
of 5-HT could contribute to the subsequent abnormal development of serotonergic
neurons by decreasing stimulation of 5-HT1A receptors. In order to test this hypothesis,
pregnant control and ethanol-fed dams were treated with buspirone, a 5-HT 1A agonist,
from ED13 to ED20 to determine whether treatment with a 5-HT1A agonist could prevent
or reverse ethanol-associated developmental abnormalities. Additional control and
ethanol-fed dams were treated with saline instead of buspirone. The offspring of these
dams were used for analysis of 5-HT reuptake and 5-HT 1A receptors. All rats used in
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these studies were distinct from those described in sections 2 and 3. Nonetheless, a
portion of these studies replicated the work reported in those sections. In addition, it
expanded the earlier studies to include additional brain regions and/or ages, and
strengthened the observations by including a large sample number.
Following subcutaneous injection of buspirone, the pregnant rats sometimes
exhibited brief and mild symptoms of the serotonin syndrome (Smith and Peroutka,
1986). These rats exhibited a flattened body posture and outstretched forepaws.

In

addition, the buspirone-treated control (CB) dams exhibited a smaller weight gain than
that noted in either of the pair-fed groups (Table 4). In contrast, the weight gain in both
of the ethanol-treated groups (ethanol-saline, ES; ethanol-buspirone, EB) was comparable
to that of the control-saline (CS) group. Despite the noted effects on the dams, the weight
gain in the offspring of buspirone-treated control- and ethanol-fed rats was not
significantly different at PN5, PN19 and PN35 (Fig. 18).
Table 5 contains the values for the specific binding of 0.8 nM and 2.4 nM
[3H]citalopram to brain sections obtained from the offspring of saline-treated, pair-fed
control rats (CS). Specific binding was readily detected in the DR by ED19 and in the
PCx by PN5. On PN19 and PN35 the highest binding was found in the DR and MnR.
The rank order of binding was DR

> MnR > LH - SN - AMG > MS - CA3 >

Striatum - PCx - FCx. This pattern was generally similar to that noted in the earlier
experiment (Table 2).
When [3H]citalopram binding was compared in the offspring of pair-fed control
and ethanol dams, we noted that the ethanol-exposed offspring had a significant decrease
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in binding in several regions. Binding was decreased at one or both ligand concentrations
in the FCx (PN19, Fig. 19), PCx (PN19, Fig. 20), LH (PN19 & PN35 Fig. 21), SN
(PN19 & PN35, Fig. 22), MS (PN19, Fig. 23) and striatum (PN19 & PN35, Fig.24).
In contrast, binding was increased in the DR (Fig. 25) on PN5 and MnR (Fig. 26) on
PN19 and PN35. The noted observations in the DR, LH and SN confirm earlier findings;
those in the MS and ST expand the first study which did not examine the latter brain
areas. It should also be noted that in both investigations, we did not detect any ethanolassociated changes in the hippocampus (CA3, Fig. 27) or amygdala (Fig.28). A few
significant differences were noted in one, but not both studies. For example, the latter
study detected significantly decreased [3H]citalopram binding in the frontal and parietal
cortex. A similar, though nonsignificant trend was found in the frontal cortex in the first
investigation.
When the PH]citalopram binding was compared in the offspring of saline- and
buspirone treated dams, maternal treatment with buspirone prevented or reversed some
of the ethanol-associated developmental abnormalities in 5-HT reuptake sites. Buspirone
prevented the decline in binding of PH]citalopram at either the low or high concentration
noted in the FCx (PN19, Fig. 19), LH (PN19 & PN35, Fig. 21), SN (PN35, Fig. 22),
and MS (PN19, Fig. 23). Similarly, buspirone treatment reversed the ethanol-associated
increase in binding in the DR (PN5, Fig. 25) and MnR (PN19, Fig 26). In contrast,
maternal buspirone treatment had no effect on the decreased number of reuptake sites in
the PCx (Fig. 20) and Striatum (Fig. 24). Buspirone treatment alone had little effect on
[3H]citalopram binding to reuptake sites.

TABLE4
WEIGHT INCREASE DURING PREGNANCY
(From EDl to ED20)
n

cs
CB
ES
EB

5
5
5
5

Weight increase (g)
136.0±13.4a
110.4±14.3*
124.8±14.3
118.4±11.7

aData are presented as the mean± SD.
*p<0.05 compared to CS.
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Fig. 18. Effect of buspirone treatment on the weight of offspring at PN5, PN19 and
PN35. The results are presented as the mean values obtained from pups of eight different
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TABLES
SPECIFIC BINDING OF [3H]-CITALOPRAM IN THE CONTROL SALINE GROUP
Specific binding (pmol/mg protein equivalent)

Region

Age

0.8nM [3H]-citalopram
(n)

FCx

PN19
PN35

0.194±0.116
0.243±0.141

(7)
(7)

0.509±0.180
0.719±0.208

(6)
(6)

PCx

PN5
PN19
PN35

0.278±0.147
0.325±0.172
0.290±0.151

(5)
(6)
(6)

0.334±0.223
0.607±0.260
0.687±0.159

(8)
(6)
(6)

MS

PN19
PN35

0.619±0.245
0.570±0.304

(7)
(7)

1.045±0.306
1.103±0.286

(7)
(7)

Striatum

PN19
PN35

0.322±0.155
0.343±0.170

(7)
(7)

0.701±0.173
0.713±0.208

(7)
(7)

CA3

PN19
PN35

0.441±0.219
0.534±0.277

(8)
(8)

0.922±0.265
0.981±0.242

(8)
(8)

LH

PN19
PN35

1.091±0.397
0.975±0.264

(7)
(7)

1.919±0.397
1.658±0.327

(7)
(7)

AMG

PN19
PN35

0.781±0.303
1.013±0.322

(7)
(7)

1.298±0.489
1.626±0.425

(7)
(7)

SN

PN19
PN35

1.129±0.309
1.071±0.227

(7)
(7)

1.629±0.474
1.710±0.278

(7)
(7)

DR

ED19
PN5
PN19
PN35

0.386±0.207
0.330±0.109
1.769±0.209
1.757±0.214

(6)
(5)
(7)
(7)

0.471±0.282
0.320±0.188
2.547±0.582
2.485±0.308

(6)
(7)
(7)
(7)

MnR

PN19
PN35

1.592±0.234
1.343±0.263

(6)
(6)

2.400±0.405
1.910±0.315

(7)
(7)

All the data are presented as the mean± SD.
Abbreviations are same as in Table 2 except MS, medial septum.
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Fig. 19. Effects of buspirone treatment on the binding of [3H]citalopram in the
frontal cortex. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 5. Statistical
analysis was performed on the specific binding values. The asterisk (*) denotes values
which are significantly different from those in the age-matched control saline group.
Abbreviations are as follows: CS, control saline; CB, control buspirone; ES, ethanol
saline; EB, ethanol buspirone; ED, embryonic day; PN, postnatal day.
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Fig. 20. Effects of buspirone treatment on the binding of [3H]citalopram in the
parietal cortex. Results are expressed as percent of the specific binding obtained from
the control saline group at each age. The control saline values are given in Table 5.
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes
values which are significantly different from those in the age-matched control saline
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Fig. 21. Effects of buspirone treatment on the binding of [3H]citalopram in the
lateral hypothalamus. Results are expressed as percent of the specific binding obtained
from the control saline group at each age. The control saline values are given in Table
5. Statistical analysis was performed on the specific binding values. The asterisk (*)
denotes values which are significantly different from those in the age-matched control
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3
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3
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3
[ H]citalopram (F = 11.6, p = 0.01). Abbreviations are the same as those in the Fig. 19.
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Fig. 22. Effects of buspirone treatment on the binding of [3H]citalopram in the
substantia nigra. Results are expressed as percent of the specific binding obtained from
the control saline group at each age. The control saline values are given in Table 5.
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes
values which are significantly different from those in the age-matched control saline
group (PN19, 0.8 nM [3H]citalopram: F = 27.0, p = 0.002; PN19, 2.4 nM [3H]citalopram:
F = 12.1, p = 0.01). The dollar sign($) denotes values which are significantly different
from those in the age-matched control buspirone group (PN19, 0.8 nM [3H]citalopram:
F = 27.0, p = 0.002; PN19, 2.4 nM [3H]citalopram: F = 12.1, p = 0.01). Abbreviations
are the same as those in the Fig. 19.

86

~CS

r. CB

-

ES

~ EB

Cl)

.: 100
DJ

e-c

80

0

(.)

~

-C> 60
c
"C
c
:c 40

·(.)

It:

·c:;

8.

Cl)

20

0.8nM CIT

2.4nMCIT

0.8nM CIT

2.4nM CIT

PN 35

PN 19

Fig. 23. Effects of buspirone treatment on the binding of [3H]citalopram in the
medial septum. Results are expressed as percent of the specific binding obtained from
the control saline group at each age. The control saline values are given in Table 5.
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes
values which are significantly different from those in the age-matched control saline
group (PN19, 0.8 nM [3H]citalopram: F = 8.0, p = 0.03). The pound (#) and the dollar
signs ($) denotes values which are significantly different from those in the age-matched
ethanol saline and control buspirone, respectively (PNl 9, 2.4 nM [3H]citalopram: F = 7.1,
p = 0.04). There was a significant ethanol x buspirone interaction (PN19, 0.8 nM
3
[ H]citalopram: F = 6.4, p = 0.04). Abbreviations are the same as those in the Fig. 19.
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Fig. 24. Effects of buspirone treatment on the binding of [3H]citalopram in the
striatum. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 5. Statistical
analysis was performed on the specific binding values. The asterisk (*) denotes values
which are significantly different from those in the age-matched control saline group (at
PN19, 0.8 nM [3H]citalopram: F = 8.7, p = 0.02; PN35, 2.4 nM [3H]citalopram: F =7.3,
p = 0.04). The dollar sign($) denotes values which are significantly different from those
in the age-matched control buspirone group (PN19, 0.8 nM [3H]citalopram: F = 8.7, p =
0.02; PN35, 2.4 nM [3H]citalopram: F = 7.3, p = 0.04). Abbreviations are the same as
those in the Fig. 19.
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Fig. 25. Effects ofbuspirone treatment on the binding of [3H]citalopram in the dorsal
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Fig. 26. Effects of buspirone treatment on the binding of [3H]citalopram in the
median raphe. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 5. Statistical
analysis was performed on the specific binding values. The asterisk (*) denotes values
which are significantly different from those in the age-matched control saline group
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9.3, p = 0.02). Abbreviations are the same as those in the Fig. 19.
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Fig. 27. Effects of buspirone treatment on the binding of [3H]citalopram in the CA3.
Results are expressed as percent of the specific binding obtained from the control saline
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performed on the specific binding values. Abbreviations are same as those in the Fig. 19.
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amygdala. Results are expressed as percent of the specific binding obtained from the
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in the Fig. 19.
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The PH]-8-0H-DPAT binding study was also conducted in order to see whether
maternal treatment with a 5-HT1A agonist, buspirone, prevents or reverses ethanolassociated developmental abnormalities in 5-HT 1A receptors. Table 6 contains the values
for the specific binding of 1.0 nM and 2. 7 nM PHJ-8-0H-DPAT to brain sections
obtained from the offspring of CS rats. The binding pattern of PHJ-8-0H-DPAT at PNl 9
and PN35 was similar to that observed in earlier experiments (Table 3). The binding was
high in the DG, DR, LS and low in the MnR, PCx and FCx.
Compared to the binding in the offspring of CS, ethanol-exposed offspring had
a transient increase of [3H]-8-0H-DPAT binding in the DG (Fig. 29) at PN19 and a
decrease of binding in the PCx (Fig. 30) at PN35. These observations confirm the earlier
findings. The binding in the DR (Fig. 31) and MnR (Fig. 32) was unaffected by in utero
exposure in both the first and second experiments. The changes in the binding of [3H]-80H-DPAT in the LS (Fig. 33) and FCx (Fig. 34) were significant in this experiment; a
similar, though nonsignificant trend was found in the earlier investigation.
Maternal treatment with buspirone appeared to prevent ethanol-associated
developmental abnormalities in 5-HT1A receptors. Buspirone seemed to reverse the
ethanol-associated increase in the binding of [3H]-8-0H-DPAT in the DG at PN19.
Buspirone also appeared to prevent the decreased binding of either the 1.0 nM or 2. 7 nM
[3H]-8-0H-DPAT in the PCx and LS of PN35 ethanol-exposed rats. Buspirone treatment
during the embryonic period did not significantly affect the binding of PHJ-8-0H-DPAT
in most brain regions examined in the postnatal rats. The only exception was found in
the LS on PN35.

TABLE6
SPECIFIC BINDING OF [3H]-8-0H-DPAT IN THE CONTROL SALINE GROUP
Specific binding (pmol/mg protein equivalent)
l .OnM [3H]-8-0H-DPAT
(n)

2.7nM [3H]-8-0H-DPAT
(n)

Region

Age

FCx

PN19
PN35

0.081±0.065
0.186±0.109

(6)
(6)

0.095±0.040
0.223±0.100

(6)
(6)

PCx

PN19
PN35

0.102±0.062
0.214±0.096

(6)
(6)

0.129±0.035
0.212±0.058

(6)
(6)

LS

PN19
PN35

0.354±0.080
0.472±0.182

(7)
(7)

0.448±0.183
0.634±0.200

(7)
(7)

DG

PN5
PN19
PN35

0.135±0.036
0.485±0.135
0.618±0.111

(5)
(7)
(7)

0.162±0.034
0.512±0.170
0. 722±0.132

(8)
(7)
(7)

DR

PN19
PN35

0.592±0.134
0.659±0.145

(5)
(5)

0.659±0.054
0.745±0.265

(5)
(5)

MnR

PN19
PN35

0 .464±0 .104
0.246±0.025

(4)
(4)

0.429±0.074
0.333±0.126

(4)
(4)

All the data are presented as the mean ± SD.
Abbreviations are same as in Table 3.
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Fig. 29. Effects of buspirone treatment on the binding of [3H)-8-0H-DP AT in the
dentate gyrus. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 6. Statistical
analysis was performed on the specific binding values. The asterisk (*) denotes values
which are significantly different from those in the age-matched control saline group
(PN19, 2.7 nM [3H]-8-0H-DPAT: F = 9.4, p = 0.02). Abbreviations are the same as those
in the Fig. 19.
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Fig. 30. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the
parietal cortex. Results are expressed as percent of the specific binding obtained from
the control saline group at each age. The control saline values are given in Table 6.
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes
values which are significantly different from those in the age-matched control saline
group (PN35, 1.0 nM [3H]-8-0H-DPAT: F = 8.9, p = 0.03; PN35, 2.7 nM [3H]-8-0HDPAT: F = 8.5, p = 0.03). Abbreviations are the same as those in the Fig. 19.
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Fig. 31. Effects of buspirone treatment on the binding of [3H]-8-0H-DP AT in the
dorsal raphe. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 6. Statistical
analysis was performed on the specific binding values. Abbreviations are the same as
those in the Fig. 19.
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Fig. 32. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the
median rap he. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 6. Statistical
analysis was performed on the specific binding values. Abbreviations are the same as
those in the Fig. 19.
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Fig. 33. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the
lateral septum. Results are expressed as percent of the specific binding obtained from
the control saline group at each age. The control saline values are given in Table 6.
Statistical analysis was performed on the specific binding values. The asterisk (*) denotes
values which are significantly different from those in the age-matched control saline
group (PN35, 1.0 nM [3H]-8-0H-DPAT: F = 9.6, p = 0.02). Abbreviations are the same
as those in the Fig. 19.
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Fig. 34. Effects of buspirone treatment on the binding of [3H]-8-0H-DPAT in the
frontal cortex. Results are expressed as percent of the specific binding obtained from the
control saline group at each age. The control saline values are given in Table 6. Statistical
analysis was performed on the specific binding values. The asterisk (*) denotes values
which are significantly different from those in the age-matched control saline group
(PN35, 1.0 nM [3H]-8-0H-DPAT: F = 9.6, p = 0.02). The pound(#) denotes values which
are significantly different from those in the age-matched ethanol saline. There was a
significant ethanol x buspirone interaction (PN35, 1.0 nM [3H]-8-0H-DPAT: F = 9.4, p
= 0.03). Abbreviations are the same as those in the Fig. 19.
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In Vitro Cell Culture Studies
It was hypothesized that ethanol exerts some of its damaging effects on the

developing serotonergic neurons by decreasing the concentration of serotonin and other
essential trophic factors. The first portion of this dissertation discussed ethanol's effects
on serotonergic neurons and the role of 5-HT1A receptors. This section concentrates on
the effects of ethanol on trophic factors produced by astroglia. Astroglia from a target
region (e.g. the cortex) were cultured in the presence or absence of 100 mM ethanol.
The purity of the astroglial cultures was assessed by the presence of GF AP as shown Fig.
35-A. Media from these astroglial cultures was collected. This media was assumed to
contain trophic factors that were synthesized and secreted by astroglia. This conditioned
media (CM) was then used at a concentration of 30% or 60% to culture control fetal
rhombencephalic neurons, which contain the developing serotonergic neurons.
Serotonergic neurons stained with 5-HT antibody are shown in Fig. 35-B. The effects of
added CM (CCM or ECM) was noted on the development of several measurements of
total neuronal development (cell number, DNA content, protein content, neurite
outgrowth) and 5-HT neuronal development (5-HT immunopositive cells, 5-HT
reuptake).
The results of these studies demonstrate that addition of CM increased the 5-HT
uptake (Fig. 36), total DNA content (Fig. 37), total number of surviving neurons (Fig.
38) and the number of 5-HT immunopositive neurons (Fig. 39). CM also increased the
number of neurons which had longer neurites (Fig. 40). These observations support the

Fig. 35. Photographs of astroglial cells stained with GFAP antibody (A) and neuronal cells
stained with 5-HT antibody (B). Cultures were stained with antibody as described in the Methods
section. Cultures were photographed using a phase contrast microscope.
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hypothesis that astroglia, derived from a target region, produce trophic factors which are
necessary for normal neuronal development.
When neuronal cultures maintained in CCM were compared with those
maintained in ECM, several significant differences were noted.

That is, neuronal

cultures maintained in ECM have a decreased total DNA content (Fig. 37), total number
of surviving neurons (Fig. 38) and number of neurons with longer neurites (Fig. 40).
More importantly, the number of 5-HT immunopositive neurons (Fig. 39) and 5-HT
reuptake (Fig. 40) were decreased in the cultures maintained in the ECM. In contrast,
total protein content was not changed (Fig. 42).
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Fig. 36. Dose-dependent effect of astroglial-derived conditioned media (CM) on
neuronal [3H]5-HT uptake. Fetal rhombencephalic neurons were cultured in the presence
of conditioned media obtained from astroglial cultures. Results are expressed as the
percentage of the value in control cultures grown in chemically defined media. In the
control cultures the mean uptake of [3H]5-HT was 0.226 pmol/well/20 min. The error bars
represent the SD (n = 3 experiments. In each experiment 4 different wells were averaged
to get an n of 1.).
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Fig. 37. Effects of CCM and ECM on total DNA content. Fetal rhombencephalic
neurons were cultured in the presence of conditioned media obtained from astroglial
cultures. CCM and ECM were derived from astroglial cultures grown for 4 days in the
absence or presence of 100 mM ethanol. Results are expressed as the percentage of DNA
in control cultures grown in chemically defined media (CDM). In the CDM cultures the
mean DNA content was 2.99 µg/well. Each column and the error bar represent the mean
± SD in one experiment. The findings were replicated in a second experiment. *p<0.05
compared to CCM.
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Fig. 38. Effects of CCM and ECM on total cell number. Fetal rhombencephalic
neurons were cultured in the presence of conditioned media obtained from astroglial
cultures. CCM and ECM were derived from astroglial cultures grown for 4 days in the
absence or presence of 100 mM ethanol. Results are expressed as the percentage of
surviving cell number in the control cultures grown in chemically defined media (CDM).
In the CDM cultures the mean was 4.47 x 104 cells/well. Each column and the error bar
represent the mean ± SD in one experiment. The findings were replicated in a second
experiment. *p<0.05 compared to CCM.
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Fig. 39. Effects of CCM and ECM on the number of 5-HT immunopositive cells.
Fetal rhombencephalic neurons were cultured in the presence of conditioned media
obtained from astroglial cultures. CCM and ECM were derived from astroglial cultures
grown for 4 days in the absence or presence of 100 mM ethanol. Results are expressed
as the ratio of the number of 5-HT immunopositive cells to the total number of neurons.
Each column and the error bar represent the mean ± SD in one experiment. The findings
were replicated in a second experiment. *p<0.05 compared to CCM.
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Fig. 40. Effects of CCM and ECM on neurite length. Fetal rhombencephalic neurons
were cultured in the presence of conditioned media obtained from astroglial cultures.
CCM and ECM were derived from astroglial cultures grown for 4 days in the absence or
presence of 100 mM ethanol. The longest neurite on each neuron was measured from cell
body to the end of neurite. The results are expressed as the relative number of neurons
which had a neurite length in the categories, less than 250 µm, 250 - 500 µm or greater
than 500 µm.
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Fig. 41. Effects of CCM and ECM on
neuronal [3H]5-HT uptake. Fetal
rhombencephalic neurons were cultured in the presence of conditioned media obtained
from astroglial cultures. CCM and ECM were derived from astroglial cultures grown for
4 days in the absence or presence of 100 mM ethanol. Results are expressed as the
percentage of the [3H]5-HT uptake in control cultures grown in chemically defined media
(CDM). In the CDM cultures the mean [3H]5-HT uptake was 6.32 pmol/mg protein/20
min. Each column and the error bar represent the mean ± SD in one experiment. The
findings were replicated in a second experiment. *p<0.05 compared to CCM.
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Fig. 42. Effects of CCM and ECM on neuronal protein content. Fetal rhombencephalic
neurons were cultured in the presence of conditioned media obtained from astroglial
cultures. CCM and ECM were derived from astroglial cultures grown for 4 days in the
absence or presence of 100 mM ethanol. Results are expressed as the percentage of
protein in control cultures grown in chemically defined media (CDM). In the CDM
cultures the mean protein content was 17.49 µg/well. Each column and the error bar
represent the mean ± SD in one experiment. The finding was replicated in the second
experiment.
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CHAPTER V
DISCUSSION

Animals
The FAS model used in this dissertation included rats which were fed alcohol
chronically before conception and throughout the gestation. Since maternal malnutrition,
especially protein deficiency, is known to affect brain development (Druse et al., 1980;
Smith and Druse, 1982), protein-rich, and nutritionally well-balanced diets (Norohona
and Druse, 1982) were pair-fed to control and ethanol consuming rats. The comparable
weight gains of mothers and of offspring in the pair-fed groups indicate that these two
groups of rats were comparably nourished. Although the ad lib control rats consumed
more diet and had a greater apparent weight gain during pregnancy, the weights of their
offspring were not significantly different from those of the offspring of pair-fed control
rats. Moreover, we rarely found any significant differences in terms of 5-HT reuptake
and 5-HT1A binding sites between the offspring of pair-fed and ad lib control rats.
Buspirone treatment did not affect diet consumption. This is consistent with a
previous report in which subcutaneous injections of low doses of buspirone (up to 1.25
mg/kg) increased food intake, but a higher dose (2.5 - 5 mg/kg) such as used in this
study did not affect food consumption (Fletcher and Davies, 1990). Even though
111
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buspirone-treated saline rats had a decreased maternal weight gain, the number of
pups/litter and the pup weight were not different.
Blood alcohol levels were in the physiological range for humans. Our values
ranged from 75 to 120 mg/dl. In most states one is arrested for drunken driving with a
BAL of 100 mg/dl or less. Since it has been recognized that heavier ethanol exposure
leads to more severe effects in human FAS (Streissguth et al., 1988), one might expect
higher BALs to cause more damage than that seen in our studies.

5-HT Reuptake Sites and 5-HT 1A Receptor Sites
In order to quantitate the 5-HT nerve terminals, quantitative autoradiography
(QAR) of PH]citalopram-labeled serotonin reuptake sites was used. 5-HT reuptake sites
are highly localized on the 5-HT nerve terminals (Kuhar and Aghajanian, 1973) and
citalopram selectively binds to the 5-HT reuptake sites (D 'Amato et al., 1987a; Duncan
et al., 1992). Compared to binding assays using membrane homogenates, QAR provides
improved localization and quantitation of reuptake sites in small, anatomically defined
regions of the brain (Young and Kuhar, 1979; Palacios et al., 1981; Pazos and Palacios,
1985).
The 5-HT reuptake sites in the dorsal raphe seem to reach a peak density at about
3 weeks after birth, and at this age the dorsal raphe contained the highest concentration
of 5-HT reuptake sites among the regions (Pranzatelli and Martens, 1992). A dense patch
of 5-HT reuptake sites was found in the parietal cortex at PN5 and PN19. This
observation resembles the innervation pattern of 5-HT immunopositive fibers observed
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by D' Amato et al. (1987b).
Ligand binding was assessed at 2 concentrations; one concentration approximates
the K0 and the second concentration was three times the K0 • Any changes of ligand
binding at the concentration approximating K0 can potentially detect changes in the both
affinity and density of receptors, whereas abnormalities detected at the higher
concentration can detect changes only in the density of receptors. In some regions
ethanol-associated differences are found at one but not both concentrations. However,
generally a similar trend was found at the other ligand concentration, suggesting that
perhaps a greater n was needed to demonstrate significance at other concentration.
The results of quantitation of 5-HT reuptake sites showed that in the offspring
of ethanol-fed rats 5-HT reuptake sites were increased in the dorsal raphe at PN5, and
in the median raphe at PN19 and PN35. In contrast to those cell body regions, the
reuptake sites were decreased in the frontal cortex, parietal cortex, lateral hypothalamus,
substantia nigra, medial septum and striatum at PN19. The decreased 5-HT reuptake sites
were also found in the lateral hypothalamus and substantia nigra at PN35. Ethanolassociated changes of 5-HT reuptake sites in dorsal raphe, lateral hypothalamus and
substantia nigra were consistently found in both the first and second investigation. The
changes in the frontal cortex were significant in the second study; similar trends were
found in the first study. In contrast, significant changes in the parietal cortex and median
raphe may not be meaningful because the changes were only significant in one study and
at only one concentration. The results of the first and second studies on 5-HT reuptake
sites were summarized in Table 7. In a previous study from this laboratory, 5-HT
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reuptake sites were measured in few, gross brain regions of the rat offspring (Druse and
Paul, 1989). In that study, 5-HT uptake was decreased in the motor cortex of ethanolexposed rats at both PN19 and PN35. Similarly, decreased 5-HT reuptake sites in the
frontal cortex were found in the present study. In addition, the present study considerably
expands the earlier study by including many more regions and even including fetal brain
tissue.
5-HT reuptake sites were increased in the dorsal raphe of the ethanol-exposed
rats. This finding could indicate 5-HT hyperinnervation (sprouting) due to the ethanolassociated deficit of serotonin, because a similar hyperinnervation of 5-HT fibers has
been observed in the brainstem of neonatal rats that have been treated with 5,7-DHT, a
5-HT neurotoxin (Pranzatelli and Martens, 1992).
In contrast to the raphe region, 5-HT reuptake sites were decreased in the
terminal regions (e.g. frontal cortex, lateral hypothalamus, substantia nigra, medial
septum and striatum). Decreased reuptake sites may indicate the delayed development of
serotonergic fibers in ethanol-exposed rats. This is supported by the observations that the
catch-up growth of 5-HT fibers was found in some regions at later ages. Delayed
development may be caused by either decreased number of raphe 5-HT neurons, or
decreased projections from raphe to target areas or both. In utero ethanol exposure has
been demonstrated to decrease cell number in many regions such as somatosensory
cortex, the hippocampal CA3 region and the cerebellum (Barnes and Walker, 1981;
Bonthius and West, 1990; Miller and Potempa, 1990). Decreased 5-HT projections could
be caused by either alterations in cell adhesion molecules (CAM) or altered levels of
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trophic factors (e.g. 5-HT) or chemotactic factors which guide projecting nerve fibers.
Interestingly, in the cell line (neurolastoma x glioma hybrid) ethanol inhibited the cellcell adhesion by altering the level of N-CAM and Ll (Charness et al., 1994).
In utero ethanol may indirectly affect the development of 5-HT neurons possibly

through the modulation of trophic factors, such as 5-HT. Previous studies from this
laboratory as well as others demonstrated that serotonin content was decreased in the
offspring of ethanol-exposed animals (Druse et al., 1991; Elis et al., 1976, 1978;
Rathbun and Druse, 1985). More importantly, the decreased serotonin content was
observed in the fetuses as early as ED15 in the brainstem and ED19 in the cortex (Druse
et al., 1991). Fetal 5-HT acts as a developmental signal (Lauder, 1990). In addition to
influencing growth cone elongation and neurite outgrowth to target areas (Haydon et al.,
1984, 1987), 5-HT has been demonstrated to regulate the normal development and
maturation of serotonergic neurons in the fetal brain (Budnik et al., 1989; De Vitry et
al., 1986; Whitaker-Azmitia and Azmitia, 1986; Whitaker-Azmitia et al., 1987). The
effects of serotonin on its own neurons seem to be mediated through interaction with 5HT1A receptors (Whitaker-Azmitia and Azmitia, 1986; Whitaker-Azmitia et al., 1987).
Treatment of pregnant rats with buspirone, a 5-HT1A receptor agonist, prevented the
abnormal development of 5-HT terminals in the dorsal raphe (PN5), medial septum
(PN19), frontal cortex (PN19), substantia nigra (PN35) and lateral hypothalamus (PN19
and PN35) in the offspring of ethanol-exposed rats. This suggests that at least part of the
abnormalities in the 5-HT terminal density induced by in utero ethanol exposure were
due to decreased stimulation of 5-HT1Areceptors. The effects of ethanol and buspirone
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on citalopram binding to 5-HT reuptake sites were summarized in Table 7. These results
are consistent with a previous report that the cortical deficit of 5-HT and its metabolite,
5-HIAA, in ethanol-exposed offspring was prevented by maternal treatment with
buspirone (Tajuddin and Druse, 1993).
There could be possible mechanisms by which in utero ethanol alters 5-HT
content. Serotonin synthesis depends on the concentration of tryptophan, the substrate for
tryptophan hydroxylase (Tong and Kaufman, 1975). The amount of tryptophan transport
may be decreased, since ethanol impairs placental nutrient transport (Schenker, 1989).

In utero ethanol exposure may indirectly affect 5-HT content by affecting other systems
such as the production of corticosterone. Pregnant rats fed with alcohol-containing diet
increased plasma corticosterone (Weinberg and Bezio 1987). It has been also shown that
rats exposed to ethanol in utero have elevated plasma and brain corticosterone levels at
birth (Kakihana et al., 1980; Taylor et al., 1982a). Alteration of corticosterone level in
fetus as well as mother may affect the normal development of tryptophan hydroxylase,
a serotonin synthesizing enzyme since corticosterone is required for the normal
development of tryptophan hydroxylase (Sze, 1980).
The results of the present experiments also indicate that in utero ethanol exposure
has region- and age-specific effects on the development of 5-HT fibers. Similar regionspecific effects of in utero ethanol exposure have been observed in the hippocampus.
Hippocampal pyramidal cells in the CAI region are decreased by prenatal ethanol
exposure, whereas the cells in the CA3 region were not affected (Barnes and Walker,
1981). The present studies also indicate that many of the detected developmental
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abnormalities are transient. Transient, age-specific ethanol effects have also been
demonstrated in the cerebellum (Volk, 1977).
In some regions (e.g. the parietal cortex and striatum) buspirone did not prevent
or reverse the abnormalities of 5-HT terminal density. This may be due to differences
between the timing of the buspirone treatment (ED13 to ED21) and key developmental
processes in the unaffected regions. Alternatively, ethanol-associated 5-HT terminal
abnormalities in these regions may be due to factors other than the fetal deficit of
serotonin. In utero ethanol exposure may affect the production of trophic factors, which
consequently affect the development of 5-HT terminals. This effect may be mediated by
ethanol's action on astroglial cells. Astroglial cells are known to produce growth factors
which are essential for the neuronal survival and differentiation during brain development
(Manthorpe et al., 1986).
The development of postsynaptic 5-HT1A receptors were increased in the dentate
gyros at PN19 and decreased in the parietal cortex at PN35 by ethanol exposure in utero.
In contrast, the development of 5-HT1A receptors in the raphe at both PN19 and PN35
was not affected. Although the binding of PH]-8-0H-DPAT in the raphe regions of the
fetal brain was not measurable in this study, membrane homogenate binding studies from
this laboratory demonstrated that the binding of 10 nM [3H]-8-0H-DPAT was
significantly increased in ethanol-exposed rat fetuses on ED19 (Druse et al., 1991). Thus,

in utero ethanol exposure adversely affects the developmental pattern of 5-HT1A receptors.
Decreased fetal serotonin may contribute to the developmental abnormalities in
5-HT 1A receptors. This hypothesis is supported by studies that found delayed 5-HT target
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differentiation in the offspring brain, when pregnant rats were treated with pCPA, a 5HT synthesis inhibitor (Lauder and Krebs, 1978). The expression of 5-HT 1 receptors in
those offspring was affected in both brainstem and forebrain regions (Whitaker-Azmitia
et al., 1987). However, buspirone treatment during the embryonic period did not always
prevent the effects of in utero ethanol exposure on 5-HT 1A receptors. Table 8 summarized
the effects of ethanol and buspirone on 8-0H-DPAT binding to 5-HT 1A receptors. This
suggests that the abnormal development of 5-HT1A receptors in ethanol-exposed rats may
be due to more than the decreased stimulation of 5-HT 1A receptors on developing raphe
neurons. There may also be altered levels of other trophic factors such as astroglialderived growth factors or decreased stimulation of other fetal brain 5-HT receptors (e.
g. 5-HT2 receptors).
The mechanism by which buspirone exerts its effects on the fetal brain is
presently unknown. However, the effects of buspirone in the adult brain are mediated
through its interaction with 5-HT 1A receptors. Buspirone binds to 5-HT 1A receptors with
high affinity as indicated by an IC 50 of 9.5 nM for displacing PH]-8-0H-DPAT
(Peroutka,

1985). In addition, the binding pattern of in vivo PH]buspirone

autoradiography is remarkably similar to the distribution pattern of 5-HT1A receptors
(Matheson and Tunnicliff, 1991). Electrophysiological, biochemical and pharmacological
studies demonstrated that buspirone acts as a full agonist on the 5-HT 1A receptors of
serotonergic dorsal raphe neurons (Meller et al., 1990; VanderMaelen et al., 1986). In
the hippocampus buspirone acts as a partial agonist on the postsynaptic 5-HT1A receptors
(Andrade and Nicoll, 1987; Yocca et al., 1986). Since 5-HT1A receptors and mRNA are

119

present in the fetal rat brain (Daval et al., 1987; Hillion et al., 1990), the effects of
maternal buspirone treatment are presumably mediated through its action on fetal 5-HT 1A
receptors. Buspirone not only acts on the neuronal receptors, but may also act on the
astroglial 5-HT1A receptors, whose activation stimulates the production of serotonergic
growth factors, such as SlOOJ} (Azmitia et al., 1990; Whitaker-Azmitia and Azmitia,
1989; Whitaker-Azmitia et al., 1990).
There is also the possibility that the effects of buspirone could be mediated
through other neurotransmitter systems. Although its binding affinity to D 2 receptors is
low as indicated by an IC50 of 260 nM for displacement of [3H]spiperone from striatal
membranes (Riblet et al., 1982), buspirone can act on dopamine D2 receptors as an
antagonist. The latter effect consequently increases dopaminergic neurotransmission
(Riblet et al., 1984). One also can not exclude the possibility that buspirone treatment
elevates maternal ACTH, corticosterone and prolactin (Gilbert et al.,

1988;

Montefrancesco et al., 1990; Meltzer et al., 1991), and that these changes contribute to
the protective effects of buspirone. In fact, ACTH stimulates the development of
serotonergic neurons in culture (Davila et al., 1986).

Effects of Astroglial Cells on the Survival and
Differentiation of 5-HT Neurons In Vitro
During brain development astroglial cells play an important role in the proper
maturation of the nervous system. For example, radial glial cells guide the migration of
immature neurons (Rakic, 1972). Astroglial cells secrete soluble molecules which are
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essential for neuronal growth and survival (Banker, 1980; Kadle et al., 1988; Lieth et
al., 1989; Manthorpe et al., 1986; Muller and Seifert, 1982). Prenatal exposure to
ethanol induces premature degradation of the network of radial glial fibers in the cortex
(Miller and Robertson, 1993).
Ethanol exposure has been shown to alter the function of astroglial cells. For
example, ethanol decreases glutamine synthetase activity in astroglial cells (Babu et al.,
1994; Davies and Vernadakis, 1984) as well as hexose uptake (Singh et al., 1990). It
appears that astroglial cells are more susceptible to ethanol than neurons in terms of their
function (Babu et al., 1994; Davies and Vernadakis, 1984; Guerri et al., 1990; Snyder
et al., 1992). When rhombencephalic astroglial cells and neurons were cultured in a
serum-containing media, ethanol decreased rhombencephalic astroglial protein content
and astroglial 5-HT uptake (Lokhorst and Druse, 1993b), while having no effect on the
rhombencephalic neuronal protein and 5-HT uptake (Lokhorst and Druse, 1993b). In
addition, glutamine synthetase activity was decreased in the astroglial cells derived from
the ethanol-treated rats, whereas the neuron specific enolase activity was not affected in
the neurons derived from the same animal (Babu et al., 1994). The ethanol-associated
decrement in astroglial protein content and synthesis may be indicative of decreased
astroglial production of neurotrophic factors.
The results of the present cell culture study indicate that conditioned media (CM),
derived from target astroglia, contained neuronal growth factors since CM enhanced the
number of neurons and 5-HT immunopositive neurons, total DNA content, and 5-HT
uptake. The effect of CM on 5-HT immunopositive neurons and serotonin uptake suggest
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that target astroglial cells produce growth factors essential for serotonergic neurons as
well as other neurons.
Total number of neurons, total DNA content and the number of 5-HT
immunopositive neurons were decreased in the cultures grown in the conditioned media
derived from astroglial cells treated with 100 mM ethanol for 4 days (ECM). Serotonin
uptake was also decreased in the cultures grown in the ECM. The cultures showed a
disturbed pattern of neurite outgrowth; the relative number of neurons having medium
length neurites was decreased. This demonstrates that astroglial exposure to ethanol
decreases the astroglial production of growth factors which are involved with neuronal
survival and growth. The possible neurotrophic factors which could be affected by
ethanol include SlOOB, fibroblast growth factor (FGF), epidermal growth factor (EGF)
and insulin-like growth factors I and II (IGF-1 & IGF-11). SlOOB is synthesized and
secreted mainly by astrocytes and acts on CNS neurons (reviewed by Walicke, 1989).
Serotonergic neurons are among those which respond to SlOOB. FGF appears to be
synthesized by astrocytes (Ferrara et al., 1988). Basic FGF (bFGF) has been shown to
promote neuron survival and neurite extension in hippocampal (Walicke et al., 1986),
cortical (Morrison et al., 1986) and mesencephalic neurons (Ferrari et al., 1989) in vitro.
EGF immunoreactivity and EGF receptors have been demonstrated in the frontal and
parietal cortex, and striatum of developing rats (Fallon et al., 1984; Quirion et al.,
1988). EGF promotes the maturation of telencephalic neurons (Monnet-Tschudi and
Honegger, 1989). The receptors for IGF-1 and IGF-11 are found in fetal and adult
mammalian brain (reviewed by Baskin et al., 1988). IGF-1 promotes survival and neurite
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outgrowth of fetal hypothalamic neurons (Torres-Aleman et al., 1990).
There are several possible mechanisms by which ethanol affects astroglial
function, including the production of growth factors. Chronic ethanol exposure has been
shown to alter phosphoinositide (Pl) hydrolysis in astrocytes (Ritchie et al., 1988). PI
hydrolysis generates diacylglycerol which functions as an essential cofactor for protein
kinase C, and inositol triphosphate which regulates ca+ 2 mobilization. Thus, altered PI
hydrolysis may lead to the alteration of Ca +2 and protein kinase C levels. Both Ca +2 and
protein kinase C are important mediators of cell proliferation and differentiation
(reviewed by Clapham, 1995; Clemens et al., 1992; Nishizuka, 1992; Rosen et al., 1995;
Whitaker, 1995). Cytosolic ca+ 2 levels seem to be quantitatively correlated with
transcription factor expression (Negulescu et al., 1994). Intracellular Ca+ 2 levels are also
involved in cell death such as programmed cell death (Nicotera et al., 1994) and
excitotoxicity (Schanne et al., 1979; Dugan and Choi, 1994). Therefore, effects of
ethanol on the alteration of PI hydrolysis may be ultimately involved in gene regulation
and/or cell death. Ethanol may alter gene regulation by acting through alterations of
second messengers, and by disturbing gene transcription. In fact, ethanol exposure has
been shown to increase the transcription rate of the stress protein Hsc70 and tyrosine
hydroxylase in neural cell lines in culture (Miles et al., 1991; Gayer et al., 1991). In
primary cultures of cortical astrocytes ethanol has been also shown to increase the GF AP
mRNA levels (Fletcher and Shain, 1993).

Concluding Remarks
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The present study demonstrates that in utero ethanol exposure adversely affects
the development of 5-HT reuptake sites and 5-HT1A receptors. This study also
demonstrates that ethanol exposure decreases astroglial production of neurotrophic
factors. Maternal treatment with buspirone, a 5-HT 1A agonist, has been shown in this and
a prior study to overcome or prevent some of the damaging effects of ethanol. Therefore,
the mechanism by which ethanol causes these abnormalities may be due partly to the
decreased stimulation of 5-HT1A receptors and decreased production of astroglial cellderived growth factors that are essential for normal development of 5-HT and other
neurons. Decreased stimulation of raphe 5-HT 1A receptors may result in altered
development of 5-HT terminals as seen in altered 5-HT reuptake sites. Decreased
stimulation of astroglial 5-HT1A receptors potentiates the ethanol effect on the decreased
production of astroglial cells.
However, additional studies are needed to assess buspirone's effects on other
neurotransmitter systems which were affected by in utero ethanol exposure. In addition,
more studies are needed to address the mechanism by which in utero ethanol exposure
decreases the serotonin content and astroglial growth factors in the fetal brain. A
schematic diagram summarizing the postulated action mechanism of ethanol and
buspirone is presented in Fig. 43.

TABLE 7
EFFECTS OF ETHANOL AND BUSPIRONE ON CITALOPRAM BINDING TO 5-HT
REUPTAKE SITES

Region

Age

FCx

PN19
PN35

PCx

PN5
PN19
PN35

Study 1

-.!.-.!.-

0.8 nM
Study 2

Buspirone

.i

.i

Study 1

2.4nM
Study 2

-.!.-

.i

Buspirone

.i

MS

PN19
PN35

.i

.i

.i

.i

Striatum

PN19
PN35

.i

.i

-.!.-

-.!..i

CA3

PN19
PN35

LH

PN19
PN35

.i
.i

.i
.i

.i
.i

.i
-.!.-

.i

AMG

PN19
PN35

SN

PN19
PN35

-.!..i

.i
.i

.i
-.!.-

.i

.i

DR

ED19
PN5
PN19
PN35

t

-t-

-t-

-tt

t

t

t

MnR

PN19
PN35

t

.i

t

The solid arrows ct' .i) indicate that values from ethanol-exposed offspring were significantly different from
those of control saline-treated offspring (P < 0.05). The broken arrows (- t-, -.!.-) indicate nonsignficant
trends (P > 0.05). The dotted lines (---) are used to demonstrate that in utero ethanol exposure had no effect
on 5-HT reuptake sites. Abbreviations are same as in Table 5.
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TABLE 8
EFFECTS OF ETHANOL AND BUSPIRONE ON 8-0H-DPAT BINDING TO 5-HT1A
RECEPTORS
1.1 nM
Region

Age

FCx

PN19
PN35

PCx

PN19
PN35

DG

PN5
PN19
PN35

LS

PN19
PN35

DR

PN19
PN35

MnR

PN19
PN35

Study 1

Study 2

2.75 nM
Buspirone

Study 1

Study 2

t

t

Buspirone

"'
-t-

t

t

This table summarizes the results obtained in two experiments in which [3H)-8-0H-DPAT was
used to radiolabel 5-HT1A receptors. The solid arrows (t, t) indicate that values from ethanolexposed offspring were significantly different from those of control saline-treated offspring (P <
0.05). The broken arrows (- t-, -t-) indicate nonsignficant trends (P > 0.05). The dotted lines
(---) are used to demonstrate that in utero ethanol exposure had no effect on 5-HT IA receptors.
Abbreviations are same as in Table 3.
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Astroglia
5-HT A
1

Target Neuron

Fig. 43. Proposed action mechanisms of ethanol and buspirone on the serotonergic
system. Ethanol decreases serotonin content and astroglial production of neurotrophic
factors. Decreased serotonin less stimulates raphe 5-HT 1A receptors, which results in
altered development of serotonergic fibers. Decreased serotonin also less stimulates
astroglial 5-HT IA receptors, which potentiates ethanol's effect on the decreased production
of neurotrophic factors. Buspirone prevents ethanol-associated abnormal development of
serotonergic fibers by stimulating both raphe and astroglial 5-HT 1A receptors. However,
further studies are required for the effects of buspirone acting on D 2 receptors as an
antagonist, which, in turn, affects the development of 5-HT fibers. Abbreviations are as
follows: D2 , dopamine D2 receptor; 5-HT 1A, 5-HT 1A receptor; NTF, neurotrophic factor;
TR, tryptophan.
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APPENDIX
STATISTICAL SIGNIFICANCE LEVEL OF BINDING ASSAY RESULTS
Figure

Region

Age

[Ligand]
[

3

DR

3

PN 5
PN19
PN35

4

MnR

PN19
PN35

5

LH

PN19
PN35

6

SN

PN19
PN35

7

Amygdala

PN19
PN35

8

CA3

PN19
PN35

9

PCx

PN5
PN19

F-ratio

P value

H)Citalopram
0.8
2.4
0.8
2.4
0.8
2.4

nM
nM
nM
nM
nM
nM

19.4
2.6
0.1
2.6
1.4
0.4

0.0004
0.12
0.9
0.1
0.3
0.7

0.8
2.4
0.8
2.4

nM
nM
nM
nM

1.2
0.6
7.7
0.4

0.3
0.6
0.0071
0.7

0.8
2.4
0.8
2.4

nM
nM
nM
nM

12.2
8.2
5.3
12.1

0.001
0.006
0.02
0.0013

0.8
2.4
0.8
2.4

nM
nM
nM
nM

2.4
6.6
17.8
2.9

0.1
0.01
0.0005
0.09

0.8
2.4
0.8
2.4

nM
nM
nM
nM

0.2
1.3
1.2
1.4

0.8
0.3
0.3
0.3

0.8
2.4
0.8
2.4

nM
nM
nM
nM

0.1
0.7
0.8
0.2

0.9
0.5
0.5
0.8

0.8nM
2.4 nM
0.8 nM
2.4 nM

0.1
0.3
0.3
1.5

0.9
0.8
0.8
0.3
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Figure

10

Region

FCx

Age

[Ligand]

F-ratio

P value

PN35

0.8 nM
2.4 nM

1.4
0.1

0.3
0.9

PN19

0.8
2.4
0.8
2.4

0.9
1.3
0.6
1.5

0.43
0.3
0.6
0.3

1.1 nM
2.75 nM
1.1 nM
2.75 nM
1.1 nM
2.75 nM

3.8
2.0
1.0
4.0
0.4
0.1

0.6
0.2
0.4
0.05
0.7
0.9

1.1 nM
2.75 nM
1.1 nM
2.75 nM

1.0
1.4
4.2
4.3

0.4
0.3
0.04
0.04

1.1 nM
2.75 nM
1.1 nM
2.75 nM

0.2
1.7
1.9
1.2

0.8
0.2
0.2
0.3

1.1 nM
2.75 nM
1.1 nM
2.75 nM

1.3
1.0
0.4
2.0

0.3
0.4
0.7
0.2

1.1 nM
2.75 nM
1.1 nM
2.75 nM

2.3
1.3
0.1
0.3

0.2
0.3
0.9
0.8

1.1 nM
2.75 nM
1.1 nM
2.75 nM

0.9
0.6
0.7
1.9

0.5
0.6
0.5
0.2

PN35

[

12

DG

3

H)-80H-DPAT

PN5
PN19
PN35

13

PCx

PN19
PN35

14

FCx

PN19
PN35

15

LS

PN19
PN35

16

DR

PN19
PN35

17

MnR

nM
nM
nM
nM

PN19
PN35
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Region

Age

[Ligand]
[

19

FCx

PN19

PN35

20

PCx

PN5

PN19

PN35

21

LH

PN19

3

Group

F-ratio

P value

H]Citalopram

0.8 nM

Ethanol
Buspirone
Interaction

4.2
0.3
2.8

0.09
0.6
0.1

2.4 nM

Ethanol
Buspirone
Interaction

1.3
0.002
7.0

0.3
1.0
0.045

nM

Ethanol
Buspirone
Interaction

0.5
2.0
2.3

0.5
0.2
0.2

2.4 nM

Ethanol
Buspirone
Interaction

0.5
0.03
0.9

0.5
0.9
0.4

0.8 nM

Ethanol
Buspirone
Interaction

0.5
0.3
1.5

0.5
0.6
0.3

2.4nM

Ethanol
Buspirone
Interaction

0.4
0.4
0.2

0.6
0.6
0.6

0.8 nM

Ethanol
Buspirone
Interaction

8.7
0.6
0.1

0.03
0.5
0.8

2.4 nM

Ethanol
Buspirone
Interaction

0.04
0.2
0.03

0.8
0.7
0.9

0.8 nM

Ethanol
Buspirone
Interaction

0.03
1.4
2.2

0.9
0.3
0.2

2.4 nM

Ethanol
Buspirone
Interaction

0.3
0.9
1.8

0.6
0.4
0.2

0.8 nM

Ethanol
Buspiron
Interaction

13.7
2.3
9.8

O.Ql
0.2
0.02

0.8
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Region

Age

PN35

[Ligand]

Group

F-ratio

P value

2.4 nM

Ethanol
Buspirone
Interaction

7.4
0.1
0.1

0.03
0.7
0.7

0.8 nM

Ethanol
Buspirone
Interaction

1.7
12.5
11.6

O.Ql
O.Ql

Ethanol
Buspirone
Interaction

O.Ql
2.2

0.2
0.9
0.2

0.8 nM

Ethanol
Buspirone
Interaction

27.0
0.2
0.99

0.002
0.6
0.4

2.4 nM

Ethanol
Buspirone
Interaction

12.1
0.2
3.8

0.7

0.8 nM

Ethanol
Buspirone
Interaction

5.9
3.8
1.0

0.05
0.1
0.4

2.4 nM

Ethanol
Buspirone
Interaction

20.4
0.5
0.17

0.004
0.4
0.7

0.8 nM

Ethanol
Buspirone
Interaction

8.0
0.3
6.4

0.03
0.6
0.04

2.4 nM

Ethanol
Buspirone
Interaction

5.7
7.1
2.3

0.05
0.04
0.2

0.8 nM

Ethanol
Buspirone
Interaction

0.05
0.7
0.5

0.8
0.4
0.5

2.4 nM

Ethanol
Buspirone
Interaction

0.4
1.1

0.5
0.3
0.8

2.4 nM

22

SN

PN19

PN35

23

MS

PN19

PN35

1.83

O.l

0.2

O.Ql
O.l
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Region

Age

[Ligand]

Group

F-ratio

P value

24

Striatum

PN19

0.8 nM

Ethanol
Buspirone
Interaction

8.7
1.3
0.5

0.03
0.3
0.5

2.4 nM

Ethanol
Buspirone
Interaction

38.7
0.003
0.1

0.0008
0.96
0.8

0.8 nM

Ethanol
Buspirone
Interaction

0.03
0.3
0.4

0.9
0.6
0.6

2.4 nM

Ethanol
Buspirone
Interaction

7.3
3.3
0.3

0.04
0.1
0.6

0.8 nM

Ethanol
Buspirone
Interaction

0.01
0.9
0.6

0.9
0.4
0.5

2.4 nM

Ethanol
Buspirone
Interaction

0.05
0.3
0.4

0.8
0.6
0.5

0.8 nM

Ethanol
Buspirone
Interaction

4.3
1.9
0.3

0.1
0.2
0.6

2.4 nM

Ethanol
Buspirone
Interaction

6.4
0.2
1.4

0.045
0.7
0.3

0.8 nM

Ethanol
Buspirone
Interaction

0.8
0.5
0.5

0.4
0.5
0.5

2.4 nM

Ethanol
Buspirone
Interaction

0.3
0.0002
1.8

0.6
0.99
0.2

0.8 nM

Ethanol
Buspirone
Interaction

0.08
0.001
5.0

0.8
0.98
0.07

2.4 nM

Ethanol
Buspirone
Interaction

3.0
0.9
0.002

0.1
0.4
0.97

PN35

25

DR

ED19

PN5

PN19

PN35
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Figure

Region

Age

[Ligand]

Group

F-ratio

P value

26

MnR

PN19

0.8 nM

Ethanol
Buspirone
Interaction

0.2
2.2
2.2

0.7
0.2
0.2

2.4 nM

Ethanol
Buspirone
Interaction

30.2
0.00
4.6

0.003
0.999
0.09

0.8 nM

Ethanol
Buspirone
Interaction

9.3
1.9
2.2

0.02
0.2
0.2

2.4 nM

Ethanol
Buspirone
Interaction

0.4
0.2
0.007

0.5
0.7
0.9

0.8 nM

Ethanol
Buspirone
Interaction

2.5
0.2
0.1

0.2
0.7
0.7

2.4 nM

Ethanol
Buspirone
Interaction

0.06
0.08
0.0097

0.8
0.8
0.9

0.8 nM

Ethanol
Buspirone
Interaction

0.3
0.02
0.5

0.6
0.9
0.5

2.4 nM

Ethanol
Buspirone
Interaction

0.6
0.2
0.3

0.5
0.7
0.6

0.8 nM

Ethanol
Buspirone
Interaction

4.4
8.6
0.2

0.08
0.03
0.7

2.4 nM

Ethanol
Buspirone
Interaction

32.0
0.0053
0.0083

0.001
0.9
0.9

0.8 nM

Ethanol
Buspirone
Interaction

0.2
0.03
0.9

0.7
0.9
0.4

2.4 nM

Ethanol
Buspirone
Interaction

0.4
0.07
0.09

0.5
0.8
0.8

PN35

27

CA3

PN19

PN35

28

Amygdala

PN19

PN35
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Region

Age

[Ligand]
[

29

DG

PN5

PN19

PN35

30

PCx

PN19

PN35

31

DR

PN19

3

Group

F-ratio

P value

H]-8-0H-DPAT

1.0 nM

Ethanol
Buspirone
Interaction

0.1
1.8
0.6

0.7
0.2
0.5

2.7nM

Ethanol
Buspirone
Interaction

0.09
0.5
0.5

0.8
0.5
0.5

1.0 nM

Ethanol
Buspirone
Interaction

5.0
0.8
2.5

0.07
0.4
0.2

2.7nM

Ethanol
Buspirone
Interaction

9.4
0.07
2.02

0.02
0.8
0.2

1.0 nM

Ethanol
Buspirone
Interaction

0.2
0.04
0.2

0.7
0.8
0.7

2.7 nM

Ethanol
Buspirone
Interaction

0.03
0.4
0.2

0.9
0.6
0.7

1.0 nM

Ethanol
Buspirone
Interaction

0.3
0.2
0.3

0.6
0.7
0.6

2.7 nM

Ethanol
Buspirone
Interaction

1.3
6.7
0.8

0.3
0.05
0.4

1.0 nM

Ethanol
Buspirone
Interaction

8.9
1.4
3.0

0.03
0.3
0.1

2.7 nM

Ethanol
Buspirone
Interaction

8.5
3.4
2.8

0.03
0.1
0.2

1.0 nM

Ethanol
Buspirone
Interaction

0.3
0.04
0.6

0.6
0.8
0.5
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Region

Age

PN35

32

MnR

PN19

PN35

33

LS

PN19

PN35

[Ligand]

Group

F-ratio

P value

2.7 nM

Ethanol
Buspirone
Interaction

2.8
0.5
0.2

0.1
0.5
0.7

1.0 nM

Ethanol
Buspirone
Interaction

0.0004
0.2
0.1

0.98
0.6
0.7

2.7 nM

Ethanol
Buspirone
Interaction

0.4
0.6
0.1

0.5
0.5
0.7

1.0 nM

Ethanol
Buspirone
Interaction

0.32
0.119
0.7

0.58
0.74
0.4

2.7 nM

Ethanol
Buspirone
Interaction

0.006
0.1
0.1

0.9
0.7
0.8

1.0 nM

Ethanol
Buspirone
Interaction

0.4
0.2
0.007

0.5
0.7
0.9

2.7nM

Ethanol
Buspirone
Interaction

0.2
0.03
0.00

0.7
0.9
0.998

1.0 nM

Ethanol
Buspirone
Interaction

0.02
0.4
1.7

0.9
0.6
0.2

2.7nM

Ethanol
Buspirone
Interaction

0.02
0.03
3.9

0.9
0.9
0.1

1.0 nM

Ethanol
Buspirone
Interaction

9.6
0.003
6.8

0.02
0.96
0.04

2.7 nM

Ethanol
Buspirone
Interaction

0.9
2.4
20.0

0.4
0.2
0.0042
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Region

Age

[Ligand]

Group

F-ratio

P value

34

FCx

PN19

1.0 nM

Ethanol
Buspirone
Interaction

0.004
0.3
2.9

0.96
0.6
0.2

2.7 nM

Ethanol
Buspirone
Interaction

0.4
0.2
4.4

0.5
0.6
0.09

1.0 nM

Ethanol
Buspirone
Interaction

0.9
4.2
9.4

0.4
0.1
0.03

2.7 nM

Ethanol
Buspirone
Interaction

0.4
1.7
1.8

0.5
0.2
0.2

PN35

REFERENCES
Abel, E.L. (1979) Prenatal effects of alcohol on adult learning in rats. Pharmacol.
Biochem. Behav. 10:239-243.
Abel, E.L. (1984) Fetal Alcohol Syndrome and Fetal Alcohol Effects. Plenum Press,
New York.
Abel, E.L. and Sokol, R.J. (1991) A revised conservative estimate of the incidence of
FAS and its economic impact. Alcohol. Clin. Exp. Res. 15:514-524.
Abel, E.L., Jacobson, S. and Sherwin, B.T. (1983) In utero acohol exposure: Functional
and structural brain damage. Neurobehav. Toxicol. Tetratol. 5:363-366.
Acsady, L., Halasy, K. and Freund, T.F. (1993) Calretinin is present in non-pyramidal
cells of the rat hippocampus-111. Their inputs from the median raphe and medial
septal nuclei. Neuroscience 52:829-841.
Adell, A., Carceller, A. and Artigas, F. (1993) In vivo brain dialysis study of the
somatodendritic release of serotonin in the raphe neuclei of the rat. Effects of 8hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60: 1673-1681.
Aghajanian, G.K., Rosecrans, J.A. and Sheard, M.H. (1967) Serotonin: release in the
forebrain by stimulation of midbrain raphe. Science 156:402-403.
Aitken, A.R. and Tork, I. (1988) Early development of serotonin-containing neurons and
pathways as seen in wholemount preparations of the fetal rat brain. J. Comp.
Neurol. 274:32-47.
Altaman, H.J., Normile, H.J., Galloway, M.P., Ramirez, A. and Azmitia, E.C. (1990)
Enhanced spatial discrimination learning in rats following 5, 7-D HT-induced
serotonergic deafferentation of the hippocampus. Brain Res. 518:61-66.
Altura, R.M., Altura B.T., Carella, A., Chatterjee, M., Halvey, S. and Tejani, N.
(1983) Alcohol produces spasms of human umbilical blood vessels: relationship
to fetal alcohol syndrome (FAS). Eur. J. Pharmacol. 86:311-312.
Andrade, R. and Nicoll, R.A. (1987) Novel anxiolytics discriminate between postsynaptic
serotonin receptors mediating different physiological responses on single neurons

136

137
of the rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 336:5-10.
Angevine, J.B. and Sidman, R.L. (1961) Autoradiographic study of cell migration during
histogenesis of cerebral cortex in the mouse. Nature 192:766-768.
Apostol, G. and Creutzfeldt, O.D. (1974) Cross-correlation between the activity of septal
units and hippocampal EEG during arousal. Brain Res. 67:65-75.
Aronson, M. and Olegard, R. (1987) Children of alcoholic mothers. Pediatrician 14:5761.
Aronson, M., Kyllerman, M., Sabel, K.-G., Sandin, B. and Olegard, R. (1985) Children
of alcoholic mothers: Developmental, perceptual and behavioural characteristics
as compared to matched controls. Acta. Paediatr. Scand. 74:27-35.
Assaf, S. Y. and Miller, J.J. (1978) The role of a raphe serotonin system in the control
of septal unit activity and hippocampal desynchronization. Neuroscience 3:539-

550.
Auer, R.N., Jensen, M.L. and Whishaw, I.Q. (1989) Neurobehavioral deficit due to
ischemic brain damage limited to half of the CAl sector of the hippocampus. J.
Neurosci. 9: 1641-1647.
Azmitia, E.C. and Segal, M. (1978) An autoradiographic analysis of the differential
ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp.
Neural. 179: 641-668.
Azmitia, E.C. and Gannon, P.J. (1986) Anatomy of the serotonergic system in the
primate and sub-primate brain. Adv. Neural. 43:407-468.
Azmitia, E.C., Dolan, K. and Whitaker-Azmitia, P.M. (1990) S-1008 but not NGF,
EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res.
516:354-356.
Babu, P.P., Kumari, L.R. and Vemuri, M.C. (1994) Differential changes in cell
morphology, macromolecular composition and membrane protein profiles of
neurons and astrocytes in chronic ethanol treated rats. Mol. Cell. Biochem.
130:29-40.
Baillie, P. and Morrison, S.D. (1963) The nature of the suppression of food intake by
lateral hypothalamic lesions in rats. J. Physiol. 165:227-245.
Baker, P.C. and Quay, W.B. (1969) Serotonin metabolism in early embryogenesis, and
the development of brain retinal tissues: a review. Brain Res. 12:273-295.

138
Balagura, S., Wilcox, R.H. and Coscina, D.V. (1969) The effect of diencephalic lesions
on food intake and motor activity. Physiol. Behav. 4:229-233.
Banker, G.A. (1980) Trophic interactions between astroglial cells and hippocampal
neurons in culture. Science 209:809-810.
Bar-Peled, 0., Gross-Isseroff, R., Ben-Hur, H., Hoskins, I., Groner, Y. and Biegon,
A. (1991) Fetal human brain exhibits a prenatal peak in the density of serotonin
5-HT1A receptors. Neurosci. Lett. 127: 173-176.
Barnes, D.E. and Walker, D.W. (1981) Prenatal ethanol exposure permanently reduces
the number of pyramidal neurons in rat hippocampus. Dev. Brain Res. 1:333-340.
Barron, S., Tieman, S.B. and Riley, E.P. (1988) Effects of prenatal alcohol exposure
on the sexually dimorphic nucleus of the preoptic area of the hypothalamus in
male and female rats. Alcohol. Clin. Exp. Res. 12:59-64.
Baskin, D.G., Wilcox, B.J., Figlewicz, D.P. and Dorsa, D.M. (1988) Insulin and
insulin-like growth factors in the CNS. Trends Neurosci. 11: 107-111.
Bauer-Moffett, C. and Altman, J. (1975) Ethanol-induced reductions in the growth of
infant rats. Exp. Neurol. 48:378-382.
Beck, S.G. and Choi, K.C. (1991) 5-Hydroxytryptamine hyperpolarizes CA3
hippocampal pyramidal cells through an increase in potassium conductance.
Neurosci. Lett. 133:93-96.
Bianchi, C., Siniscalchi, A. and Beani, L. (1989) Effect of 5-HT on PH]-acetylcholine
release from guinea pig striatal slices. Br. J. Pharmacol. 97:213-221.
Biegon, A., Kargman, S. and Snyder, L. (1986) Chaterization and localization of
serotonin receptors in human brain post-mortem. Brain Res. 363:91-98.
Bennett, J.P. Jr., Enna, S.J., Bylund, D.B., Gillin, J.C. Wyatt, R.J. and Snyder, S.H.
(1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Arch. Gen.
Psychiatry 36:927-934.
Bliss, T.V.P. (1979) Synaptic plasticity in the hippocampus. Trends Neurosci. 2:42-45.
Bliss, T.V.P., Goddard, G.V. and Riives, M. (1983) Reduction oflong-term potentiation
in the dentate gyros of the rat following selective depletion of Monoamines. J.
Physiol. 334:475-491.
Blue, M.E. and Molliver, M.E. (1985) Postnatal development of the serotonergic

139

innervation of the serotonergic of the cerebral cortex of the rat. Soc. Neurosci.
Abstr. 11: 1128.
Blundell, J.E. (1979) Serotonin and feeding. In: Serotonin in Health and Disease, vol.
5, (ed. W. B. Essman), pp. 403-450. Spectrum, New York.
Bond, N.W. and DiGiusto, E.L. (1976) Effects of prenatal alcohol consumption on openfield behavior and alcohol preference in rats. Psychopharmacology 46: 163-165.
Bond, N.W. and DiGiusto, E.L. (1977) Prenatal alcohol consumption and open-field
behavior in rats: Effects of age at time of testing. Psychopharmacology 52:311312.
Bonthius, D.J. and West, J.R. (1990) Alcohol-induced neuronal loss in developing rats:
increased brain damage with binge exposure. Alcohol. Clin. Exp. Res. 14: 107118.
Borges, S. and Lewis, P.D. (1982) A study of alcohol effects on brain during gestation
and lactation. Teratology 25:283-289.
Borges, S. and Lewis, P.D. (1983) Effects of ethanol on postnatal cell acquisition in the
rat cerebellum. Brain Res. 271:388-391.
Bourgoin S., Faivre-Bauman, A. Benda, P. Glowinski J. and Hamon M. (1974) Plasma
tryptophan and 5-HT metabolism in the CNS of the newborn rat. J. Neurochem.
23:319-327.
Bourgoin, S., Artaud, F., Adrien, J., Hery, F., Glowinski, J. and Hamon, M. (1977)
5-hydroxytryptamine catabolism in the rat brain during ontogenesis. J.
Neurochem. 28:415-422.
Branchey, L. and Friedhoff, A.J. (1976) Biochemical and behavioral changes in rats
exposed to ethanol in utero. Ann. N. Y. Acad. Sci. 273:328-330.
Brien, J.F., Loomis, C.W., Tranmer, J. and McGath, M. (1983) Diposition of ethanol
in human maternal venous blood and amniotic fluid. Am. J. Obstet. Gynecol.
146:181-186.
Brown, N.A., Goulding, E.H. and Fabro, S. (1979) Ethanol embryotoxicity: Direct
effects on mammalian embryos in vitro. Science 206:573-575.
Budnik, V., Wu, C.F. and White, K. (1989) Altered branching of serotonin-containg
neurons in Drosophila mutants unable to synthesize serotonin and dopamine. J.
Neurosci. 9:2866-2877.

140
Bunny, B.S. and Aghajanian, G.K. (1978) d-Amphetamine-induced depression of central
dopamine neurons: evidence for mediation by both autoreceptors and a
striatonigral feedback pathway. Naunyn Schmiedebergs Arch. Pharmacol.
307:255-261.
Burd, L. and Martsolf, J.T. (1989) Fetal alcohol syndrome: diagnosis and syndrome
variability. Physiol. Behav. 46:39-43.
Burton, K. (1956) A study of the conditions and mechanisms of the dephenylamine
reaction for the colorimetric estimation of DNA. Biochem. J. 62:315-323.
Carter, C.J. and Pycock, C.J. (1979) The effects of 5,7-dihydroxytryptamine lesions of
extrapyramidal and mesolimbic sites on spontaneous motor behavior and
amphetamine-induced stereotypy. Naunyn Schmiedebergs Arch. Pharmacol.
308:51-54.
Cedar, H. (1988) DNA methylation and gene activity. Cell 53:3-4.
Chafetz, M.D., Thomson, R.G., Evans, S.H. and Gage, P.H. (1981) Biochemical
specificity of septal hyperactivity: a behavioral discrimination. Behav. Brain Res.
2:409-420.
Charness, M.E., Safran, R.M. and Perides, G. (1994) Ethanol inhibits neural cell-cell
adhesion. J. Biol. Chem. 269:9304-9309.
Chernoff, G.S. (1977) The fetal alcohol syndrome in mice: an animal model. Teratology
15:223-230.
Chubakov, A.R., Gromova, E.A., Konovalov, G.V., Sarkisova, E.F. and Chumasov,
E.I. (1986) The effects of serotonin on the morpho-functional development of rat
cerebral neocortex in tissue culture. Brain Res. 369:285-297.
Chumasov, E.I., Chubakov, A.R., Konovalov, G.V., and Gromova, E.A. (1980) Effect
of serotonin on growth and differentiation of hippocampal cells in culture.
Neurosci. Behav. Physiol. 10: 125-131.
Clapham, D.E. (1995) Calcium signaling. Cell 80:259-268.
Clarren, S.K. and Smith, D.W. (1978) The fetal alcohol syndrome. N. Engl. J. Med.
298: 1063-1067.
Clarren, S.K., Alvord, E.C., Jr., Sumi, S.M., Streissguth, A.P. and Smith, D.W.
(1978) Brain malformations related to prenatal exposure to ethanol. J. Pediatr.
92:64-67.

141
Claustre, Y., Rouquier, L. and Scatton, B. (1988) Pharmacological characterization of
serotonin-stimulated phosphoinositide turnover in brain regions of the immature
rat. J. Pharmacol. &p. Ther. 244: 1051-1056.
Clemens, M.J., Trayner, I. and Menaya, J. (1992) The role of protein kinase C
isoenzymes in the regulation of cell proliferation and differentiation. J. Cell Sci.
103:881-887.
Conry, J. (1990) Neuropsychological deficits in fetal alcohol syndrome and fetal alcohol
effects. Alcohol. Clin. &p. Res. 14:650-655.
Coop, C.F. and McNaughton, N. (1991) Buspirone affects hippocampal rhythmical slow
activity through serotonin 1A rather than dopamine D 2 receptors. Neuroscience
40:169-174.
Coscina, D.V., Grant L.D., Balagura, S. and Grossman, S.P. (1972) Hyperdipsia after
serotonin-depleting midbrain lesions. Nature 235:63-74.
Costall, B., Hui, S.C.G. and Naylor, R.J. (1979) The importance of serotonergic
mechanisms for the induction of hyperactivity by amphetamine and its antagonism
by intra-accumbens (3,4-dihydroxy-phenyl amino)-2-imidazoline (DPI).
Neuropharmacology 18:605-609.
Cowan, P.J., Anderson, I.M. and Grahame-Smith, D.G. (1990) Neuroendocrine effects
of azapirones. J. Clin. Psychopharmacol. 10:21S-25S.
D'Amato, R.J., Largent, B.L., Snowman, A.M. and Snyder, S.H. (1987a) Selective
labeling of serotonin uptake sites in rat brain by PH]citalopram contrasted to
labeling of multiple sites by PH]imipramine. J. Pharmacol. &p. Ther. 242:364371.
D' Amato, R.J., Blue, M.E., Largent, B.L., Lynch, D.R., Ledbetter, D.J., Molliver, M.
E. and Snyder, S.H. (1987b) Ontogeny of the serotonergic projection to rat
neocortex: Transient expression of a dense innervation to primary sensory areas.
Proc. Natl. Acad. Sci. 84:4322-4326.
Daval, G., Verge, D., Becerril, A., Gozlan, H., Sampinato, U. and Hamon, M. (1987)
Transient expression of 5-HT1A receptor binding sites in some areas of rat CNS
during postnatal development. Int. J. Dev. Neurosci. 5: 171-180.
Davies, D.L. and Cox, W.E. (1991) Delayed growth and maturation of astrocytic
cultures following exposure to ethanol: electron microscopic observations. Brain
Res. 547:53-61.

142
Davies, D.L. and Vernadakis, A. (1984) Effects of ethanol on cultured glial cells:
proliferation and glutamine synthetase activity. Dev. Brain Res. 16:27-35.
Davila, M.I., de Kloet, R. and Azmitia, E.C. (1986) Effects of neuropeptides on the
maturation of serotonergic neurons in tissue culture. Soc. Neurosci. Abstr.
12: 152.
Davila-Garcia, M.I. and Azmitia, E.C. (1990) Neuropeptides as positive neuronal growth
regulatory factors: effects of ACTH and leu-enkephalin on cultured serotonergic
neurons. In: Molecular Aspects ofDevelopment and Aging of the Nervous System,
(ed. J.M. Lauder), pp. 75-92. Plenum Press, New York.
Davison, A. N. and Dobbing, J. (1968) The developing brain. In: Applied
Neurochemistry (eds. A.N. Davison and J. Dobbing), pp. 253-286. Blackwell
Scientific Publications, Oxford.
De France, J.F. (1976) The Septa! Nuclei. Plenum Press, New York.
Deguchi, T. and Barchas, J. (1972) Regional distribution and developmental change of
tryptophan hydroxylase activity in rat brain. J. Neurochem. 19:927-929.
De Vitry, F., Hamon, M., Catelon, J., Dubois, M. and Thibault, J. (1986) Serotonin
initiates and autoamplifies its own synthesis during mouse central nervous system
development. Proc. Natl. Acad. Sci. 83:8629-8633.
Dewey, S.L. and West, J.R. (1984) Evidence for altered lesion-induced sprouting in the
dentate gyrus of adult rats exposed to ethanol in utero. Alcohol. 1:81-88.
Diaz, J. and Samson, H.H. (1980) Impaired brain growth in neonatal rat pups exposed
to ethanol. Science 208:751-753.
Di Chiara, G., Morelli, M., Porceddu, M.L., Mulas, M. and Del Fiacco, M. (1980)
Effect of discrete kainic acid-induced lesions of corpus caudatus and globus
pallidus on glutamic acid decarboxylase of rat substantia nigra. Brain Res.
189: 193-208.
Dillon, K.A., Gross-Isseroff, R., Israeli, M. and Biegon, A. (1991) Autoradiographic
analysis of serotonin 5-HT 1A receptor binding in the human brain postmortem:
effects of age and alcohol. Brain Res. 554:56-64.
Dinopoulos, A., Dori, I. and Parnavelas, J.G. (1993) Serotonergic innervation of the
mature and developing lateral septum of the rat: A light and electron microscopic
immunocytochemical analysis. Neuroscience 55:209-222.

143
Dobbing, J. and Sands, J. (1979) Comparative aspects of the brain growth spurt. Early
Hum. Dev. 3:79-83.
Dohler, K.-D., Coquelin, A., Davis, F., Hines, M., Shryne, J.E. and Gorski, R.A.
(1984) Pre- and postnatal influence of testosterone and diethylstilbesterol on
differentiation of the sexually dimorphic nucleus of the preoptic area in male and
female rats. Brain Res. 302:291-295.
Dohler, K.-D., Coquelin, A., Davis, F., Hines, M., Shryne, J.E., Sickmoller, P.M.,
Jarzab, B. and Gorski, R.A. (1986) Pre- and postnatal influence of an estrogen
antagonist and an androgen antagonist on differentiation of the sexually dimorphic
nucleus of the preoptic area in male and female rats. Neuroendocrinology 42:443448.
Dow, K.E. and Riopelle, R.J. (1985) Ethanol neurotoxicity: Effects on neurite formation
and neurotrophic factor production in vitro. Science 228:591-593.
Dray, A., Gonye, T.J., Oakley, N.R. and Tanner, T. (1976) Evidence for the existence
of a raphe projection to the substantia nigra in rat. Brain Res. 113:45-57.
Druse, M.J. (1992) Effects of in utero ethanol exposure on the development of CNS
neurotransmitter systems. In: Development ofthe Central Nervous System: Effects
ofAlcohol and Opiates. (ed. M.W. Miller), pp. 139-167. Wiley-Liss, New York.
Druse, M.J. and Paul, L.H. (1988) Effects of in utero ethanol exposure on serotonin
uptake in cortical regions. Alcohol 5:455-459.
Druse, M.J., Noronha, A.B., Gnaedinger, J.M. and Smith, D.M. (1980) Effects of
maternal alcohol consumption and maternal malnutrition on CNS membranes in
offspring. Teratology 21:36A.
Druse, M.J., Kuo, A. and Tajuddin, N. (1991) Effects of in utero ethanol exposure on
the developing serotonergic system. Alcohol. Clin. Exp. Res. 15:678-684.
Dugan, L.L. and Choi, D.W. (1994) Excitotoxicity, free radicals, and cell membrane
changes. Ann. Neurol. 35:S17-S21.
Duncan, G.E., Little, K.Y., Kirkman, J.A., Kaldas, R.S., Stumpf, W.E. and Breese,
G.R. (1992) Autoradiographic characterization of [3H]imipramine and
[3H]citalopram binding in rat and human brain: species differences and
relationships to serotonin innervation patterns. Brain Res. 591:181-197.
Ellis, J., Krsiak, M., Poschlova, N. and Masek, K. (1976) The effect of alcohol
administration during pregnancy on the concentration of noradrenaline, dopamine

144
and 5-hydroxytryptamine in the brain of offspring of mice. Act Nerv. Super.
(Praha) 18:220-221.
Ellis, J., Krsiak, M. and Poschlova, N. (1978) Effect of alcohol given at different
periods of gestation on brain serotonin in offspring. Act Nerv. Super. (Praha)
20:287-288.
Engel, G., Gothert, M., Hoyer, D., Schlicker, E. and Hillenbrand, K. (1986) Identity
of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat
brain cortex with 5-HTlB binding sites. Naunyn Schmiedebergs Arch. Pharmacol.
332:1-7.
Fallon, J.H., Seroogy, K.B., Loughlin, S.E., Morrison, R.S., Bradshaw, R.A., Knauer,
D.J. and Cunningham, D.D. (1984) Epidermal growth factor immunoreactive
material in the central nervous system: location and development. Science
224: 1107-1109.
Feighner, J.P., Merideth, C.H. and Hendrickson, G.A. (1982) A double-blind
comparison of buspirone and diazepam in outpatients with generalized anxiety
disorder. J. Clin. Psychiatry 43: 103.
Ferguson, J., Henriken, S., Cohen, H., Mitchell, G., Barchas, J. and Dement, W.
(1970) 'Hypersexuality' and behavioral changes caused by administration of pchlorphenylalanine. Science 168:499-501.
Ferrara, N., Ousley, F. and Gospodarowicz, D. (1988) Bovine brain astrocytes express
basic fibroblast growth factor, a neurotrophic and angiogenic mitogen. Brain Res.
462:223-232.
Ferrari, G., Minozzi, M.-C., Toffano, G., Leon, A. and Skaper, S.D. (1989) Basic
fibroblast growth factor promotes the survival and development of mesencephalic
neurons in culture. Dev. Biol. 133: 140-147.
Ferre, S. and Artigas, F. (1993) Dopamine D2 receptor-mediated regulation of serotonin
extracellular concentration in the dorsal raphe nucleus of freely moving rats. J.
Neurochem. 61:772-775.
Fibiger, H.C. and Miller, J.J. (1977) An anatomical and electrophysiological
investigation of the serotonergic progection from the dorsal raphe nucleus to the
substantia nigra in the rat. Neuroscience 2:975-987.
Fillion, G., Beaudoin, D., Rousselle, J.C. and Jacobs, J. (1980) [3H]5-HT binding sites
and 5-HT-sensitive adenylate cyclase in glial cell membrane fraction. Brain Res.
198:361-374.

145
Fillion, G., Beaudoin, D., Fillion, M.-P., Rousselle, J.-C., Robaut, C. and Netter, Y.
(1983) 5-Hydroxytryptamine receptors in neurons and glia. J. Neural Transm.
Suppl. 18:307-317.
Fletcher, P.J. and Davies, M. (1990) The involvement of 5-hydroxytryptaminergic and
dopaminergic mechanisms in the eating induced by buspirone, gepirone and
ipsapirone. Br. J. Pharmacol. 99:519-525.
Fletcher, T.L. and Shain, W. (1993) Ethanol-induced changes in astrocyte gene
expression during rat central nervous system development. Alcohol. Clin. Exp.
Res. 17:993-1001.
Freidman, J.M. (1982) Can maternal alcohol ingestion cause neural tube defects? J.
Pediatr. 101 :232-234.
Freund, T.F., Gulyas, A.I., Acsady, L., Gores, T. and Toth, K. (1990) Serotonergic
control of the hippocampus via local inhibitory interneurons. Proc. Natl. Acad.
Sci. USA 87:8501-8505.
Gale, K. (1979) GABA receptors in rat substantia nigra: changes in response to lesions
and chronic drug treatment. Soc. Neuroscience. Abstr. 9:71P.
Gallager, D. W. (1982) Spontaneous unit activity of neurons within the dorsal raphe
nucleus of the neonatal rat. Life Sci. 30:2109-2113.
Garro, A.J., McBeth, D.L., Lima, V. and Lieber, C.S. (1991) Ethanol consumption
inhibits fetal DNA methylation in mice: implications for the fetal alcohol
syndrome. Alcohol. Clin. Exp. Res. 15:395-398.
Gayer, G.G., Gordon, A. and Miles, M.F. (1991) Ethanol increases tyrosine hydroxylase
gene expression in NlE-115 neuroblastoma cells. J. Biol. Chem. 266:2227922284.
Giambalvo, C.T. and Snodgrass, S.T. (1978) Biochemical and behavioral effects of
serotonin neurotoxins on the nigro-striatal dopamine system: comparison of
injection sites. Brain Res. 152:555-566.
Gilbert, F., Brazell, C., Tricklebank, M.D. and Atahl, S.M. (1988) Activation of5-HT 1A
receptor subtype increases rat plasma ACTH concentration. Eur. J. Pharmacol.
147:431-439.
Gladfelter, W.E. and Brobeck, J.R. (1962) Decreased spontaneous locomotor activity in
the rat induced by hypothalamic lesions. Am. J. Physiol. 203: 811-817.

146
Goddard, G.V. (1964) Functions of the amygdala. Psycho/. Bull. 62:89-109.
Goldberg, J.I. and Kater, S.B. (1989) Expression and function of the neurotransmitter
serotonin during development of Helisoma nervous system. Dev. Biol. 131:483495.
Golden, N.L., Sokol, R.J., Kuhnert, B.R. and Bottoms, S. (1982) Maternal alcohol use
and infant development. Pediatrics 70:931-934.
Gozlan, H., Daval, G., Verge, D., Stampinato, U., Fattaccini, C.M., Gallissot, M.C.
and El Mestikawy, S. (1990) Aging associated changes in serotonergic and
dopaminergic pre- and post-synaptic neurochemical markers in rat brain.
Neurobiol. Aging 11:437-449.
Grant, K.A., Choi, E. Y. and Samson, H.H. (1983) Neonatal ethanol exposure: effects
on adult behavior and brain growth parameters. Pharmacol. Biochem. Behav. 18
(suppl. 1):331-336.
Greene, T., Emhart, C.B., Martier, S., Sokol, R. and Ager, J. (1990) Prenatal alcohol
exposure and language development. Alcohol. Clin. &p. Res. 14:937-945.
Groves, P.M., Wilson, P.J., Young S.J. and Rebec, G.V. (1975) Self-inhibition by
dopaminergic neurons. Science 190:522-529.
Guerri, C., Saez, R., Sancho-Tello, M., Martin de Aquilera, E. and Renau-Piqueras, J.
(1990) Ethanol alters astrocyte development: a study of critical periods using
primary cultures. Neurochem. Res. 15:559-565.
Hablitz, J.J. (1986) Prenatal exposure to alcohol alters short-term plasticity in
hippocampus. &p. Neurol. 93:423-427.
Hagan, M.D., Jones, B.J., Jordan, C.C. and Tyers, M.B. (1990) Effect of 5-HT3
receptor antagonists on responses to selective activation of mesolimbic
dopaminergic pathways in the rat. Br. J. Pharmacol. 99:227-232.
Hall, M.D., El Mestikawy, S., Emerit, M.B., Pichat, L., Hamon, M. and Gozlan, H.
(1985) [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre- and
postsynaptic 5-hydroxytryptamine sites in various regions of the brain. J.
Neurochem. 44: 1685-1696.
Hammer, R.P. Jr. and Scheibel, A.B. (1981) Morphologic evidence for a delay of
neuronal maturation in fetal alcohol exposure. &p. Neurol. 74:587-596.
Hamon, M. and Bourgoin, S. (1979) Ontogenesis of tryptophan transport in rat brain.

147
J. Neural Transm. Suppl. 15:93-105.

Hamon, M. and Bourgoin, S. (1982) Characteristics of 5-HT metabolism and function
in the developing brain. In: Biology of Serotonergic Transmission (ed. N.N.
Osborne), pp. 197-220, John Wiley & Sons Ltd.
Hamon, M., Lanfumey, L., El Mestikawy, S., Boni, C., Miquel, M.C., Bolanos, F.,
Schechter, L. and Gozlan, H. (1990) The main features of central 5-HT1
receptors. Neuropsychopharmacology 3:349-360.
Handa, R.J., Hines, M., Schoonmaker, J.N., Shryne, J.E. and Gorski, R.A. (1986)
Evidence that serotonin is involved in the sexually dimorphic development of the
preoptic area in the rat brain. Dev. Brain Res. 30:278-282.
Hanson, J.W., Jones, K.L. and Smith D.W. (1976) Fetal alcohol syndrome: experience
with 41 patients. JAMA 235:1458-1460.
Hanson, J.W., Strissguth, A.P. and Smith, D.W. (1978) The effects of moderate alcohol
consumption during pregnancy on fetal growth and morphogenesis. J. Pediatr.
92:457-460.
Hard, E., Musi, B., Dahlgren, l.L., Engel, J., Larsson, K., Liljequist, S. and Lindh,
A.S. (1985a) Impaired maternal behavior and altered central serotonergic activity
in the adult offspring of chronically ethanol treated dams. Acta Pharmacol.
Toxicol. 56:347-353.
Hard, E., Engel, J., Larsson, K., Liljequist, S. and Musi, B. (1985b) Effects of maternal
ethanol consumption on the offspring sensory-motor development, ultrasonic
vocalization, audiogenic immobility reaction and brain monoamine synthesis. Acta
Pharmacol. Toxicol. 56:354-363.
Harris, S.R., Osborn, J.A., Weinberg,J., Loock, C. and Junaid, K. (1993) Effects of
prenatal alcohol exposure on neuromotor and cognitive development during early
childhood: a series of case reports. Phys. Ther. 73:608-617.
Hartig, P.R., Hoffman, B.J., Kaufman, M.J. Hirata, F. (1990) The 5-HT1c receptor.
Ann. N. Y. Acad. Sci. 600: 149-167.
Haydon, P.G., McCobb, D.P. and Kater, S.B. (1987) Serotonin selectively inhibits
growth cone motility and synaptogenesis of specific identified neurons. Science
236:561-564.
Haydon, P.G., McCobb, D.P. and Kater, S.B. (1987) The regulation of neurite
outgrowth, growth cone motility, and electrical synaptogenesis by serotonin. J.

148
Neurobiol. 18: 197-215.
Heaton, M.B., Swanson, D.J., Paiva, M. and Walker, D.W. (1992) Ethanol exposure
affects trophic factor activity and responsiveness in chick embryo. Alcohol 9: 161166.
Hellendall, R.P., Schambra, U.B., Liu, J.P. and Lauder, J.M. (1993) Prenatal
expression of 5-HT,c and 5-HT2 receptors in the rat central nervous system. &p.
Neurol. 120: 186-201.
Henderson, G.I., Turner, D., Patwardhan, R.V., Lumeng, L., Hoyumpa, A.M. and
schenker, S. (1981) Inhibition of placental valine uptake after acute and chronic
maternal ethanol consumption. J. Pharmacol. &p. Ther. 216:465-472.
Herregodts, P., Velkeniers, B., Ebinger, G., Michotte, Y., Vanhaelst, L. and HooghePeters E. (1990) Development of monoaminergic neurotransmitters in fetal and
postnatal rat brain: analysis by HPLC with electrochemical detection. J.
Neurochem. 55:774-779.
Hertz, L. and Tamir, H. (1981) Some properties of an astrocytic protein fraction that
binds serotonin. J. Neurochem. 37:1331-1334.
Hery, F., Soubrie, P., Gourgoin, S., Montrastruc, J. L., Artaud, F. and Glowinski, J.
(1980) Dopamine released from dendrites in the substantia nigra control the nigral
and striatal release of serotonin. Brain Res. 193:143-151.
Heym, J. and Gladfelter, W.E. (1982) Serotonergic innervation of the lateral
hypothalamus: evidence from synaptosomal uptake studies. Brain Res. Bull.
8:131-137.
Hillion, J., Dumas Milne-Edwards, J.B., Catelon, J., de Vitry, F., Gros, F. and Hamon,
M. (1993) Prenatal developmental expression of rat brain 5-HT,A receptor gene
followed by PCR. Biochem. Biophys. Res. Comm. 191:991-997.
Hjorth, S. and Carlsson, A. (1982) Buspirone: effects on central monoaminergic
transmission - possible relevance to animal experimental and clinical findings.
Eur. J. Pharmacol. 83:299-303.
Hockl, P.F., Diaz, G.S. and Carlos, L. (1993) Prolactin-releasing effect of buspirone
in developing and adult male and female rats. Proc. Soc. &p. Biol. Med.
202:447-450.
Hoff, S.F. (1988) Synaptogenesis in the hippocampal dentate gyrus: Effects of in utero
ethanol exposure. Brain Res. Bull. 21:47-54.

149
Hoyer, D. (1988) Molecular pharmacology and biology of 5-HT 1c receptors. Trends
Pharmacol. Sci. 9:89-94.
Hoyer, D., Engel, G. and Kalkman, H.O. (1985) Characterization of the 5-HTrn
recognition site in rat brain: binding studies with [1 25 I]-iodocyanopindolol. Eur.
J. Pharmacol. 118:1-12.
Hume, R.I., Role, L.W. and Fischbach, G.D. (1983) Acetylcholine release from growth
cones detected with patches of acetylcholine receptor-rich membranes. Nature
305:632-634.
Humphrey, P.P.A., Hartig, P. and Hoyer, D. (1993) A proposed new nomenclature for
5-HT receptors. Trends Pharmacol. Sci. 14:233-236.
Idanpaan-Heikkila, J. E., Fritchie, G. E., Ho, B. T. and Mcissac, W. M. (1971)
Placental transfer of 14C-ethanol. Am. J. Obstet. Gynecol. 110:4266-428.
Idanpaan-Heikkila, J.,Jouppila, P., Akerblom, H. K., Isoaho, R., Kauppila, E. and
Koivisto, M. (1972) Elimination and metabolic effects of ethanol in mother, fetus
and newborn infant. Am. J. Obstet. Gynecol. 112:387-393.
Imai, H., Steindler, D.A. and Kitai, S.T. (1986) The organization of divergent axonal
projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243:363380.
Imperato, A.N. and Angelucci, L. (1989) 5-HT 3 receptors control dopamine release in
the nucleus accumbens of freely moving rats. Neurosci. Lett. 101:214-217.
Jacobs, B.L. and Azmitia, E.C. (1992) Structure and function of the serotonin system.
Physiol. Rev. 72: 165-229.
Jacobs, B.L., Simon, S., Ruimy, D.D. and Trulson, M.E. (1977) A quantitative
rotational model for studying serotonergic function in the rat. Brain Res. 124:271281.
Jones, K.L. and Smith, D.W. (1973) Recognition of the fetal alcohol syndrome in early
infancy. Lancet 2:999-1001.
Jones, K.L., Smith, D.W., Ulleland, C.N. and Strissguth, A.P. (1973) Pattern of
malformations in offspring of chronic alcoholic mothers. Lancet 1: 1267-1271.
Jones, P.J.H., Leichter, J. and Lee, M. (1981) Placental blood flow in rats fed alcohol
before and during gestation. Life Sci. 29: 1153-1159.

150
Jorgensen, M.B. and Diemer, N.H. (1982) Selective neuron loss after cerebral ischemia
in the rat: possible role of transmitter glutamate. Acta Neurol. Scand. 66:536-546.
Kadle, R., Suksang, C., Roberson, E.D. and Fellows, R.E. (1988) Identification of
insulin-like factor in astrocyte conditioned medium. Brain Res. 460:60-67.
Kai, Y., Oomura, Y. and Shimizu, N. (1988) Responses of rat lateral hypothalamic
neuron activity to dorsal raphe nuclei stimulation. J. Neurophysiol. 60:524-535.
Kakihana, R., Butte, J.C. and Moore, J.A. (1980) Endocrine effects of maternal
alcoholization: plasma and brain testosterone, dihydrotestosterone, estradiol and
corticosterone. Alcohol. Clin. Exp. Res. 4:57-61.
Katz, D.M. and Kimelberg, H.K. (1985) Kinetics and autoradiography of high affinity
uptake of serotonin by primary astrocyte cultures. J. Neurosci. 5:1901-1908.
Kaufman, S. (1974) Properties of pterin-dependent aromatic amino acid hydroxylases.
In: Aromatic Amino Acids in the Brain (eds. G.E.W. Wolstenholme and D.W.
Fitzsimons), pp. 85-108, North-Holland Elsevier, Amsterdam.
Kilpatrick, G.J., Jones, B.J. and Tyers, M.B. (1987) Identification and distribution of
5-HT3 receptors in rat brain using radioligand binding. Nature 330:746-748.
Kirksey, D.F. and Slotkin, T.A. (1979) Concomitant development of [3H]-dopamine and
[3H]-5-hydroxytryptamine uptake systems in rat brain regions. Br. J. Pharmacol.
67:387-391.
Kohler, C., Chan-Palay, V. and Steinbusch, H. (1982) The distribution and origin of
serotonin-containing fibers in the septal area: a combined immunohistochemical
and fluorescent retrograde tracing study in the rat. J. Comp. Neurol. 209:91-111.
Kohler, C., Radesater, A.C., Lang, W. and Chan-Palay, V. (1986) Distribution of
serotonin-IA receptors in the monkey and post-mortem human hippocampal
region: a quantitative autoradiographic study using the selective agonist [3H]8-0HDPAT. Neurosci. Lett. 72:43-48.
Kojima, H., Mineta-Kitajima, R., Saitoh-Harada, N. Kurihara, T., Takahashi, Y.,
Furudate, S., Shiratake, M., Nakamura, K. and Tamai, Y. (1994) Prenatal
ethanol exposure affects the activity and mRNA expression of neuronal membrane
enzymes in rat offspring. Life Sci. 55:1433-1442.
Kolasa, K., Fusi, R., Garattini, S., Consolo, S. and Ladinsky, H. (1982) Neurochemical
effects ofbuspirone, a novel psychotropic drug, on the central cholinergic system.
J. Pharm. Pharmacol. 34:314-317.

151
Komguth, S.E., Rutledge, J.J., Sunderland, E., Siegel, F., Carlson, I. Smollens, J.,
Juhl, U. and Young, B. (1979) Impeded cerebellar development and reduced
serum thyroxine levels associated with fetal alcohol intoxication. Brain Res.
177:347-360.
Kosofsky, B.E. and Molliver, M.E. (1987) The serotonergic innervation of cerebral
cortex: different classes of axon terminals arise from dorsal and median raphe
nuclei. Synapse 1: 153-168.
Krsiak, M., Elis, N., Poschlova, N. and Masek, K. (1977) Increased aggressiveness and
lower brain serotonin levels in offspring of mice given alcohol during gestation.
J. Stud. Alcohol 38: 1696-1704.
Kuhar, M.J. and Aghajanian, G.K. (1973) Selective accumulation of 3H-serotonin by
nerve terminals of raphe neurons: an autoradiography study. Nature 241: 187-189.
Kuriyama, K., Rauscher, G.E. and Sze P.Y. (1971) Effect of acute and chronic
administration of ethanol on the 5-hydroxytryptamine turnover and tryptophan
hydroxylase activity of the mouse brain. Brain Res. 26: 450-454.
Kyllerman, M., Aronson, M., Sabel, K.-G., Sandin, B. and Olegard, R. (1985) Children
of alcoholic mothers: Growth and motor performance compared to matched
control. Acta. Paediatr. Scand. 74:20-26.
Lanfumey, L. and Jacobs, B. (1982) Developmental analysis of raphe dorsalis unit
activity in the rat. Brain Res. 242:317-320.
Lancaster, F.E., Mayur, P.N., Tsalos, T. Samorajski, T. and Wiggins, R.C. (1982) The
synthesis of myelin and brain subcellular membrane proteins in the offspring of
rats fed ethanol during pregnancy. Brain Res. 235:105-113.
Lankford, K., DeMello, F.G. and Klein, W.L. (1987) A transient embryonic dopamine
receptor inhibits growth cone motility and neurite outgrowth in a subset of avian
retina neurons. Neurosci. Lett. 75:169-174.
Lauder, J.M. and Bloom, F.E. (1974) Ontogeny of monoamine neurons in the locus
coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J.
Comp. Neurol. 155:469-481.
Lauder, J.M. and Krebs, H. (1978) Serotonin as a differentiation signal in early
neurogenesis. Dev. Neurosci. 1: 15-30.
Lauder, J.M., Wallace, J.A., Krebs, H., Petrusz, P. and McCarthy, K. (1982) In vivo
and in vitro development of serotonergic neurons. Brain Res. Bull. 9:605-625.

152
Lauder, J.M. (1990) Ontogeny of the serotonergic system in the rat: serotonin as a
developmental signal. Ann. N. Y. Academic Sci. 600:297-313.
Lauder, J.M. (1993) Neurotransmitters as growth regulatory signals: role of receptors
and second messengers. Trends Neurosci. 16:233-240.
Lee, E.H.Y., Lin, W.R., Chen, H.Y., Shiu, W.H. and Liang, K.C. (1992) Fluoxetine
and 8-0H-DPAT in the lateral septum enhances and impairs retention of an
inhibitory avoidance response in rats. Physiol. Behav. 51:681-688.
Le Prince, G., Copin, M.-C., Hardin, H., Belin, M.-F., Bouilloux, J.-P. and Tardy, M.
(1990) Neuron-glia interactions: effect of serotonin on the astroglial expression
of GFAP and its encoding message. Dev. Brain Res. 51:295-298.
Leslie, M.J., Bennett-Clarke, C.A. and Rhoades R.W. (1992) Serotonin lB receptors
form a transient vibrissa-related pattern in the primary somatosensory cortex of
the developing rat. Dev. Brain Res. 69:143-148.
Levitt, P. and Moore, R. Y. (1978) Developmental organization of raphe serotonin
neuron groups in the rat. Anat. Embryo!. 154:241-251.
Lidov, H. W. and Molliver, M.E. (1982) Immunohistochemical study of the development
of serotonergic neurons in the rat CNS. Brain Res. Bull. 9:559-604.
Lidov, H.W. and Molliver, M.E. (1982a) Immunohistochemical study of serotonin
neuron development in the rat: ascending pathways and terminal fields. Brain Res.
Bull. 8:389-430.
Lieth, E., Towle, A.C. and Lauder, J.M. (1989) Neuronal-glial interactions: Quantitation
of astrocytic influences on development of catecholamine neurons. Neurochem.
Res. 14:979-985.
Liu, J. and Lauder, J.M. (1991) Serotonin and nialamide differentially regulate survival
and growth of cultured serotonin and catecholamine neurons. Dev. Brain Res.
60:59-67.
Liu, J. and Lauder, J.M. (1992) Serotonin promotes region-specific glial influences on
cultured serotonin and dopamine neurons. Glia 5:306-317.
Liu, K.P., Tamir, H., Hsiung, S., Adlersberg, M. and Gershon, M.D. (1987) Prenatal
development of serotonin binding protein in relation to other transmitter-related
characteristics of central serotonergic neurons. Dev. Brain Res. 32:31-41.
Lochry, E.A. and Riley, E.P. (1980) Retention of passive avoidance and T-maze

~

153
in rats exposed to alcohol prenatally. Neurobehav. Toxicol. 2:107-115.
Lokhorst, D.K. and Druse, M.J. (1993a) Effects of ethanol on cultured fetal serotonergic
neurons. Alcohol. Clin. Exp. Res. 17:86-93.
Lokhorst, D.K. and Druse, M.J. (1993b) Effects of ethanol on cultured fetal astroglia.
Alcohol. Clin. Exp. Res. 17:810-815.
Lowry, O.H., Rosebrough, N.H., Farr, A.L. and Randall, R.H. (1951) Protein
measurement with folin phenol reagent. J. Biol. Chem. 193: 265-275.
Maeda, T., Kaneko, S. and Satoh, M. (1994) Inhibitory influence via 5-HT3 receptors
on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal
slices. Neurosci. Res. 18:277-282.
Manthorpe, M., Rudge, J.S., Varon, S. (1986) Astroglial cell contributions to neuronal
survival and neuritic growth. In: Astrocytes (eds. S. Fedoroff and A. Vernadakis)
pp. 315-375. Academic Press, New York
Maricq, A.V., Peterson, A.S., Brake, A.J., Myers, R.M. and Julius, D. (1991) Primary
structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion
channel. Science 254:432-437.
Marlier, L., Teilhac, J.-R., Cerruti, C. and Privat, A. (1991) Autoradiographic mapping
of 5-HT1 , 5-HT1A, 5-HT 18 and 5-HT2 receptors in the rat spinal cord. Brain Res.
550: 15-23.
Marshall, J.P., Turner, B.H. and Teitelbaum, P. (1971) Sensory neglect produced by
lateral hypothalamic damage. Science 174:523-525.
Matheson, G.K. and Tunnicliff, G. (1991) Localization of rH]buspirone binding in rat
brain by autoradiography. In: Buspirone: Mechanisms and Clinical Aspects (eds.
G. Tunnicliff, A.S. Eison and D.P. Taylor), pp. 163-176. Academic Press, San
Diego.
Maura, G. and Raiteri, M. (1986) Cholinergic terminals in rat hippocampus possess 5HT18 receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol.
129:333-337.
Mayordomo, F., Renau-Piqueras, J., Megias, L., Guerri, C., Iborra, F.J., Azorin, I.
and Ledig, M. (1992) Cytochemical and stereological analysis of rat cortical
astrocytes during development in primary culture. Effect of prenatal exposure to
ethanol. Int. J. Dev. Biol. 36:311-321.

154
McCobb, D.P., Haydon, P.G. and Kater, S.B. (1988) Dopamine and serotonin inhibition
of neurite elongation of different identified neurons. J. Neurosci. Res. 19: 19-26.
McGivem, R.F., Clancy, A.N., Hill, M.A. and Nobel, E.P. (1984) Prenatal alcohol
exposure alters adult expression of sexually dimorphic behavior in the rat. Science
224:896-898.
McGivem, R.F., Raum, W.J., Salido, E. and Redei, E. (1988) Lack of prenatal
testosterone surge in fetal rats exposed to alcohol: Alteration in testicular
morphology and physiology. Alcohol. Clin. Exp. Res. 12:243-247.
McGivem, R. F., Randa, R.J. and Redei, E. ( 1993) Decreased postnatal testosterone
surge in male rats exposed to ethanol during the last week of gestation. Alcohol.
Clin. Exp. Res. 17:1215-1222.
McMillen, B.A., Matthews, R.T., Sanghera, M.K., Shepard, P.D. and German, D.C.
(1983) Dopamine receptor antagonism by the novel antianxiety drug, buspirone.
J. Neurosci. 3:733-738.
Meller, E., Goldstein, M. and Bohmaker, K. (1990) Receptor reserve for 5hydroxytryptamine1A-mediated inhibition of serotonin synthesis: Possible
relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mo!.
Pharmacol. 37:231-237.
Meltzer, H.Y., Gudelsky, G.A., Lowy, M.T., Nash, J.F. and Koenig, J.I. (1991)
Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic
mechanisms. In: Buspirone: Mechanisms and Clinical Aspects (eds. G. Tunnicliff,
A.S. Eison and D.P. Taylor), pp. 163-176. Academic Press, San Diego.
Metzer, H.Y., Simonovic, M., Fang, V.S. Gudelsky, G.A. (1982) Effect of buspirone
on rat plasma prolactin levels and striatal dopamine turnover.
Psychopharmacology 78:49-53.
Michaelis, E. (1990) Fetal alcohol exposure: cellular toxicity and molecular events
involved in toxicity. Alcohol. Clin. Exp. Res. 14:819-826.
Middlemiss, D.N., Bremer, M.E. and Smith, S.M. (1988) A pharmacological analysis
of the 5-HT receptor mediating inhibition of 5-HT release in the guniea pig
frontal cortex. Eur. J. Pharmacol. 157:101-107.
Miles, M.F., Diaz J.E. and DeGuzman, V.S. (1991) Mechanisms of neuronal adaptation
to ethanol. Ethanol induces Hsc70 gene transcription in NG 108-15 neuroblstoma
x glioma cells. J. Biol. Chem. 266:2409-2414.

155
Miller, M. W. ( 1987) Effect of prenatal exposure to alcohol on the distribution and time
of origin of corticospinal neurons in the rat. J. Comp. Neurol. 257:372-382.
Miller, M.W. (1988) Effect of prenatal exposure to ethanol on the development of
cerebral cortex: I. Neuronal generation. Alcohol. Clin. Exp. Res. 12:440-449.
Miller, M.W. (1989) Effects of prenatal exposure to ethanol on neocortical development:
II. Cell proliferation in the ventricular and subventricular zones of the rat. J.
Comp. Neurol. 287:326-338.
Miller, M.W. and Potempa, G. (1990) Numbers of neurons and glia in mature rat
somatosensory cortex: Effects of prenatal exposure to ethanol. J. Comp. Neurol.
293:92-102.
Miller, M.W. and Robertson, S. (1993) Prenatal exposure to ethanol alters the postnatal
development and transformation of radial glia to astrocytes in the cortex. J.
Comp. Neurol. 337:253-266.
Millhouse, O.E. (1969) A Golgi study of the descending medial forebrain bundle. Brain
Res. 15:341-363.
Milner, B. (1972) Disorders of learning and memory after temporal lobe lesions in man.
Clin. Neurosurg. 19:421-446.
Monnet-Tschudi, F. and Honneger, P. (1989)1nfluence of epidermal growth factor on the
maturation of fetal rat brain cells in aggregate culture. Dev. Neurosci. 11 :30-40.
Montefrancesco, G., Giorgi, G., Dal Pra, P., Fiaschi A.I., Micheli, L. and Segre, G.
(1990) Plasma ACTH levels in buspirone-treated rats. Arch. Int. Pharmacodyn.
Ther. 305:183-188.
Moore, R.Y., Halaris, A.E. and Jones B.E. (1978) Serotonin neurons of the midbrain
raphe: ascending projections. J. Comp. Neurol. 180:417-438.
Morilak, D.A. and Ciaranello, R.D. (1993) Ontogeny of 5-hydroxytryptamine:i receptor
immunoreactivity in the developing rat brain. Neuroscience 55:869-880.
Morris, P.L., Mayberg, H.S., Bolla, K., Wong, D.F., Dannals, R.F., Starkstein, S.E.
and Robinson, R. G. (1993) A preliminary study of cortical S2 serotonin
receptors and cognitive performance following stroke. J. Neuropsychiatry & Clin.
Neurosci. 5:395-400.
Morrison, J.H., Foote, S.L., Molliver, M.E., Bloom, F.E. and Lidov, G.W. (1982)
Noradrenergic and serotonergic fibers innervate complementary layers in monkey

156
visual cortex: an immunohistochemical study. Proc. Natl. Acad. Sci. USA
79: 2401-2405.
Morrison, R.S., Sharma, A., de Vellis, J. and Bradshaw, R.A. (1986) Basic fibroblast
growth factor supports the survival of cerebral cortical neurons in primary
culture. Proc. Natl. Acad. Sci. USA 83:7537-7541.
Muller, H.W. and Seifert, W. (1982) A neurotrophic factor (NTF) released from primary
glial cultures supports survival and fiber outgrowth of cultured hippocampal
neurons. J. Neurosci. Res. 8: 195-204.
Muramatsu, M., Tamaki-Ohashi, J., Usuki, C., Araki, H., Chaki, S. and Aihara, H.
(1988) Serotonin-2 receptor-mediated regulation of release of acetylcholine by
minaprine in cholinergic nerve terminal of hippocampus of rat.
Neuropharmacology 27: 603-609.
Muramatsu, M., Tamaki-Ohashi, J., Usuki, C., Araki, H., Chaki, S. and Aihara, H.
(1988a) 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of
dopamine release from rat brain striatal slices. Eur. J. Pharmacol. 153:89-95.
Nauta, W.J.H. and Haymaker, W. (1969) Hypothalamic nuclei and fiber connections.
In: The Hypothalamus (eds. W. Haymaker, E. Anderson and W.J.H. Nauta), pp.
1366-209.
Nedergaard, S., Bolam, J.P. and Greenfield, S.A. (1988) Facilitation of a dendritic
calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature
333:174-177.
Nedergaard, S., Flatman, J.A. and Engberg, I. (1991) Excitation of substantia nigra pars
compacta neurons by 5-hydroxytryptamine in vitro. Neuroreport 2:239-332.
Negulescu, P.A., Shastri, N. and Cahalan, M.D. (1994) Intracellular calcium dependence
of gene expression in single T lymphocytes. Proc. Natl. Acad. Sci. USA 91 :28732877.
Neijt,

H.C., Te Duis, I.J. and Vijverberg, R.P.M. (1988) Pharmacological
characterisation of serotonin3 receptor-mediated electrical response in cultured
mouse neuroblastoma cells. Neuropharmacology 27:301-307.

Nelson, D.L., Herbet, A., Glowinski, J. and Hamon, M. (1979) [3H]Harmaline as a
specific ligand of MAO A-II. Measurement of the turnover rates of MAO A
during ontogenesis in the rat brain. J. Neurochem. 32: 1829-1836.
Nicotera, P., Zhivotovsky, B. and Orrenius, S. (1994) Nuclear calcium transport and the

157
role of calcium in apoptosis. Cell Calcium 16:279-288.
Nio, E., Kogure, K., Yae, T. and Onodera, H. (1991) The effects of maternal ethanol
exposure on neurotransmission and second messenger systems: a quantitative
autoradiographic study in the rat brain. Dev. Brain Res. 62:51-60.
Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation
of protein kinase C. Science 258:607-614.
Nomura, Y., Naitoh, F. and Segawa, T. (1976) Regional changes in monoamine content
and uptake of the rat brain during postnatal development. Brain Res. 101:305-315.
Noronha, A.B. and Druse, M.J. (1982) Maternal ethanol consumption and synaptic
membrane glycoproteins in offspring. J. Neurosci. Res. 8:83-97.
O'Hearn, E. and Molliver, M.E. (1984) Organization of raphe cortical projections in rat:
a quantitative retrograde study. Brain Res. Bull. 13:709-726.
Olegard, R., Sabel, K.G., Aronsson, M., Sandin, B., Johansson, P.R., Carlsson, C.,
Kyllerman, M., Iversen, K. and Hrbek, A. (1979) Effects on the child of alcohol
abuse during pregnancy. Acta. Paediatr. Scand. [Suppl] 275: 112-121.
Olpe, H.R. and Koella, W.P. (1977) The responses of striatal cells upon stimulation of
the dorsal and median raphe nuclei. Brain Res. 122:357-360.
Ols, M.E. (1973) Short-term changes in the firing pattern of hypothalamic neurons
during Pavlovian conditioning. Brain Res. 58:95-116.
Palacios, J.M., Niehoff, D.L. and Kuhar, M.J. (1981) Receptor autoradiography with
tritum-sensitive film: potential for computerized densitometry. Neurosci. Lett.
25: 101-105.
Palkovits, M., Brownstein, M. and Saavedra, J. M. (1974) Serotonin content of the
brainstem nuclei in the rat. Brain Res. 80:237-249.
Park, D.H., Snyder, D.W. and Joh, T.H. (1986) Postnatal developmental changes of
tryptophan hydroxylase activity in serotonergic cell bodies and terminals of rat
brain. Brain Res. 378:183-185.
Parker, S., Udani, M., Gavaler, J.S. and Van Thiel, D.H. (1984) Adverse effects of
ethanol upon the adult sexual behavior of male rats exposed to in utero.
Neurobehav. Toxicol. Teratol. 6:289-293.
Pasini, A., Tortorella, A and Gale, K. (1992) Anticonvulsant effect of intranigral

158
fluoxetine. Brain Res. 593:287-290.
Paxinos, G. and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic
Press, Australia.
Pazos, A. and Palacios, J.M. (1985)Quantitative autoradiographic mapping of
serotonergic receptors in the rat brain. I. Serotonin-1 receptors. Brain Res.
346:205-230.
Pazos, A., Cortes, R. and Palacios, J.M. (1985) Quantitative autoradiographic mapping
of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res.
346:231-249.
Pazos, A., Probst, A. and Palacios, J.M. (1987) Serotonin receptors in the human brain.
Ill. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21 :97-121.
Pazos, A., Hoyer, D. and Palacios, J.M. (1985a) The binding of serotonergic ligands
to the porcine choroid plexus: charaterization of a new type of serotonin
recognition site. Eur. J. Pharmacol. 106:539-546.
Pedigo, N.W., Yamamura, H.I. and Nelson, D.L. (1981) Discrimination of multiple
[3H]5-HT binding sites by the neuroleptic spiperone in rat brain. J. Neurochem.
36:220-226.
Peiffer, J., Majaewski, F., Fishback, H., Bierich, J.R. and Volk, B. (1979) Alcohol
embryo and fetopathy. J. Neurol. Sci. 41: 125-137.
Pennington, S. (1988) Ethanol-induced growth inhibition: the role of cyclic AMP protein
kinase. Alcohol. Clin. Exp. Res. 12: 125-129.
Peroutka, S.J. (1985) Selective interaction of novel anxiolytic with 5-hydroxytryptamine1A
receptors. Biol. Psychiatry 20:971-979.
Phillips, S.C. and Cragg, B.G. (1982) A change in susceptability of rat crebellar
Purkinje cells to damage by alcohol during fetal, neonatal and adult life.
Neuropathol. Appl. Neurobiol. 8:441-454.
Pikkarainen, P.H. (1971) Metabolism of ethanol and acetaldehyde in perfused human
fetal liver. Life Sci. 10: 1359-1364.
Pranzatelli, M.R. and Martens, J.M. (1992) Plasticity and ontogeny of the central 5-HT
transporter: effect of neonatal 5,7-dihydroxytryptamine lesions in the rat. Dev.
Brain Res. 70:191-195.

159
Pycock, C.J. (1980) Turning behavior in animals. Neuroscience 5:461-514.
Quirion, R., Araujo, D., Nair, N.P.V. and Chabot, J.G. (1988) Visualization of growth
factor sites in rat forebrain. Synapse 2:212-218.
Raisman, G (1966) The connections of the septum. Brain Res. 89:317-349.
Raisman, G (1970) Some aspects of the neural connections of the hypothalamus. In: The
Hypothalamus (eds. L. Martini, M. Motta, and F. Fraschini). Academic Press,
New York.
Rajaofetra, N., Sandillon, F., Geffard, M. and Privat, A. (1989) Pre- and post-natal
ontogeny of serotonergic projections to the rat spinal cord. J. Neurosci. Res.
22:305-321.
Rakic, P. (1972) Mode of cell migration to the superficial layers of fetal monkey
neocortex. J. Comp. Neurol. 145:61-83.
Randall, C.L., Taylor, W.J. and Walker, D.W. (1977) Ethanol-induced malformations
in mice. Alcohol. Clin. Exp. Res. 1:219-224.
Rathbun, W. and Druse, M.J. (1985) Dopamine, serotonin, and acid metabolites in brain
regions from the developing offspring of ethanol-treated rats. J. Neurochem.
44:57-62.
Rawat, A.K. (1974) Brain levels and turnover rates of presumptive neurotransmitters as
withdraw! of ethanol in mice. J. Neurochem. 22:915-922.
Rawat, A.K. (1975) Ribosomal protein synthesis in the fetal and neonatal rat brain as
influenced by maternal ethanol consumption. Res. Commun. Chem. Pathol.
Pharmacol. 12:723-732.
Redei, E. and McGivern, R. (1988) Attenuation of postnatal testosterone surge and
decreased response to LH in fetal alcohol exposed males. Alcohol. Clin. Exp. Res.
12:341.
Reisine, T., Soubrie, P., Artaud, F. and Glowinski, J. (1982) Application of glutamic
acid and substance P to the substantia nigra modulates in vivo 3H-serotonin release
in the basal ganglia of the cat. Brain Res. 2366:317-327.
Renau-Piqeras, J., Zaragoza, R., De Paz, P., Baguena-Cervellera, R., Megias, L. and
Guerri, C. (1989) Effects of prolonged ethanol exposure on the glial fibrillary
acidic protein-containing intermediate filaments of astrocytes in primary culture:
a quantitative immunofluorescence and immunogold electron microscopic study.

160
J. Histochem. Cytochem. 37:229-240.

Renson, J. (1973) Assays and properties of tryptophan 5-hydroxylase. In: Serotonin and
Behavior (Eds. J. Barchas and E. Usdin), pp. 19-32, Academic Press, New York.
Ribak, C.E., Vaughn, J.E. and Roberts E. (1980) GABAergic nerve terminals decrease
in the substantia nigra following hemitransections of the striatonigral and
pallidonigral pathways. Brain Res. 192:413-420.
Ribary, U., Schlumpf, M. and Lichtensteiger, W. (1986) Analysis by HPLC-EC of
metabolites of monoamines in fetal and postnatal rat brain. Neuropharmacology
25 :981-986.
Riblet, L.A., Taylor, D.P., Eison, M.S. and Stanton, H.C. (1982) Pharmacology and
neurochemistry of buspirone. J. Clin. Psychiatry 43(12, sect. 2): 11-16.
Riblet, L.A., Eison, A.S., Eison, M.S., Taylor, D.P., Temple, D.L. and
VanderMaelen, C.P. (1984) Neuropharmacology of buspirone. Psychopathology
17 (suppl. 3):69-78.
Richter-Levin, G., Greenberger, V. and Segal, M. (1994) The effects of general and
restricted serotonergic lesions on hippocampal electrophysiology and behavior.
Brain Res. 642:111-116.
Richter-Levin, G., Greenberger, V. and Segal, M. (1993) Regional specificity of raphe
graft-induced recovery of behavioral functions impaired by combined
serotonergic/cholinergic lesions. Exp. Neurol. 121 :256-260.
Ritchie, T., Kim, H.-S., Cole, R., deVellis, J. and Noble, E.P. (1988) Alcohol-induced
alterations in phosphoinositide hydrolysis in astrocytes. Alcohol 5: 183-187.
Roivainen, R., Hundle, B. and Messing, R.O. (1994) Protein kinase C and adaptation
to ethanol. EXS 71:29-38.
Rolls, E. (1975) The Brain and Reward. Pergamon Press, New York.
Rosen, L.B., Ginty, D.D. and Greenberg, M.E. (1995) Calcium regulation of gene
expression. In: Advances in Second Messenger and Phosphoprotein Reserch Vol.
30 (ed. A.R. Means), pp. 225-253. Raven Press, New York.
Roth, B.L., Hamblin, M.W. and Ciaranello, R.D. (1991) Developmental regulation of
5-HT2 and 5-HT1c mRNA and receptor levels. Dev. Brain Res. 58:51-58.
Rudge, J.S., Manthorpe M. and Varon, S. (1985) The output of neuronotrophic and

161
neurite-promoting agents from rat brain astroglial cells: a microculture method
for screening potential regulatory molecules. Dev. Brain Res. 19: 161-172.
Sandor, G.G., Smith, D.F., MacLeod, P.M. (1981) Cardiac malformations in the fetal
alcohol syndrome. J. Pediatr. 81: 771-773.
Savoy-Moore, R.T., Dombrowski, M.P., Cheng, A., Abel, E.A. and Sokol, R.J. (1989)
Low dose alcohol contracts the human umbilical artery in vitro. Alcohol. Clin.
Exp. Res. 13:40-42.
Schanne, F., Kane, A.B., Young, E.E. and Farber, J.L. (1979) Calcium dependence of
toxic cell death. Science 206:700-702.
Schapiro, M.B., Rosman, N.P. and Kemper, T.L. (1984) Effects of chronic exposure
to alcohol on the developing brain. Neurobehav. Toxicol. Teratol. 6:351-356.
Schenker, S., Dicke, J.M., Johnson, F.R., Hays, S.E. and Henderson, G.I. (1989)
Effect of ethanol on human placental transport of model amino acid and glucose.
Alcohol. Clin. Exp. Res. 13:112-119.
Schenker, S., Becker, H.C., Randall, C.L., Phillips, D.K., Baskin, G.S. and Henderson,
G.I. (1990) Fetal alcohol syndrome: current status of pathogenesis. Alcohol. Clin.
Exp. Res. 14:635-647.
Schmechel, D.E. and Rakic, P. (1979) A Golgi study of radial glial cells in developing
monkey telencephalon: Morphogenesis and transformation into astrocytes. Anat.
Embryo!. 156: 115-152.
Schmidt, M.J. and Sanders-Bush, E. (1971) Tryptophan hydroxylase activity in
developing rat brain. J. Neurochem. 18:2549-2551.
Segal, M. (1975) Physiological and pharmacological evidence for a serotonergic
projection to the hippocampus. Brain Res. 94: 115-131.
Segal, M. (1976) 5-HT antagonists in rat hippocampus. Brain Res. 103:161-166.
Sharma, A. and Rawat, A.K. (1989) Toxicological consequences of chloroquine and
ethanol on the developing fetus. Pharmacol. Biochem. Behav. 34:77-82.
Shaywitz, B.A., Griffieth, G.G. and Warshaw, J.B. (1979) Hyperactivity and cognitive
deficits in developing rat pups born to alcoholic mothers: An experimental model
of the expanded fetal alcohol syndrome (EFAS). Neurobehav. Toxicol. 1: 113-122.
Shemer, A.V., Azmitia, E.C. and Whitaker-Azmitia, P.M. (1991) Dose-related effects

162
of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal
density and behavior. Dev. Brain Res. 59:59-63.
Sikich, L., Hickok, J.M. and Todd, R.D. (1990) 5-HT1A receptors control neurite
branching during development. Dev. Brain Res. 56:269-274.
Singh, S.P., Snyder, A.K. and Eman, S. (1990) Effects of ethanol on hexose uptake by
cultured rat brain cells. Alcohol. Clin. Exp. Res. 14:741-745.
Singh, S.P., Srivenugopal, K.S., Ehmann, S., Yuan, X.-H. and Snyder, A.K. (1994)
Insulin-like growth factors (IGF-1 and IGF-11), IGF-binding proteins, and IGF
gene expression in the offspring of ethanol-fed rats. J. Lab. Clin. Med. 124: 183192.
Siniscalchi, A., Beani, L. and Bianchi, C. (1990) Different effects of 8-0H-DPAT, a 5HT1A receptor agonist, on cortical acetylcholine release, electrocortigram and
body temperature in guinea pigs and rats. Eur. J. Pharmacol. 175:219-223.
Sipe, J.C. and Moore, R. Y. (1977) The lateral hypothalamic area: an ultrasturucturel
analysis. Cell Tissue Res. 179: 177-196.
Slotkin, T.A., Schanberg, S.M. and Kuhn, C.M. (1980) Synaptic development in brains
of rats exposed perinatally to ethanol. Experientia 36: 1005-1007.
Smith, D.M. and Druse, M.J. (1982) Effects of maternal protein deficiency on synaptic
plasma membranes in offspring. Dev. Neurosci. 5:403-411.
Smith, L.M. and Peroutka, S.J. (1986) Differential effects of 5-hydroxytryptamine 1A
selective drugs on the 5-HT behavioral syndrome. Pharmacol. Biochem. Behav.
24:1513-1519.
Snyder, A.K., Singh, S.P. and Pullen, G.L. (1986) Ethanol-induced intrauterine growth
retardation correlation with placental glucose transfer. Alcohol. Clin. Exp. Res.
10: 167-170.
Snyder, A.K., Singh, S.P. and Ehmann, S. (1992) Effects of ethanol on DNA, RNA,
and protein synthesis in rat astrocyte cultures. Alcohol. Clin. Exp. Res. 16:295300.
Sokol, R.J. and Clarren, S.K. (1989) Guidelines for use of terminology describing the
impact of prenatal alcohol on the offspring. Alcohol. Clin. Exp. Res. 13:597-598.
Sonderegger, T.B., Calmes, H., Corbitt, S. and Zimmermann, E.G. (1982) Lack of
persistent effects of low dose ethanol administered postnatally in rats.

163
Neurobehav. Toxicol. Teratol. 4:463-468.

Soubrie, P., Montastruc, J.L., Bourgoin, S., Reisine, T., Artaud, F. and Glowinski, J.
(1981) In vivo wvidence for GABAergic control of serotonin release in the cat
substantia nigra. Eur. J. Pharmacol. 69:483-488.
Sprouse, J.S. and Aghajanian, G.K. (1987) Electrophysiological responses of
serotonergic dorsal raphe neurons to 5-HT1A and 5-HTrn agonists. Synapse 1:3-9.
Staiger, J.F. and Nurnberger, F. (1991) The efferent connections of the lateral septal
nucleus in the guinea pig: projections to the diencephalon and brainstem. Cell
Tissue Res. 264:391-413.
Stanley, M. Virgilio, J. and Gershon, S. (1982) Tririated imipramine binding sites are
decreased in the frontal cortex of suicides. Science 216: 1337-1339.
Stanley, M. and Mann, J.J. (1983) Increased serotonin-2 binding sites in frontal cortex
of suicide victims. Lancet 1:214-216.
Steinbusch, H.W.M., Van der Kooy, D., Verhofstad, A.A.J. and Pellegrine, A. (1980)
Serotonergic and non-serotonergic projections from the nucleus raphe dorsalis to
caudate-putamen complex in rat, studied by a combined immunofluorescence and
fluorescent retrograde axonal ladeling technique. Neurosci. Lett. 19: 137-142.
Steinbusch, H.W.M. (198la) Distribution of serotonin-immuno-reactivity in the central
nervous system in the rat cell bodies and terminals. Neuroscience 6:557-618.
Steinbusch, H.W.M., Nieuwenhuys, R., Verhofstad, A. A. J. and Van der Kooy, D.
(198lb) The nucleus raphe dorsalis of the rat and its projection upon the
caudatoputamen. A combined cytoarchitectonic, immunohistochemical and
retrograde transport study. J. Physiol. (Paris) 77:157-174.
Steinhausen, H.-C., Willms, J. and Spohr, H.-L. (1993) Long-term psychopathological
and cognitive outcome of children with fetal alcohol syndrome. J. Am. Acad.
Child Adolesc. Psychiatry 32:990-994.
Stoltenburg-Didinger, G. and Spohr, H.L. (1983) Fetal alcohol syndrome and mental
retardation: spine distribution of pyramidal cells in prenatal alcohol-exposed rat
cerebral cortex; a Golgi study. Dev. Brain Res. 11:119-123
Streissguth, A.P., Herman, C.S. and Smith, D.W. (1978) Intelligence, behavior and
dysmorphogenesis in the fetal alcohol syndrome: a report on 20 patients. J.
Pediatr. 92:363-367.

164

Streissguth, A.P.,Landesman-Dwyer, S.L., Martin, J.C. and Smith, D.W. (1980)
Teratonic effects of alcohol in humans and laboratory animals. Science 209:353361.
Streissguth, A.P., Clarren, S.K. and Jones, K.L. (1985) Natural history of the fetal
alcohol syndrome: a ten-year follow-up of eleven patients. Lancet 4:85-92.
Streissguth, A.P., Sampson, P.D., Barr, H.M., Clarren, S.K. and Martin, D.C. (1988)
Studying alcohol teratogenesis from the perspective of the fetal alcohol syndrome:
methodological and statistical issues. Ann. N. Y. Acad. Sci. 477:63-86.
Streissguth, A.P., Barr, H.M. and Sampson, P.D. (1990) Moderate prenatal alcohol
exposure:Effects on child IQ and learning problems at age 7.5 years. Alcohol.
Clin. Exp. Res. 14:662-669.
Streissguth, A.P., Aase, I.M. Clarren, S.K., Randels, S.P., Ladue, R.A. and Smith D.
F. (1991) Fetal alcohol syndrome in adolescents and adults. JAMA 265:19611967.
Swanson, L.W. and Cowan, W.M. (1979) The connections of the septal region in the
rat. J. Comp. Neurol. 186:621-656.
Swartzwelder, H.S., Farr, K.L., Wilson, W.A. and Savage, D.D. (1988) Prenatal
exposure to ethanol decreases physiological plasticity in the hippocampus of the
adult rat. Alcohol 5: 121-124.
Sze, P. Y. (1980) Glucocorticoids as a regulatory factor for brain tryptophan hydroxylase
during development. Dev. Neurosci. 3:217-223.
Tajuddin, N. and Druse, M.J. (1989) Chronic maternal ethanol consumption results in
decreased serotonergic 5-HT1 sites in cerebral cortical reigons from offspring.
Alcohol 5:465-470.
Tajuddin, N. and Druse, M.J. (1989a) Effects of in utero ethanol exposure on cortical
5-HT2 binding sites. Alcohol 5:461-464.
Tajuddin, N.F. and Druse, M.J. (1993) Treatment of pregnant alcohol-consuming rats
with buspirone: effects on serotonin and 5-hydroxyindoleacetic acid content in
offspring. Alcohol. Clin. Exp.Res. 17: 110-114.
Tan, S.E., Berman, R.F., Abel, E.L. and Zajac, C.S. (1990) Prenatal alcohol exposure
alters hippocampal slice electrophysiology. Alcohol 7: 507-511.
Taylor, A.N., Branch, B.J. Liu, S.H. and Kokka, N. (1982) Long-term effects of fetal

165
ethanol exposure on pituitary-adrenal responses to stress. Pharmacol. Biochem.
Behav. 16:585-589.
Taylor, A.N., Branch, B.J. Cooley-Matthews, B. and Poland, R.E. (1982a) Effects of
maternal ethanol consumption on basal and rhythmic pituitary-adrenal function in
neonatal offspring. Psychoneuroendocrinology 7:49-58.
Taylor, A.N., Branch, B.J., Nelson, L.R., Lane, L.A. and Poland R.E. (1986) Prenatal
ethanol and ontogeny of pituitary-adrenal responses to ethanol and morphine.
Alcohol 3:255-259.
Teiltelbaum, P. and Epstein, A.N. (1962) The lateral hypothalamic syndrome: recovery
of feeding and drinking after lateral hypothalamic lesions. Psycho!. Rev. 69:7490.
Tissari, A.H. (1973) Serotoninergic mechanisms in ontogenesis. In: Fetal Pharmacology
(ed. L. Boreus), pp. 237-253. Raven Press, New York.
Tong, J.H. and Kaufman, S. (1975) Tryptophan hydroxylase: purification and some
properties of the enzyme from rabbit hindbrain. J. Biol. Chem. 250:4152-4158.
Tork, I. (1990) Anatomy of the serotonergic system. Ann. N. Y. Acad. Sci. 600:9-34.
Torres-Aleman, I., Naftolin, F. and Robbins R.J. (1990) Neuroscience 35:601-608.
Trent, F. and Tepper, J.M. (1991) Dorsal raphe stimulation modifies striatal-evoked
antidromic invasion of nigral dopaminergic neurons in vivo. Exp. Brain Res.
84:6620-630.
Turner, B.H. (1973) A sensorimotor syndrome produced by lesions of the amygdala and
lateral hypothalamus. J. Comp. Psycho!. 82:37-47.
Tze, W.J. and Lee, M. (1975) Adverse effects of maternal alcohol consumption on
pregnancy and fetal growth in rats. Nature 257:479-480.
Urban, J.H., Van de Kar, L.D., Lorens, S.A. and Bethea, C.L. (1986) Effect of the
anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and
unstressed rats. Pharmacol. Biochem. Behav. 25:457-462.
Van de Kar, L.D. (1991) Neuroendocrine pharmacology of serotonergic neurons. Annu.
Rev. Pharmacol. Toxicol. 31:289-320.
Van der Kooy, D. and Hattori, T. (1980) Dorsal raphe cells with collateral projections
to the caudate-putamen and substantia nigra: a fluorescent retrograde double

166
labeling study in the rat. Brain Res. 186: 1-7.
VanderMaelen, C.P., Matheson, G.K., Wilderman, R.C. and Patterson, L.A. (1986)
Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic
administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J.
Pharmacol. 129: 123-130.
Verge, D., Davi, G., Patey, A., Gozlan, H., El Mestikawy, S. and Hamon, M. (1985)
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and /or dendrities but
not terminals are of 5-HT1A subtype. Eur. J. Pharmacol. 113:463-464.
Verge, D., Davi, G., Marcinkiewicz, M., Patey, A., El Mestikawy, S., Gozlan, H. and
Hamon, M. (1986) Quantitative autoradiography of multiple 5-HT 1 receptor
subtypes in the brain of control and 5,7-DHT treated rats. J. Neurosci. 6:34743482.
Voigt, M.M., Laurie, D.J., Seeburg, P.H. and Bach, A. (1991) Molecular cloning and
characterization of a rat brain cDNA encoding a 5-hydroxytryptamine-lB
receptor. EMBO J. 10:4017-4023.
Volk, B. (1977) Delayed histogenesis in the 'embryofetal alcohol syndrome'. Acta.
Neuropathol. (Berl) 39: 157-163.
Volk, B. ( 1984) Cerebellar histogenesis and synaptic maturation following pre- and
postnatal alcohol administration: an electron-microscopic investigation of the rat
cerebellar cortex. Acta Neuropathol. (Berl) 63:57-65.
Volk, B., Maletz, J., Tiedemann, M., Mall, G., Klein, C. and Berlet, H.H. (1981)
Impaired maturation of Purkinje cells in the fetal alcohol syndrome of the rat:
light and electron microscopic investigation. Acta Neuropathol. (Berl) 54: 19-29.
Vorhees, C. V. and Butcher, R.E. (1982) Behavioural terarogenicity. In: Developmental
Toxicology (ed. K. Snell), pp. 249-297. Croom-Helm, London.
Waeber, C., Dietl, M.M., Hoyer, D., Probst, A. and Palacios, J.M. (1989) 5-HT 1
receptors in the vertebrate brain. Regional distribution examined by
autoradiography. Naunyn Schmiedebergs Arch. Pharmacol. 340:486-494.
Waeber, C., Hoyer, D. and Palacios, J.M. (1989a) 5-HT3 receptors in the human brain,
autoradiographic visualisation using [3H]ICS 205-930. Neuroscience 31:393-400.
Walicke, P.A. (1989) Novel neurotrophic factors, receptors and oncogenesis. Annu. Rev.
Neurosci. 12: 103-126.

167
Walicke, P., Cowan, W.M., Ueno, N., Baird, A. and Guillemin, R. (1986) Fibroblast
growth factor promotes survival of dissociated hippocampal neurons and enhances
neurite extension. Proc. Natl. Acad. Sci. USA 83:3012-3016.
Walker, D.W., Heaton, M.B., Smothers, C.T. and Hunter, B.E. (1990) Chronic ethanol
ingestion reduces the trophic activity contained in rat hippocampus. Alcohol. Clin.
Exp. Res. 14:350
Wallace, J.A. and Lauder, J.M. (1983) Development of the serotonergic system in the
rat embryo: an immunocytochemical study. Brain Res. Bull. 9:550-604.
Walsh, M., Truitt, E. and Davis, V.E. (1970) Acetaldehyde mediation in the
mechanisms of ethanol-induced changes in norepinephrine metabolism. Mo!.
Pharmacol. 6:416-424.
Waltman, R. and Iniquez E.S. (1972) Placental transfer of ethanol and its elimination at
term. Obstet. Gynecol. 40: 180-185.
Wang, R. Y. and Aghajanian, G.K.(1977) Inhibition of neurons in the amygdala by dorsal
raphe stimulation: Mediation theough a direct serotonergic pathway. Brain Res.
120:85-102.
Weathersbee, P.S. and Lodge, J.R. (1978) A review of ethanol's effects on the
reproductive process. J. Reprod. Med. 21:63-78.
Weinberg, J. (1988) Hyperresponsiveness to stress: Differential effects of prenatal
ethanol on males and females. Alcohol. Clin. Exp. Res. 12:647-652.
Weinberg, J. (1989) Prenatal ethanol exposure alters adrenocortical development of
offspring. Alcohol. Clin. Exp. Res. 13:73-83.
Weinberg, J. and Bezio, S. (1987) Alcohol-induced changes in pituitary-adrenal activity
during pregnancy. Alcohol. Clin. Exp. Res. 11:274-280.
West, J.R., Hodges, C.A. and Black, A.C., Jr. (1981) Prenatal exposure to ethanol
alters the organization of hippocampal mossy fibers in rats. Science 211:957-959.
West, J.R., Hamre, K.M. and Pierce, D.R. (1984) Delay in brain development induced
by alcohol in artificially reared rat pups. Alcohol 1:213-222.
Whitaker, M. (1995) Regulation of the cell division cycle by inositol triphosphate and
the calcium signaling pathway. In: Advances in Second Messenger and
Phosphoprotein Reserch Vol. 30 (ed. A.R. Means), pp. 299-310. Raven Press,
New York.

168
Whitaker-Azmitia, P.M. and Azmitia, E.C. (1986) Autoregulation of fetal serotonergic
neuronal development: role of high affinity serotonin receptors. Neurosci. Lett.
67:307-312.
Whitaker-Azmitia, P.M. and Azmitia, E.C. (1986a) [3H]5-hydroxytryptamine binding to
brain astroglial cells: differences between intact and homogenized preparations
and mature and immature cultures. J. Neurochem. 46: 1186-1189.
Whitaker-Azmitia, P.M., Lauder, J.M., Shemmer, A. and Azmitia, E.C. (1987)
Postnatal changes in serotonin1 receptors following prenatal alterations in serotonin
levels: further evidence for functional fetal serotonin 1 receptors. Dev. Brain Res.
33:285-289.
Whitaker-Azmitia, P.M., Murphy, R. and Azmitia, E.C. (1990) Stimulation ofastroglial
5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters
astroglial morphology. Brain Res. 528: 155-158.
Whitaker-Azmitia, P.M., Clarke, C. and Azmitia, E.C. (1993) Localization of 5-HT 1A
receptors to astroglial cells in adult rats: implications for neuronal-glial
interactions and psychoactive drug mechanism of action. Synapse 14:201-205.
Wilke, N., Sganga, M., Barhite, S. and Miles, M.F. (1994) Effects of alcohol on gene
expression in neural cells. EXS 71:49-59.
Williams, J. and Davies J.A. (1983) The involvement of 5-hydroxytryptamine in the
release of dendritic dopamine from slices of rat substantia nigra. J. Pharrn.
Pharrnacol. 35 :734-737.
Yakel, J.L. and Jackson, M.B. (1988) 5-HT3 receptors mediate rapid responses in
cultured hippocampus and a clonal cell line. Neuron 1:615-621.
Yocca, F.D., Hyslop, D.K., Taylor, D.P. and Maayani, S. (1986) Buspirone and
gepirone: partial agonists at the 5HT1A receptor linked to adenylate cyclase (AC)
in rat and guinea pig hippocampal preparations. Fed. Proc., Fed. Am. Soc. Exp.
Biol. 45:436.
Young, W.S. III., and Kuhar, M.J. (1979) A new method for receptor autoradiography:
[3H]-opoid receptors in rat brain. Brain Res. 179:255-270.
Young, S.H. and Poo, M.M. (1983) Spontaneous release of transmitter from growth
cones of embryonic neurons. Nature 305:634-637.
Zeisel, S.H., Mauron, C., Watkins, C.J. and Wurtman, R.J. (1981) Developmental
changes in brain indols, serum tryptophan and other serum neutral amino acids

169
in the rat. Dev. Brain Res. 1:551-564.

VITA

The author, Jung-Ae Kim, was born in Pusan, South Korea on March 8, 1963 to
Dahesa Bae and Kee Joo Kim.
In March, 1983, Mrs. Kim entered Pusan National University in Pusan, S. Korea,
receiving the degree of Bachelor of Science in Pharmacy in February, 1987. In January,
1991, she entered the Neuroscience Program, Loyola University Chicago, Maywood,
Illinois. In January, 1992, she joined the laboratory of Mary J. Druse Manteuffel, Ph.D.,
where she began to study the underlying mechanisms by which in utero ethanol exposure
causes developmental abnormalities of the serotonergic system in rat brain. Mrs. Kim was
a teaching assistant for the Medical Neuroscience course during 1992-1993.

170

APPROVAL SHEET

The dissertation submitted by Jung-Ae Kim has been read and approved by the following
committee:
Dr. Mary Druse Manteuffel, Director
Professor, Molecular and Cellular Biochemistry
Stritch School of Medicine, Loyola University Chicago
Dr. Michael A. Collins
Professor, Molecular and Cellular Biochemistry
Stritch School of Medicine, Loyola University Chicago
Dr. Lydia L. Don Carlos
Assistant Professor, Cell Biology, Neurobiology and Anatomy
Stritch School of Medicine, Loyola University Chicago
Dr. Mary A. Emanuele
Professor, Medicine and Molecular and Cellular Biochemistry
Stritch School of Medicine, Loyola University Chicago
Dr. Louis, D. Van De Kar
Professor, Pharmacology
Stritch School of Medicine, Loyola University Chicago
The final copies have been examined by the director of the dissertation and the signature
which appears below verifies the fact that any necessary changes have been incorporated
and that the dissertation is now given final approval by the Committee with reference to
content and form.
The dissertation is therefore accepted in partial fulfillment of the requirements for the
degree of Doctor of Philosophy.

··fl/a :9';~)(.t.·2.._ ~/Y(b._fi.i<'c-//.. l
Date

/

Directof s Signature

